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ABSTRACT 
Diabetes is a major metabolic disease affecting 382 million people worldwide. It is 
characterized by high levels of blood glucose and results from defective insulin production, 
impaired insulin action or both. Type 2 diabetes is the most common form of diabetes, with 
insulin resistance being its early stage. Insulin is a key hormone regulating blood glucose 
levels by promoting the utilization of glucose in muscle and fat while shutting off glucose 
production from the liver. When there is a defect in insulin signal transduction, these tissues 
are less responsive to insulin action and become insulin resistant. Liver is a major tissue for 
glucose metabolism and is prone to insulin resistance at an early stage. Liver is also a central 
organ for the metabolism of proteins and lipids. This thesis investigated whether alterations in 
protein degradation pathways may impact on insulin signal transduction in the liver and the 
mechanism involved. 
Poor diet is one of the major contributors to insulin resistance. Over consumption of food high 
in fat or carbohydrate has been shown to impair insulin action in both animals and humans. 
Although both high-fat diet and high-carbohydrate diet can result in an accumulation of lipids 
to interfere with insulin signal transduction, the mechanisms and pathways involved are 
different. This thesis focused on the crosstalk of pathways in relation to the pathogenesis of 
hepatic insulin resistance, especially in the context of over consumption of a lipogenic 
carbohydrate, namely fructose. Dietary fructose is a primary source of sweetener used in soft 
drinks and bakery products that can be commonly found in the form of simple fructose, high 
fructose corn syrup (HFCS) or intermediate metabolite of sucrose. Unlike fat or other 
nutrients, fructose is almost entirely cleared at the first pass in the liver after absorption. It has 
been recognised that accumulation of lipids outside the fat depots (ectopic lipids) is a main 
culprit for insulin resistance. Recently, studies suggest that multiple pathways may also be at 
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the interplay to impact on insulin signal transduction in the process of lipid accumulation. One 
of the suggested mechanisms is endoplasmic reticulum (ER) stress, resulting from an 
accumulation of unfolded proteins in the ER. ER stress triggers unfolded protein response 
(UPR) as a protective mechanism to inhibit protein synthesis and promote protein folding and 
degradation. This process is pivotal to resolve the stress and maintain a protein homeostasis in 
the cell under physiological conditions. However, prolonged and unresolved ER stress may 
disturb insulin signal transduction via activating inflammatory pathways or promoting lipid 
accumulation. Therefore this thesis aimed to investigate 1) the role of ER stress in high-fat 
diet- and high-fructose diet-induced insulin resistance in the liver; 2) whether protein 
degradation pathways are altered along with ER stress and associated insulin resistance; 3) 
whether interventions on the protein degradation pathways can correct the above metabolic 
disorders. 
The role of ER stress was first investigated in two mouse models of insulin resistance and 
hepatic steatosis produced by a high-fat diet (HFat) or a high-fructose diet (HFru) to mimic 
the over-consumption of fat or carbohydrate commonly occurring in humans. The results in 
Chapter 3 show that while both models developed insulin resistance and hepatic steatosis, ER 
stress and upregulated lipogenesis only occurred in the liver of HFru-fed mice. Subsequent 
studies in HFru-fed mice found that ER stress occurred prior to lipogenesis and was able to 
inhibit insulin signalling in the absence of hepatic steatosis. This was associated with an 
activation of c-Jun N-terminal kinase (JNK) and IκB kinase (IKK), which have been 
suggested to disrupt insulin signal transduction by phosphorylating the serine sites of key 
proteins of the insulin signalling pathway. Consistent with this proposed mechanism, an 
increase in the serine-phosphorylation of insulin receptor substrate (IRS)1 was observed. 
These data indicate that dietary fructose leads to insulin resistance through a different 
  
xv 
mechanism from that of dietary fat, involving induction of ER stress and activation of 
inflammatory pathways. 
To investigate the role of protein degradation in ER stress and associated insulin resistance 
induced by HFru feeding, two major protein degradation pathways were examined, namely 
autophagy and ubiquitin proteasome system (UPS). Chapter 4 describes my studies on 
autophagy, a “self-eating” process to clear off damaged intracellular components including 
unfolded/misfolded proteins and lipid droplets. Hepatic autophagy was suppressed along with 
increased ER stress during HFru (but not HFat) feeding. Therefore, further studies on the 
autophagy pathway were conducted in HFru-fed mice, in which I detected an activation of 
mammalian target of rapamycin (mTOR), a key repressor of autophagy. A time-course study 
revealed that similar changes in mTOR-autophagy pathway occurred as early as 2 hours after 
HFru feeding, prior to ER stress and steatosis. These results suggest HFru-mediated 
suppression of autophagy via activation of mTOR may be a primary cause of ER stress. To 
test this hypothesis, I restored autophagy using rapamycin, spermidine and resveratrol during 
HFru feeding. As expected, ER stress and associated activation of JNK/IKK were abolished 
and along with this, insulin signal transduction was improved. These data highlight the crucial 
role of autophagy in ER stress and insulin resistance in the context of high carbohydrate 
consumption and also provide a proof-of-concept to target autophagy for the treatment of 
these metabolic disorders. 
The studies described in Chapter 5 investigated the role of two E3 ubiquitin ligases (part of 
the UPS pathway) in ER stress, namely neural precursor cell expressed developmentally 
down-regulated protein 4 (Nedd4) and Nedd4-2. I first measured the expression of these two 
proteins in the liver of HFat- and HFru-fed mice and observed an increased expression in 
Nedd4-2 but not Nedd4 in association with ER stress. The upregulation of Nedd4-2 was 
further examined in mouse embryonic fibroblasts (MEFs), an ER stress responsive cell line. 
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After the treatment with ER stress inducers tunicamycin and thapsigargin, there was a 
dramatic elevation in a number of ER stress markers in these cells. At the same time, protein 
expression of Nedd4-2 was also increased. Further analysis showed a close correlation 
between Nedd4-2 and an ER stress effector, X-box binding protein 1 (XBP1), suggesting that 
Nedd4-2 may be regulated by XBP1. This was confirmed by knockdown of XBP1 in human 
embryonic kidney (HEK)293 cells using siRNAs, where reduced Nedd4-2 expression was 
observed. These results suggest Nedd4-2 is upregulated by ER stress, likely via activation of 
XBP1. Furthermore, in HEK293 cells, knockdown of Nedd4-2 exacerbated ER stress while 
overexpression of Nedd4-2 reduced thapsigargin-induced ER stress. Since autophagy was 
shown to play a crucial role in ER stress in Chapter 3, autophagy was measured in these cells. 
Interestingly, autophagy was found to be inhibited in Nedd4-2 deficient cells and activated in 
Nedd4-2 overexpressing cells. Collectively, these results suggest that ER stress upregulates 
Nedd4-2 to activate autophagy and this upregulation can protect against ER stress. 
In summary, studies from this thesis provide strong evidence that protein degradation 
pathways are involved in ER stress and insulin resistance. This pathogenic mechanism 
appears to be an exclusive response to lipogenic HFru rather than a bulk accumulation of 
ectopic lipids (e.g. HFat feeding). Defective autophagy or UPS pathways can result in ER 
stress and impairment in insulin signalling. Conversely, stimulation of these protein 
degradation pathways is able to resolve ER stress and attenuate impaired insulin signalling. 
The findings from this thesis identify the interactions of these protein degradation pathways 
with the insulin signalling pathway beyond their previously recognised roles in protein 
metabolism. These studies also provide a scientific rationale for targeting the degradation 
pathways for the treatment of hepatic insulin resistance and associated metabolic disorders 
resulting from over consumption of dietary carbohydrates.  
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2 
1.1 DIABETES 
Diabetes mellitus, or simply referred to as diabetes, is a major metabolic disease characterized 
by high levels of blood glucose (hyperglycaemia). According to the current WHO diagnostic 
criteria, plasma glucose ≥ 7.0 mmol/l (126 mg/dl) after an overnight fast or 2-hour plasma 
glucose ≥ 11.1 mmol/l (200 mg/dl) after glucose ingestion is regarded as diabetic [1]. 
1.1.1 Epidemiology and economic burden 
Globally, diabetes afflicts at least 387 million people at present and this number is estimated 
to increase by 55% by the year of 2035, reaching 592 million. In 2014, diabetes resulted in 
4.9 million deaths, making it the 7th leading cause of death. The prevalence and chronic nature 
of this incurable disease and its associated complications have caused heavy social and 
economic burdens alike for all countries, with global costs of least USD 612 billion (IDF 
DIABETES ATLAS, 6th Edition, 2014). 
In Australia, it was reported that 1.7 million people had diabetes in 2012 (Australian Diabetes, 
Obesity and Lifestyle Study, 2012), accounting for 8.4% of the population. Additionally, 
approximately 280 people develop diabetes every day and by 2033 it is estimated that 3.3 
million people will suffer from diabetes in Australia [2]. In 2013, there were a total number of 
9,765of diabetes related deaths and the annual cost for each diabetic patient is about USD 
6,473 (IDF DIABETES ATLAS, 6th Edition, 2014). 
1.1.2 Classification of diabetes, pathogenesis and complications  
The primary clinical symptom of diabetes is hyperglycemia which results from insufficient 
insulin secretion and/or ineffective use of insulin by the body. According to the etiologic 
classification, type 1 and type 2 diabetes are the two major types of diabetes [3]. Type 1 
diabetes, also termed as “insulin dependent diabete
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deficiency. The primary culprit of type 1 diabetes is an autoimmune system-induced 
destruction of pancreatic β cells [4]. It was estimated that 60-80% of the pancreatic β cells 
have already been destroyed by the time of clinical symptoms appear [5]. Type 1 diabetes is 
usually diagnosed in children or young adults under the age of 30 (although it can occur at 
any age), thus it is also referred to as juvenile diabetes. The precise cause of type 1 diabetes is 
still unknown. However, a number of factors have been associated with the disease, including 
genetic susceptibility, viral infection, and dietary factors such as exposure to cow milk, wheat 
proteins and vitamin D [6, 7]. 
Type 2 diabetes, previously described as “non-insulin dependent diabetes”, is the most 
common type of diabetes and can account for 90-95% of all diabetic patients [8]. It is 
characterised by insulin resistance in combination with successive reduction in insulin 
secretion. A 25-year follow-up study has found that the development of type 2 diabetes can be 
preceded and predicted by insulin resistance [9]. Impaired glucose tolerance (IGT) and/or 
impaired fasting glucose (IFG) are regarded as pre-diabetes, an early stage of type 2 diabetes 
[10]. At this stage, glucose levels do not yet match the criteria for diabetes, but are higher than 
normal levels (according to WHO recommendation, Table 1.1). Studies have suggested IGT 
is primarily caused by insulin resistance, while IFG is mainly due to insufficient insulin 
secretion and dysregulated hepatic glucose production [11, 12]. 
Table 1.1 WHO diagnostic criteria for diabetes and intermediate hyperglycemia. 
Stage Diagnostic criteria 
Impaired fasting glucose 
 
 
Fasting plasma glucose 6.1 to 6.9 mM 
         and  
2-h plasma glucose* <7.8 mM 
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Impaired glucose tolerance 
 
 
Fasting plasma glucose <7.0 mM 
 and 
2-h plasma glucose ≥7.8 mM and <11.1 mM 
Diabetes 
 
 
Fasting plasma glucose ≥7.0 mM 
  or 
2-h plasma glucose ≥11.1 mM 
*Venous plasma glucose 2-h after ingestion of 75g oral glucose load 
According to the natural history of type 2 diabetes, the occurrence of insulin resistance 
precedes insulin deficiency [13]. Insulin is a glucose-lowering hormone secreted by 
pancreatic β cells in the islets of Langerhans and is released into the blood stream upon a rise 
of blood glucose. Insulin acts at muscle and adipose tissue to promote glucose uptake; at the 
same time, it also inhibits glucose production from the liver. Therefore, insulin secretion is 
negatively correlated with insulin sensitivity and is elevated with insulin resistance [14]. 
Insulin resistance is a condition where the body becomes less responsive to insulin. To 
compensate for insulin resistance, more insulin is produced, thus leading to hyperinsulinaemia. 
This hyper secretion of insulin causes a heavy burden to β cells and is worsened as insulin 
resistance deteriorates. Eventually, β cells are exhausted. [15, 16]. Once β cells fail to produce 
sufficient insulin to meet the increased demand of insulin resistance, hyperglycaemia (type 2 
diabetes) emerges. 
Owing to hyperglycaemia and other associated conditions such as hypertension and 
dyslipidemia, people with diabetes have much higher risks of developing other diseases, 
which are referred to as diabetic complications. These complications can be classified as 
“microvascular disease” (including diabetic nephropathy, neuropathy and retinopathy) or 
“macrovascular disease” (including coronary artery disease, peripheral arterial disease and 
stroke) [17, 18]. Damage to blood vessels and organs from chronic hyperglycemia is a major 
cause of morbidity and mortality in diabetic patients. In most developed countries, diabetes is 
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a leading cause of cardiovascular disease, blindness, kidney failure and lower limb 
amputation (International Diabetes Federation, IDF). Acutely, diabetes also causes metabolic 
disorders such as ketoacidosis, a potentially fatal complication that primarily arises from 
elevated levels of ketone bodies due to the lack of insulin [19]. 
 
1.2 INSULIN RESISTANCE 
Insulin resistance is a fundamental disorder of the metabolic syndrome (or insulin resistance 
syndrome) the patients of also have high risks of developing dyslipidaemia, high blood 
pressure, and coronary heart disease [20]. During insulin resistance, the body needs higher 
levels of insulin to maintain normal blood glucose. Therefore, elevated fasting insulin levels 
can be used as diagnostic measurement [21]. Diagnosis of insulin resistance can also be 
facilitated by a glucose tolerance test (GTT), where a certain amount of glucose is given to the 
subject and blood glucose level is measured after 2 hours to estimate the efficacy of glucose 
clearance. However, as high levels of insulin can also compensate for reduced glucose 
clearance, the gold-standard method to measure insulin resistance is hyperinsulinemic-
euglycemic clamp. In this method, insulin is infused at a constant rate to achieve a steady-
state hyperinsulinemia. At the same time, glucose is infused to maintain blood glucose at a 
normal level (between 5 mM and 5.5 mM). The difference in glucose infusion rate indicates 
insulin sensitivity at the whole-body level [22, 23]. 
At the tissue level, the physiological role of insulin in glucose and lipid metabolism includes: 
1) stimulation of glucose uptake into muscle and adipose tissue by facilitating the 
translocation of glucose transporter 4 (GLUT4) to the plasma membrane; 2) inhibition of 
glucose production from liver by suppressing glycogenolysis and gluconeogenesis; 3) 
promotion of glycogen synthesis largely in liver and muscle; and 4) stimulation of glucose 
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incorporation into lipids in liver and adipose tissue. These functions of insulin are carried out 
by the insulin signalling pathway in the cell as described below [24]. 
1.2.1 Insulin signalling pathway for glucose metabolism 
 
Figure 1.1 A schematic diagram of insulin signalling cascades for glucose metabolism. 
The binding of insulin to the insulin receptor (IR) allows the recruitment and tyrosine 
phosphorylation of insulin receptor substrate (IRS) proteins. IRS proteins activate 
phosphoinositol 3-kinase (PI3K), which catalyses the conversation of phosphatidylinositol 
4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 can recruit 
Akt to plasma membrane where Akt is activated by phosphoinositide-dependent kinase 1 
(PDK1). In muscle cells and adipocytes, activated Akt can promote glucose transport by 
facilitating the translocation of GLUT4 vesicles to the plasma membrane; in liver and muscle 
cells, activated Akt can promote glycogen synthesis by inhibiting glycogen synthase kinase 3 
(GSK3) and relieving the repression of GSK3 on glycogen synthase (GS); in liver cells, 
activated Akt can suppress gluconeogenesis by inhibiting Forkhead box protein O1 (FoxO1), 
a transcriptional regulator for two key enzymes for gluconeogenesis, namely glucose 6-
phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK). 
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Due to the focus of this thesis, only part of insulin signalling cascades that involve 
phosphoinositol 3-kinase (PI3K) will be discussed. As shown in Fig. 1.1, the insulin 
signalling cascade is initiated by the binding of insulin to the insulin receptor (IR). IR is a 
transmembrane protein that belongs to the family of tyrosine kinase receptors. This binding 
leads to the conformational changes of IR, stimulating the autophosphorylation (tyrosine sites) 
and activation of the intrinsic tyrosine kinase activity. These changes result in the recruitment 
of insulin receptor substrate (IRS) proteins via tyrosine phosphorylation. IRS proteins 
subsequently bind to the p85 regulatory subunit of phosphoinositol 3-kinase (PI3K) via its Src 
homology 2 (SH2) domain. This is followed by the recruitment of the catalytic p110 subunit 
and activation of PI3K [25-27]. PI3K catalyses the phosphorylation of the 3-position hydroxyl 
group of the inositol ring of phosphatidylinositol (PI) and converts phosphatidylinositol 4,5-
bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3), which is an important 
second messenger on plasma membrane [28]. PIP3 then recruits cytosolic protein kinase Akt 
(or protein kinase B, PKB) to the plasma membrane [29] to form a complex with constitutive 
membrane threonine kinase phosphoinositide-dependent kinase 1 (PDK1), where PDK1 
phosphorylates Akt at Thr308 in its activation loop. Meanwhile, Akt is also phosphorylated at 
Ser473 in the hydrophobic C-terminal regulatory domain, likely by mTOR [30]. 
Phosphorylation of both Thr308 and Ser473 is essential for the complete activation of Akt 
[31]. 
The insulin-mediated phosphorylation of Akt plays a crucial role in glucose metabolism 
through the effector molecules. In muscle and fat cells, activated Akt phosphorylates TBC1 
domain family member 4 (TBC1D4, also known as AS160), which stimulates the 
translocation of GLUT4 vesicles to the plasma membrane [32]. While these vesicles are fused 
with the plasma membrane, GLUT4 transporters are also inserted and serve as channels for 
the entry of glucose into these cells. In liver and muscle cells, Akt phosphorylates and inhibits 
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glycogen synthase kinase 3 (GSK3) [33], which negatively regulates glycogen synthesis 
through the suppression of glycogen synthase (GS). GS is a key enzyme in glycogenesis that 
converts glucose into glycogen. By diminishing the inhibitory effects of GSK3, Akt promotes 
glycogen synthesis and glucose utilization. Furthermore, Akt also mediates the 
phosphorylation and inhibition of transcriptional protein, Forkhead box protein O1 (FoxO1) 
in liver. Activated (non-phosphorylated) FoxO1 is localized in the nucleus, where it binds to 
the promoter of its target genes and regulates their expression [34]. Once phosphorylated by 
proteins like Akt, FoxO1 is excluded out of the nucleus and degraded in the cytosol. FoxO1 
degradation leads to a decrease in its transcriptional activity and a downregulation of glucose 
6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK), two rate-limiting 
enzymes in gluconeogenesis [34]. Gluconeogenesis is the de novo synthesis of glucose from 
the three-carbon substrates (such as lactate and alanine) and is a major metabolic pathway for 
hepatic glucose output. Insulin suppresses gluconeogenesis through Akt-FoxO1 signalling 
cascade. On the other hand, glycogenolysis, the breakdown of glycogen into glucose, is also 
inhibited by Akt through the activation of mTOR and subsequent inhibition of glycogen 
phosphorylase in both liver and muscle [35]. 
1.2.2 Diet-induced insulin resistance 
The pathogenesis of insulin resistance is multifactorial. Dietary composition, sedentary 
lifestyle and genetic background can all contribute to insulin resistance [36, 37] and type 2 
diabetes [38-40]. In particular, Western diet with high fat and carbohydrate content is a most 
common dietary factor causing these metabolic disorders. There has been strong evidence 
suggesting overconsumption of high energy diet is strongly correlated with high degree of 
insulin resistance [41]. In addition, dietary compositions such as high fat and carbohydrate 
content also play a role in the generation of insulin resistance, which can be independent of 
energy consumption. 
Chapter 1 – Introduction and Literature Review 
 
9 
Dietary fat Dietary fat has long been implicated in the etiology of insulin resistance and 
glucose intolerance. Early studies can date back to the 1930s, when Himsworth H.P. fed 
rabbits a high-fat diet and observed subsequent glucose intolerance and impaired insulin 
action in glucose clearance [42]. This association was confirmed in a later study using a 
hyperinsulinemic-euglycemic technique in combination with glucose tracers in rats, showing 
that high-fat feeding resulted in severe insulin resistance with reduced glucose disposal in 
skeletal muscle and adipose tissue, as well as elevated glucose output from liver [43]. In 
humans, a study carried out in non-diabetic Pima Indian and Caucasian populations 
demonstrated that a 14-day modern high-fat diet, when compared with traditional Pima diet 
(low in fat content), resulted in a decrease in oral glucose tolerance in association with 
suppressed insulin-mediated glucose disposal [44]. Similarly, after 11 days of high-fat diet 
consumption, healthy subjects displayed hepatic insulin resistance with an apparent 
impairment in the suppression of glucose production, although no difference in glucose 
uptake in peripheral tissues was observed [45]. Long-term dietary fat intake was also revealed 
to be negatively correlated with insulin sensitivity in both lean and obese adults [46]. In 
agreement with these findings, after the consumption of a reduced fat diet for 1 year, patients 
with insulin resistance significantly improved their glucose tolerance [47]. Of interest, 
different species of fatty acids also exert distinct roles in insulin resistance. A study using 
different compositions of dietary fat has revealed that insulin sensitivity was impaired in 
subjects receiving a high saturated fatty acid (SFA) diet, but not a high monounsaturated fatty 
acid (MUFA) diet [48]. Adverse effects of dietary SFAs have also been observed in animals 
[49, 50]. Apart from saturation status, the length of dietary fatty acids also accounts for the 
differential effects on insulin sensitivity. It appears that the SFA-induced insulin resistance is 
mainly confined to long-chain SFAs [51], whereas medium-chain SFAs may even have 
beneficial effects and increase insulin-mediated glucose disposal in both diabetic and non-
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diabetic individuals [52]. Consistently, studies in mice and rats also found that long-chain 
fatty acids significantly reduced insulin sensitivity [53, 54] while this effect was diminished 
[53] or abrogated [54] by replacing with medium-chain fatty acids. In addition, dietary 
supplementation of short-chain fatty acids has also been shown to prevent insulin resistance in 
mice [55]. 
Dietary fructose Excessive consumption of refined carbohydrates is another dietary factor of 
insulin resistance. Apart from the contribution to the increase in total calorie intake, a study 
has shown the prevalence of diabetes is positively associated with the consumption of corn 
syrup [56], which is a sweetener made from the starch of corn. It was estimated that corn 
syrup represented over 20% of the total daily carbohydrate intake and 10% of the daily total 
energy intake at the end of last century [56]. As fructose tastes sweeter than glucose or 
sucrose, commercial production of high fructose corn syrup (HFCS) from common corn syrup 
was introduced in 1967. Through enzyme-catalyzed isomerization of glucose to fructose, the 
resultant HFCS usually contains 42%-90% fructose. HFCS, together with sucrose (a 
disaccharide composed of glucose and fructose from cane or beet) are the primary sources of 
fructose from diets. Globally, the average sugar consumption per capita has increased by 16% 
over the past 20 years [57]. It has long been known that high level of fructose (14%-35% total 
energy content) ingestion can lead to insulin resistance in animals and humans [43, 57-61]. 
Simply replacing starch with sucrose of the same calorie content (35%) in the diet resulted in 
insulin resistance in rats, as determined by reduced glucose infusion rate from 
hyperinsulinemic-euglycemic clamps [62]. Sucrose is broken down into glucose and fructose 
after absorption and the detrimental effect of sucrose on insulin action largely comes from 
fructose. A follow-up study pinpointed fructose but not glucose in mediating the impairment 
of hepatic glucose production and peripheral glucose disposal [59]. Similar findings have 
been reported in hamsters fed a high-fructose diet or a high-sucrose diet for 2 weeks where 
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only the high-fructose diet-fed animals displayed reduced glucose disappearance rate [60]. 
Dietary fructose also has the same effects on insulin action in humans. Seven-day 
consumption of a diet comprised of 33% energy obtained from fructose resulted in a 
significant reduction in both insulin binding activity and insulin sensitivity in healthy young 
subjects compared to those on a glucose diet [63]. In overweight or obese humans, 
consumption of 25% fructose beverage for 8 weeks impaired glucose tolerance with a 
dramatic decline in the insulin sensitivity index, while such effects were not observed with 
glucose beverage consumption [64]. A recent study has shown that even moderate amount of 
fructose (80 g/day, ~14% of total energy) intake can lead to an increase in the endogenous 
glucose production from liver at basal stage and during a hyperinsulinemic-euglycemic clamp, 
although insulin-mediated glucose clearance remained unchanged. In contrast, consumption 
of the same amount of glucose or sucrose did not have such effects [61]. In summary, studies 
in animals and humans have clearly shown a detrimental effect of fructose on insulin 
sensitivity in the liver within a relatively short period of time. This is consistent with the fact 
that fructose is almost entirely metabolised in the liver [57]. A limited number of studies in 
animals indicate that prolonged feeding with a diet rich in fructose may eventually result in 
insulin resistance in muscle as well, possibly due to a liver-driven hyperlipidemia [65]. 
Hepatic insulin resistance Liver is one of the three major tissues (muscle, fat and liver) for 
insulin-mediated glucose handling and also a unique organ where glucose can both be utilized 
and produced. During fasting, blood glucose levels are maintained by increased glucose 
production from the liver through glycogenolysis and gluconeogenesis. Hepatic insulin 
sensitivity is strongly associated with the area under the curve (AUC) during the first 30 min 
of the oral glucose tolerance test (OGTT) in humans [66] and defects in hepatic insulin 
signalling by liver-specific insulin receptor knockout also led to systemic insulin resistance in 
mice [67]. It is interesting to note that under both high-fructose and high-fat feeding 
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conditions, insulin resistance appears to occur in the liver first [68, 69]. This is likely due to 
the crucial role of liver in both carbohydrate and lipid metabolism. 
After an oral ingestion of glucose, the glucose uptake in the liver of healthy subjects can 
increase 6 fold under the resultant combination of hyperinsulinemia and hyperglycemia [70]. 
Meanwhile, glucose production from liver is also suppressed to encounter the rise of blood 
glucose [70, 71]. These contributions from liver are even higher after fructose ingestion 
compared to glucose. Following intestinal absorption via glucose transporter (GLUT)5, 
fructose is transported through the portal vein to the liver where GLUT2 facilitates its entry. 
Unlike glucose, fructose catabolism is primarily initiated by fructokinase, which converts 
fructose to fructose-1-phosphate and liver is the major metabolic tissue expressing this 
enzyme [72]. Hexokinase, which can be found in most metabolic tissues including skeletal 
muscle and heart, can also catalyse fructose phosphorylation, converting fructose to fructose-
6-phosphate [73]. However, due to the substantially low affinity, there is much less chance for 
this reaction to occur in vivo. Therefore, fructose is almost entirely metabolised in the liver. 
The resultant fructose-1-phosphate is further hydrolysed by fructose-1-phosphate aldolase and 
eventually yields glyceraldehyde-3-phosphate. Glyceraldehyde-3-phosphate can be further 
utilized in tricarboxylic acid cycle (TCA) to generate energy; alternatively, it can also be used 
as a substrate to produce glucose or triglycerides. 
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Figure 1.2 Fructose metabolism in the liver 
Liver is also heavily involved in the catabolism of dietary lipids. Most dietary lipids appear in 
the form of triglycerides, which need to be broken down into fatty acids and glycerol before 
absorbed by intestine. In the intestine, triglycerides are resynthesized and ultimately 
assembled into chylomicrons to enter the systemic circulation from the lymphatic system. 
Triglycerides within the chylomicrons can be hydrolysed by lipoprotein lipase in the 
endothelium of various tissues including liver, muscle, and adipose tissue. The resultant fatty 
acids can be taken up by these tissues for utilization. Then chylomicron remnants are formed 
and liver is responsible for the removal of these remnant particles from the circulation [74]. 
The multifunctional role of liver renders itself susceptible to environmental challenges, such 
as an overload of nutrients. The molecular mechanisms by which dietary fat and carbohydrate 
lead to the impairment of insulin action involve dysregulated lipid metabolism and ER stress 
in particular, which will be reviewed in Sections 1.3 and 1.4 respectively. 
 
1.3 LIPID METABOLISM 
Lipid metabolism is an important biological process for maintaining energy homeostasis. In 
response to nutrition oversupply, surplus energy is stored primarily in the form of 
triglycerides (fat); while under nutrition deficit, triglycerides can be catabolised and used as 
sources for energy. Adipose tissue is the major site for lipid storage, but once the net energy 
exceeds the storage capacity of adipose tissue, excess lipids can “overflow” to tissues that 
normally contain little triglycerides. The deposition of triglycerides in non-adipose tissue such 
as liver and muscle is termed as ectopic lipid accumulation, which is a determinant of tissue-
specific insulin resistance [75]. For example, studies in transgenic mice found that site-
specific overexpression of lipoprotein lipase in liver or muscle induced lipid accumulation in 
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these tissues, which is associated with insulin resistance [76, 77]. Moreover, surgical 
implantation of adipose tissue into mice with lipotrophic diabetes was able to reduce liver 
triglycerides and improve hepatic insulin sensitivity and whole body glucose tolerance [78]. 
In contrast, removal of adipose tissue from healthy hamsters induced severe hepatic steatosis, 
which was inversely co-related with hepatic insulin sensitivity and glucose tolerance [79]. In 
humans, 8 weeks of high energy diet consumption resulted in dramatic elevation in 
intrahepatic lipids, measured by Magnetic Resonance Imaging (MRI). This was associated 
with a marked increase in hepatic glucose production and reduction in insulin sensitivity [80]. 
Studies using Nuclear Magnetic Resonance (NMR) spectroscopy also showed lipid content in 
muscle is inversely correlated with insulin sensitivity [81] and intramyocellular abnormalities 
of lipid metabolism are associated with whole body insulin resistance [82, 83]. Furthermore, 
reductions in ectopic lipids are accompanied with the reversal of insulin resistance. For 
example, weight loss by a hypocaloric diet dramatically reduced triglycerides and normalized 
insulin sensitivity in the liver of diabetic patients [84]. Reduction in intramyocellular 
triglycerides was also found to be associated with reversal of insulin resistance in muscle due 
to weight loss [85].  
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Figure 1.3 A schematic diagram of the disruption of lipids on insulin signalling. (A) In 
muscle, fatty acids are usually obtained from plasma and converted into long-chain fatty acid 
acyl-CoAs (LCCoAs). LCCoAs act as precursor for key lipid metabolic intermediates such as 
diacylglycerol (DAG) and ceramides. DAG can activate protein kinase C (PKC)θ, which is a 
Ser/Thr kinase and inhibits insulin receptor substrate 1 (IRS1) via Ser/Thr phosphorylation. 
This inhibitory phosphorylation disrupts the interaction between IRS1 and PI3K and leads to 
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the suppression of Akt. In addition, ceramides can also suppress Akt through 
dephosphorylation. As a result, Akt-mediated glucose transporter (GLUT) 4 translocation and 
glucose uptake are inhibited. At the same time, phosphorylation of glycogen synthase kinase 
(GSK) is reduced, leading to the suppression of glycogen synthase (GS) and glycogen 
synthesis. (B) In liver, LCCoAs can be obtained from plasma or de novo synthesis. In 
comparison to muscle, DAG activates the ε form of PKC in the liver. Activated PKCε can 
directly inhibit insulin receptor (IR). DAG and ceramides-mediated suppression of Akt also 
inhibits GSK phosphorylation and glycogen synthesis in the liver. Meanwhile, suppression of 
Akt activates Forkhead box protein O (FoxO)1, leading to the upregulation of glucose 6 
phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) and 
gluconeogenesis. Adapted from Savage D.B. et al. Physiol Rev. 2007 [86]. 
 
As discussed in Section 1.2.1, insulin-stimulated tyrosine phosphorylation of IRS and 
downstream PI3K activation is crucial for insulin action. These signalling cascades have been 
shown to be impaired in association with insulin resistance after lipid infusion in both humans 
[87] and animals [88], suggesting defective insulin signalling can be responsible for lipid-
induced insulin resistance. It was further revealed that the impairment in insulin signalling can 
be regulated by diacylglycerol/ceramide-mediated protein kinase C (PKC) activation (Fig. 1.2) 
[89]. Diacylglycerol (diglyceride) is a precursor of triglyceride consisting of two fatty acid 
chains and a glycerol molecule. It is a lipid intermediate that can be derived from the 
hydrolysis of triglyceride or de novo synthesis from glycerol-3-phosphate and long chain fatty 
acyl-CoA (LCCoA). Diacylglycerol can bind to novel PKCs (nPKCs, including PKCθ in 
muscle and PKCε in liver) and promote their translocation from cytosol to plasma membrane, 
where these PKCs phosphorylate IRS1 at serine sites. This serine-phosphorylation of IRS1 
impairs the its interaction with PI3K and impairs the subsequent signal transduction in 
response to insulin [89]. Ceramides is another species of lipid intermediate, composed of 
sphingosine and fatty acids. They can be synthesized de novo from fatty acid-CoAs and 
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serines. Similar to the action of diacylglycerol, ceramides can inhibit insulin signal 
transduction via activating atypical isoform of PKC, PKCζ. Additionally, ceramides have also 
been shown to directly inhibit insulin-mediated Akt phosphorylation by activating protein 
phosphatase 2A (PP2A) [90]. 
In summary, accumulation of ectopic lipids from dysregulated lipid metabolism is a major 
cause of insulin resistance and it mainly comes from two sources: increased lipid synthesis 
(e.g. dietary carbohydrate) and/or reduced fatty acid oxidation [91]. 
1.3.1 Triglyceride synthesis 
Biosynthesis of triglycerides mainly happens in liver and adipose tissue. This involves the 
generation of fatty acids and glycerol, and the esterification of these two moieties to produce 
triglycerides. Through consumption of dietary fat, both fatty acids and glycerol can be 
obtained from the lipase-catalysed hydrolysis of triglycerides (lipolysis). Conversely, dietary 
carbohydrate cannot directly provide fatty acids or glycerol and both of them need to be 
synthesized de novo, predominantly in the liver and adipose tissue [92].  
Fatty acid synthesis The synthesis of fatty acids using acetyl-CoA as substrate is termed as de 
novo lipogenesis. This process is directly regulated by a number of enzymes. The first step 
occurs in the cytosol, where acetyl-CoA is carboxylated by acetyl-CoA carboxylase (ACC) to 
form malonyl-CoA. Catalysed by fatty acid synthase (FAS), two carbons from acetyl-CoA are 
successively added onto malonyl-CoA, which eventually forms palmitic acid, a saturated fatty 
acid of 16 carbons. Further elongated of the fatty acid chain is catalysed by elongation of very 
long chain fatty acids protein (ELOVL), while desaturated bonds are added by stearoyl-CoA 
desaturase (SCD) [93]. 
Triglyceride synthesis Subsequent reactions of glycerol-3-phosphate and fatty acid occur in 
the endoplasmic reticulum. Glycerol-3-phosphate is firstly esterified by fatty acid CoA at C1 
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position in a reaction catalysed by glycerol-3-phosphate acyltransferase (GPAT) to form 
lysophosphatidic acid. The latter is then acylated at C2 position with another fatty acid CoA 
by acylglycerophosphate acyltransferase (AGPAT) to form phosphatidic acid. At the next 
stage, a key intermediate−diacylglycerol is produced via the removal of the phosphate group 
from phosphatidic acid, a process catalysed by phosphatidic acid phosphohydrolase (PAP). 
Finally, the diacylglycerol is acylated again at C3 position by diacylglycerol acyltransferase 
(DGAT) to form the triacylglycerol, or triglyceride. 
Ceramide synthesis In the ER, palmitoyl-CoA can also react with serine to form 3-
ketodihydrosphingosine, catalysed by palmitoyl transferase. 3-ketodihydrosphingosine is then 
reduced to dihydrosphingosine via the action of 3-ketodihydrosphingosine reductase, which is 
followed a dihydroceramide synthase-mediated acylation to produce dihydroceramide. At the 
final step, dihydroceramide is unsaturated by the enzyme dihydroceramide desaturase 1 to 
form ceramides. 
Regulation of lipid synthesis The expression of ACC, FAS, ELOVL6, and SCD1 from de 
novo lipogenesis is under the synergistic regulation of sterol regulatory element binding 
protein 1 (SREBP-1) and carbohydrate-responsive element-binding protein (ChREBP), which 
have been shown to be activated by carbohydrate, fatty acids and insulin in mice [94]. Both 
SREBP-1 and ChREBP are predominately expressed in the liver and adipose tissue, which are 
the two major sites for lipogenesis.  
SREBP-1 is a member of the basic helix-loop-helix leucine zipper transcription factor family 
that binds to the sterol regulatory element (SRE) in the promoter region of lipogenic genes. It 
is originally synthesized as full-length precursor and resides in the ER membrane as a 
complex with SREBP-cleavage activating protein (SCAP) and the insulin-induced gene 
(Insig). Once activated, SCAP undergoes conformational changes and disassociates from 
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Insig to facilitate the translocation of SREBP-1 precursor to the Golgi apparatus. In Golgi, 
SREBP-1 precursor is cleaved by site-1 protease (S1P) and site-2 protease (S2P) to release the 
N-terminal domain and turns into the mature form (mSREBP-1) [95]. mSREBP-1 translocates 
into the nucleus to regulate the expression of a series of key enzymes that involves in de novo 
lipogenesis including ACC, FAS, ELOVL6 and SCD1 [94], as well as enzymes that regulate 
triglyceride synthesis including GPAT and DGAT [96]. In skeletal muscle and adipose tissue 
of humans, the activity of SREBP-1 has been shown to be stimulated by insulin, which can 
enhance the binding affinity of SREBP-1 to the promoter region [97]. Complex 1 of the 
mammalian target of rapamycin (mTORC1) has been suggested to play a critical role in this 
process [98]. Apart from insulin, simple carbohydrates, such as fructose, sucrose and glucose 
have also been shown to induce SREPB-1 expression in an insulin-independent manner in 
mice [99]. Interestingly, fructose appears to have more potent effect in the upregulation of 
SREBPs than glucose in mice [100]. In contrast, dietary fatty acids such as polyunsaturated 
fatty acids (PUFAs) have been shown to suppress SREBP-1 mRNA expression as well as its 
maturation [101, 102]. The transcriptional activity of SREBP-1 is also under the regulation of 
a number of nuclear receptors. It has been reported that peroxisome proliferator-activated 
receptor α (PPARα) activation can directly enhance SREBP-1 promoter activity in vivo [103]. 
This effect is additive to its capability of promoting SREBP-1 cleavage and maturation [104]. 
Another important nuclear receptor Liver X receptor (LXR) has also been shown to activate 
SREBP-1 via increasing its promoter activity [105]. 
ChREBP belongs to the same protein family as SREBP-1. ChREBP binds to the carbohydrate 
response element (ChRE) and has been shown to be stimulated by glucose and cAMP in vitro 
[106]. Similar to SREBP-1, ChREBP also directly binds to the promoter of lipogenic proteins 
ACC and FAS and regulates the expression of these genes in hepatocytes [107]. A recent 
study suggested that the expression of other key enzymes in triglyceride synthesis including 
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SCD1, ELOVL6 and GPAT are also under the regulation of ChREBP in the liver of mice 
[108]. Activity of ChREBP is coordinated by nutrients and other transcriptional factors. Cell 
studies have shown that glucose can upregulate ChREBP mRNA expression and facilitate its 
translocation from the cytosol to the nucleus [109, 110]. In contrast, dietary fatty acids like 
PUFAs can suppress ChREBP activity by increasing ChREBP mRNA decay and inhibiting 
the protein translocation [111]. Besides nutrients, activation of LXR can also enhance 
ChREBP gene expression and modulates ChREBP activity [112]. 
Some of these lipogenic enzymes or transcriptional factors can also be regulated at post- 
transcriptional levels. For example, in animals AMPK is known to suppress ACC activity via 
an inhibitory phosphorylation [113]. A recent study in mice has found that AMPK can also 
phosphorylate SREBP-1 at Ser372 site to inhibit its proteolytic processing and transcriptional 
activity [114]. More recently, it has been suggested that lipogenesis may be influenced by ER 
stress and the detailed relationship between these two will be reviewed in Section 1.4.2. 
1.3.2 Fatty acid oxidation 
The major element of lipid as source of energy is fatty acids released from triglycerides 
through lipolysis. Free fatty acids are oxidized to generate NADH/FADH2 and acetyl CoA. 
The latter can enter citric acid cycle for further energy generation. Both liver and skeletal 
muscle are active sites for fatty acid oxidation, which takes place in various organelles in the 
form of β-oxidation, α-oxidation and ω-oxidation. Among them, β-oxidation in mitochondria 
is the major type of oxidation in mammals [115]. Prior to β-oxidation, free fatty acids need to 
be activated to enter mitochondria. This step occurs in the cytosol, where fatty acids are 
conjugated with coenzyme A (CoA) in a reaction catalysed by acyl-CoA ligases. The resultant 
fatty acyl-CoAs diffuse through the outer mitochondrial membrane and is further transported 
across the inner mitochondrial membrane with the assistance of carnitine acyltransferases. 
Once inside the mitochondrial matrix, fatty acyl-CoAs can be oxidized. β-oxidation is the 
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generation of acetyl-CoA by consecutive removal of 2-carbon units from the fatty acyl-CoA 
chain at β-carbon position. This involves four major steps: 1) two hydrogens are removed 
from fatty acyl-CoA by acyl-CoA dehydrogenases to form a double bond between C2 and C3 
and upon receiving the two hydrogens, flavin adenine dinucleotide (FAD) is converted to 
FADH2; 2) product from the first reaction is hydrated by enoyl CoA hydratase at the double 
bond to form 3-L-hydroxyacyl CoA; 3) the hydroxyl group is converted into keto group by 3-
L-hydroxyacyl-CoA dehydrogenase while another two hydrogens are transferred to 
nicotinamide adenine dinucleotide (NAD+) to form NADH; 4) the terminal acetyl-CoA group 
on the 3-ketoacyl CoA molecule is cleaved by β-ketothiolase to produce an acetyl-CoA and a 
new fatty acyl-CoA which is two carbons shorter. This process continues until the entire chain 
is broken down into acetyl CoA units to generate NADH/FADH2 for mitochondrial respiration 
to produce energy either stored in ATP or released as heat. 
 
1.4 ENDOPLASMIC RETICULUM STRESS 
In the past decade, a number of studies have suggested a causative role of endoplasmic 
reticulum (ER) stress in type 2 diabetes [116-119]. ER is a multifunctional organelle in all 
eukaryotic cells. It is categorized as smooth endoplasmic reticulum (SER) and rough 
endoplasmic reticulum (RER). The SER is involved in lipid synthesis, carbohydrate 
metabolism and calcium homeostasis, while the RER, with ribosomes attached onto its outer 
membrane, is a major site for protein synthesis and protein folding. During translation, newly 
synthesized polypeptide chains begin to fold into three-dimensional structure in the ER lumen 
with the assistance of molecular chaperones and then transported to the Golgi apparatus for 
further modification. Proper folding of proteins is monitored and ensured by the quality 
control machinery. When protein unfolding occurs, the lectin-type chaperones calnexin and 
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calreticulin can facilitate the refolding of immature glycoproteins to reach their native 
conformation. Terminally unfolded proteins in the ER are retrotranslocated to the cytoplasm 
and disposed by the ER-associated degradation (ERAD). This machinery can be affected by 
changes in ER environment such as temperature and calcium concentration, or protein 
overloading that exceeds the ER folding capacity. When the quality control mechanisms are 
overwhelmed, unfolded proteins and protein aggregates accumulate in the ER, causing ER 
stress [120].  
ER stress has been found in tissues that are active in protein and lipid synthesis, such as liver, 
pancreas, brain and adipose tissue. Chronic ER stress can lead to neurodegenerative diseases 
including Alzheimer’s disease, Parkinson’s disease, as well as metabolic diseases including 
cardiovascular diseases, non-alcoholic fatty liver disease and diabetes [121]. In type 2 
diabetes, ER stress is found to be associated with both β cell dysfunction and insulin 
resistance. Disruption of proinsulin conformation by mutation in the insulin 2 gene has also 
been shown to induce ER stress, which results in severe apoptosis of β cells and development 
of type 2 diabetes in mice, known as Akita diabetic mice [122]. Diabetes in Akita mice can be 
reversed through the attenuation of ER stress and consequent improvement in β cell function 
by pharmacological agents [123]. In type 2 diabetic patients, ER stress has also been observed 
in the pancreatic autopsy [124] as well as isolated β cells after exposure to glucose [116]. For 
the past decade, ER stress has also been suggested to be an important mechanism underlying 
insulin resistance apart from ectopic lipid accumulation, particularly in the liver. In high-fat 
diet-fed mice and ob/ob mice with insulin resistance, ER stress has been observed in liver and 
adipose tissue but not in muscle [118]. In obese humans with insulin resistance, ER stress is 
also present in liver and adipose tissue [125, 126] and improvement of insulin sensitivity by 
weight loss is accompanied with the reversal of ER stress indicators [125]. More importantly, 
in diet-induced and genetic animal models of insulin resistance, treatment of chemical 
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chaperones 4-phenyl butyric acid (PBA) and taurine-conjugated derivative (TUDCA) has 
been reported to alleviate ER stress, normalize hyperglycemia and restore insulin action in 
liver, muscle and adipose tissue [119]. Similar effects can also be achieved by overexpression 
of molecular chaperones such as 78-kDa glucose-regulated protein (Grp78) [127] and 150-
kDa oxygen-regulated protein (ORP150) [117]. In obese humans, TUDCA or PBA therapy 
for 2-4 weeks results in marked increase in insulin sensitivity [128, 129] and improvement in 
β cell functions [128]. 
1.4.1 Unfolded protein response (UPR) 
ER stress can be experimentally induced by disrupting ER-Golgi trafficking (with brefeldin 
A), depleting ER calcium stores (with thapsigargin), inhibiting N-linked glycosylation (with 
tunicamycin), inhibiting disulfide bond formation (with dithiothreitol) or directly 
overexpressing unfolded proteins [130]. ER stress triggers an adaptive mechanism−unfolded 
protein response (UPR) to alleviate ER stress and restore ER homeostasis. This is achieved by 
arresting protein translation, upregulating molecular chaperone expression and facilitating 
unfolded protein degradation. These functions are mainly carried out through three canonical 
pathways initiated by three ER-resident transmembrane proteins, namely inositol-requiring 
protein 1 (IRE1), PKP-like endoplasmic reticulum kinase (PERK), and activating 
transcription factor 6 (ATF6). When unfolded proteins accumulate in the ER lumen, Grp78 
dissociates from IRE1, PERK and ATF6 to facilitate the folding process. Consequently, this 
dissociation allows the activation of these three mediators (Fig. 1.3) [131].  
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Figure 1.4 Classic pathways in unfolded protein response (UPR). Accumulation of 
unfolded proteins triggers ER stress, which initiates the UPR as an adaptive mechanism. The 
UPR dissociates the molecular chaperone 78-kDa glucose-regulated protein (Grp78) from its 
binding partners, including inositol-requiring protein 1 (IRE1), PKP-like endoplasmic 
reticulum kinase (PERK), and activating transcription factor 6 (ATF6). Unbound Grp78 can 
facilitate protein folding in the ER lumen. Meanwhile, this dissociation activates the master 
proteins PERK, IRE1 and ATF6, which initiate three canonical pathways aiming to attenuate 
translation and to enhance protein folding and degradation. Adapted from Flamment M. et al. 
Trends Endocrinol Metab. 2012 [132]. 
 
IRE1 IRE1 is composed of a luminal ER stress-sensing domain and a cytoplasmic domain 
that has both serine/threonine kinase activity and endoribonuclease activity. There are two 
isoforms of IRE1 in mammalian cells, IRE1α and IRE1β. The former is ubiquitously 
expressed [133] while the latter has only been reported in intestine and lung [134, 135]. Upon 
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sensing ER stress, Grp78 is released from the binding site and the luminal domain of IRE1 
undergoes dimerization, allowing the cytoplasmic domains to be close to the ER membrane. 
This change facilitates transautophosphorylation of IRE1 kinase domain, which in turn 
activates the endoribonuclease domain [136]. The endoribonuclease activity of IRE1 is 
essential for the activation of X-box binding protein 1 (XBP1), which is a basic leucine zipper 
(bZIP) transcriptional factor that regulates a number of UPR genes. Maturation of XPB1 
requires a non-conventional mRNA splicing where IRE1 endoribonuclease initiates the 
removal of a 26 nucleotide intron from XBP1 mRNA, producing a larger form of XPB1. The 
unspliced form of XPB1 (uXPB1) is inactivate, whereas the spliced form (sXBP1) is able to 
translocate into the nucleus and bind to ER stress response element (ERSE) that contains UPR 
gene promoters. Known targets of sXBP1 include molecular chaperones (e.g. Grp78) and 
genes involved in ER associated protein degradation (ERAD) [130]. In addition, activated 
IRE1 binds the adaptor protein TNF receptor associated factor 2 (TRAF2) to activate 
apoptosis signal-regulating kinase 1 (ASK1), which subsequently phosphorylates and 
activates c-Jun N-terminal kinase (JNK) [137]. 
PERK Similar to IRE1, PERK is also a serine/threonine protein kinase with a ER stress-
sensing luminal domain. Upon dissociation from Grp78, PERK is activated through 
oligomerization in ER membrane and transautophosphorylation [138]. Activated PERK 
subsequently phosphorylates the α-subunit of eukaryotic translational initiation factor 2 
(eIF2α), leading to its inactivation and global translation attenuation [139]. However, 
translation of activating transcription factor 4 (ATF4) is selectively upregulated by eIF2α 
phosphorylation. ATF4 is a member of the bZIP family of transcription factors. It induces the 
expression of genes involved in amino acid biosynthesis and transport, anti-oxidative stress 
response, and apoptosis, such as growth arrest and DNA damage 34 (GADD34) [140] and 
C/EBPα-homologous protein (CHOP or GADD153) [141]. At the late stage of ER stress, 
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prolonged CHOP activation can trigger apoptosis through the downregulation of anti-
apoptotic protein B cell lymphoma 2 (Bcl2) [141].  
ATF6 ATF6 is another bZIP-containing transcription factor. Two isoforms, ATF6α and 
ATF6β are both ubiquitously expressed. Functionally, ATF6α is heavily involved in the 
regulation of UPR genes whereas none of such gene target has been identified with ATF6β. In 
response to ER stress, the dissociation of Grp78 allows ATF6 trafficking to the Golgi 
complex, where ATF6 is cleaved by two proteases, site-1 protease (S1P) and site-2 protease 
(S2P) [142]. Like XBP1, only the cleaved form of ATF6 translocates to the nucleus, where it 
binds to ERSE in the promoter of UPR genes. Known target genes of ATF6α include 
chaperone protein Grp78, protein disulphide isomerase (PDI) and ER degradation-enhancing 
α-mannosidase-like protein 1 (EDEM1) [143]. 
UPR is an adaptive mechanism to maintain cellular homeostasis and cell survival. However, 
unresolved or prolonged activation of the UPR pathways can impair insulin signal 
transduction and cause insulin resistance. The molecular mechanism by which UPR activation 
leads to defective insulin action is complex and most research has pointed to the critical role 
of ER stress-induced inflammation, which will be reviewed in detail in Section 1.5.2. 
1.4.2 UPR and lipid metabolism 
ER is the major organelle where lipid metabolism, especially lipid synthesis, occurs as many 
of the enzymes reside in the ER. UPR activation in response to ER stress stimuli can lead to 
dysregulation of lipid metabolism and ectopic lipid accumulation. It has been reported that ER 
stress induced by homocysteine can lead to hepatic steatosis with increased triglycerides and 
cholesterols in both cultured cells and mouse liver. These changes are associated with the 
activation of SREBPs and can be abolished by overexpression of molecular chaperone Grp78 
[144]. In another study, Grp78 overexpression in the liver of ob/ob mice attenuates ER stress 
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and inhibits SREBP-1c maturation, which leads to a reduction in the expression of SREBP 
target genes. As a consequence, liver triglyceride and cholesterol contents are reduced and 
insulin action is improved [127]. 
IRE1 plays a key role in maintaining lipid homeostasis. Genetic ablation of IRE1 in the liver 
results in moderate steatosis in chow fed mice, which is exacerbated after the induction of ER 
stress. This is accompanied by increased expression of lipogenic transcription regulators 
peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer-binding protein β 
(C/EBPβ), ChREBP, and LXRα, as well as their targets genes DGAT2, ACC1 and SCD1 
[145]. Furthermore, IRE1 downstream effector XPB1 is suggested to have an independent 
role in lipogenesis. Site-specific deletion of XBP1 in the liver results in downregulation of 
lipogenic enzymes (such as DGAT2, SCD1, and ACC2), and induces hypocholesterolemia 
and hypotriglyceridemia, suggesting that XBP1 is required for lipid synthesis in the liver 
[146]. sXBP1 has also been shown to interact with the promoter of the SREBP-1c gene and 
induce the expression of SREBP-1c and FAS [147]. In adipocytes, evidence also shows 
sXPB1 is important for adipogenesis, where it binds to the promoter of key adipogenic factor 
CCAAT-enhancer-binding protein β (C/EBPβ) and upregulates its expression [148].  
PERK is suggested to be essential for lipogenesis in adipocytes and mammary epithelial cells. 
It is shown that SREBP maturation is dependent on Insig1 translation attenuation, which is 
induced in PERK and eIF2α-dependent manner. PERK deletion in mammary epithelium 
inhibits the expression of lipogenic enzymes such as FAS, SCD1 and ATP citrate lyase (ACL). 
Consequently, triglyceride and fatty acid contents are reduced in the PERK-deficient 
mammary gland [149]. Genetic deletion of ATF4, downstream of PERK in mice results in 
reduced white adipose tissue mass and cell volume, which comes from reduced lipogenesis 
and enhanced lipid catabolism. In white adipose tissue of ATF4 knockout mice, the 
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expression of key lipogenic proteins SREBP-1c, FAS and SCD1 are suppressed. Meanwhile, 
lipolysis is enhanced, measured by elevated glycerol release rate, increased hormone-sensitive 
lipase (HSL) activity as well as upregulated Atgl and Perilipin A expression. Genes that are 
responsible for fatty acid β-oxidation including pparα, cpt1, aco1 and mcad are all 
significantly upregulated in the white adipose tissue of ATF4 knockout mice [150]. 
The third branch of UPR, ATF6, may also play an important role in lipid metabolism under 
certain conditions. In the liver of ATF6α knockout mice, induction of ER stress with 
tunicamycin results in triglyceride and cholesterol accumulation as well as lipid droplet 
formation. This is attributed to impaired fatty acid β-oxidation, due to the reduction in 
expression of PPARα, CPT-II and acyl-CoA oxidase-1 (Acox-1); and suppressed lipoprotein 
secretion caused by the decrease in Apolipoprotein B-100 (ApoB-100) expression [151, 152]. 
Interestingly, de novo lipogenesis in the liver of ATF6α knockout mice was suppressed and to 
a degree similar to the control littermates after tunicamycin injection [152]. However, ATF6 
does not seem to play a role in de novo lipogenesis induced by high-fructose diet [153] or 
activation of PPARα [69]. 
 
1.5 INFLAMMATION 
Inflammation is a protective response of the body’s immune system in reaction to harmful 
stimuli, such as pathogens or injury [154]. It has long been known that inflammation is 
associated with insulin resistance. In 1988, Svenson KL et al. reported that patients with 
active rheumatoid arthritis had a significant reduction in insulin sensitivity measured by 
glucose clearance rate. The impairment in insulin sensitivity was improved after 1 week of 
treatment with anti-inflammatory corticosteroids [155]. The concept of integration of 
inflammation with metabolic diseases started with a publication by Hotamisligil et al. in 1993, 
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which directly linked inflammation to insulin resistance [156]. In this study, they found a 
dramatic induction of tumor necrosis factor α (TNFα) gene expression in adipose tissue from 
obese and insulin resistant animals (ob/ob mouse, db/db mouse and fa/fa Zucker rat), while 
neutralization of TNFα in fa/fa Zucker rat resulted in a marked increase in insulin-stimulated 
glucose disposal into peripheral tissues. In later studies, elevated TNFα expression was also 
observed in the adipose tissue [157] and muscle of insulin resistant subjects [158]. Apart from 
TNFα, other inflammatory cytokines such as interleukin 6 (IL6), resistin and visfatin have 
gradually been identified as messengers between inflammation and metabolism [159-161]. A 
later study found that these cytokines can be released from macrophages and therefore, 
infiltration of macrophages was suggested to play a key role in insulin resistance in animal 
models of diet-induced and genetic obesity [162]. 
It is now generally believed that insulin resistance is associated with low grade and chronic 
inflammation. Mechanistic studies have identified several inflammatory pathways which may 
interfere with insulin signal transduction and lead to insulin resistance [163, 164]. As 
described in Section 1.2.1, phosphorylation of the tyrosine residues in insulin receptor 
substrates (IRS) is essential for insulin signal transduction. Several serine/threonine kinases 
from these inflammatory pathways commonly phosphorylate IRS at serine/threonine residues 
[164], and this phosphorylation inhibits the tyrosine phosphorylation of IRS in response to 
insulin, resulting in the inhibition of IRS-initiated downstream events [165]. c-Jun N-terminal 
kinases (JNK) and inhibitor of NF-κB kinase (IKK) are two well-characterised inflammatory 
kinases that interfere with insulin signalling by this mechanism. 
JNK belongs to the mitogen-activated protein kinase (MAPK) family and there are three 
isoforms: JNK1, JNK2 and JNK3. JNK 1 and 2 are ubiquitously expressed while JNK3 is 
mainly found in the brain [166]. JNK can be activated by cytokines like TNFα and interleukin 
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1 (IL1) and environmental stresses. Activated JNK regulates the transcription activity of 
activator protein-1 (AP-1) proteins including c-Jun, JunB and activating transcription factor 2 
(ATF2). JNK also phosphorylates IRS1 at serine 307 site and inhibits insulin-stimulated IRS1 
tyrosine phosphorylation, which can be abolished by mutation of serine 307 to alanine of IRS-
1 [163]. JNK activity is shown to be elevated in the liver, muscle and adipose tissue of obese 
mice with insulin resistance [167]. Genetic deletion of JNK1 results in reduced IRS1 serine 
phosphorylation and improved insulin sensitivity with enhanced insulin signalling in both 
genetic and dietary mouse models of obesity [167]. In the liver of obese and diabetic mice, 
local expression of dominant-negative JNK is able to reverse insulin resistance and lower 
fasting blood glucose levels. Consistently, expression of wild type JNK in the liver of normal 
mice results in reduced insulin sensitivity and glucose intolerance [168].  
IKK is an enzyme complex consisting three subunits, namely IKKα, IKKβ and IKKγ. IKK 
can positively regulate nuclear factor-κB (NF-κB), a transcriptional factor activated in 
response to inflammation. Under basal condition, NF-κB stays inactive in the cytoplasm by 
forming a complex with inhibitory proteins known as inhibitors of NF-κB (IκB). Stress or 
other environmental stimuli can activate IKK through phosphorylation. Activated IKK in turn 
phosphorylates IκB, which leads to IκB degradation. NF-κB is therefore released and 
translocates to the nucleus where it regulates the expression of inflammatory cytokines such 
as TNFα and IL6 [169]. Apart from this regulatory effect on insulin signalling, IKK also 
directly phosphorylates IRS1 on serine residues and inhibits insulin action [170, 171]. 
1.5.1 Lipids and inflammation 
Lipid accumulation has been shown to cause inflammation in various tissues. In cultured 3T3-
L1 adipocytes, it was reported that at a concentration of 500 µM, free fatty acids inhibit 
insulin-stimulated GLUT4 translocation and glucose uptake, which is associated with 
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JNK/IKKβ activation and increased TNFα secretion [172]. Toll-like receptors (TLRs) appear 
to play an important role in fatty acids-induced inflammation. TLR-4 is upregulated during 
3T3-L1 adipocyte differentiation and the expression is further enhanced following fatty acid 
stimulation [173]. In macrophages, NF-κB is activated in a TLR-4 dependent manner by 
saturated fatty acids but not unsaturated fatty acids [174]. Mice with TLR-4 deficiency 
display less NF-κB activation during lipid infusion and are protected from the resultant 
impairment in insulin signalling and glucose disposal in muscle [175]. In C2C12 muscle cells, 
treatment with palmitate induces insulin resistance, which is associated with activation of 
Toll-like receptor 2 (TLR-2), JNK, protein kinase C, and NF-κB. These effects were partially 
reversed by co-treatment of a TLR2 antagonist antibody, mAb 2.5 [176]. Apart from TLRs, 
the nucleotide-binding oligomerization domain receptor (NOD-like receptor or NLR) is 
another protein family that mediates the activation of inflammatory pathways in response to 
saturated fatty acids. NLR molecules such as nucleotide-binding domain, leucine-rich repeats 
containing family, pyrin domain-containing 3 (NLRP3) binds to the adaptor protein apoptotic 
speck protein containing a caspase recruitment domain (ASC) and procaspase-1 to form 
inflammasome, which causes the release of interleukin 1β (IL1β) and interleukin 18 (IL18) 
[177]. Palmitate treatment activates reactive oxygen species (ROS), which induces NLRP3 
inflammasome as well as IL1β and IL18 production. Knockout of NLRP3, ASC, or IL1β 
protect mice from high-fat diet-induced inflammation and insulin resistance [178]. 
1.5.2 UPR and inflammation 
For the past decade, ER stress has emerged to be a mechanism to trigger inflammation and 
insulin resistance, especially in the liver. At the molecular level, David Ron and colleagues 
established a specific role of IRE1 in the regulation of JNK activity and it was revealed that 
cytoplasmic domain of IRE1 binds TRAF2 and leads to JNK activation [179]. In a later study, 
Hotamisligil and colleagues provided more detail of how IRE1 may impair insulin action 
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[137]. They found that ER stress induced by obesity increases IRE1 and JNK activity and 
serine-phosphorylation of IRS1 in mice. In cells, treatments with ER stress inducers 
tunicamycin (which inhibits protein glycosylation), or dithiothreitol (which interupts disulfide 
bond formation) activate IRE1-JNK pathway and inhibit insulin-stimulated tyrosine-
phosphorylation of IRS1, while these effects are abolished by IRE1 deletion [137]. 
Consistently, treatment of ob/ob mice with chemical chaperones can alleviate ER stress with 
reduced IRE1 activity, which leads to reduced JNK phosphorylation and improved whole 
body insulin sensitivity [119]. A recent study has also revealed that IRE1 is a key link 
between ER stress and insulin resistance in the liver during high-fructose diet feeding and 
IRE1-induced disruption of insulin signalling is mediated by JNK [55]. Apart from JNK 
activation, IRE1 is also found to play a central role in NF-κB activation. Upon ER stress, IKK 
forms a complex with IRE1 through the adapter protein TRAF2, which is crucial for NF-κB 
activation. This response is diminished in IRE1 deficient cells after exposure to ER stress 
inducers [180].  
PERK is another key link between UPR and inflammation. Depletion of ER calcium by 
inhibiting sarcoplasmic/ER calcium-ATPase (SERCA) leads to UPR activation and JNK 
phosphorylation. PERK has been shown to be essential for this process, because the deletion 
of PERK results in attenuated JNK activation [181]. In a Drosophila model of chronic ER 
stress, activation of PERK pathway independently activates JNK via the interaction with Ras-
related C3 botulinum toxin substrate 1 (Rac1) [182]. Phosphorylation of the PERK 
downstream effector eIF2α has been reported to activate the NF-κB pathway and facilitate 
NF-κB binding to the promoter region. This activation is mediated by the repression of IκBα 
translation caused by eIF2α phosphorylation, which relieves the inhibition on NF-κB [179]. 
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Genetic and pharmacological inhibition of ATF6 has also been shown to attenuate NF-κB 
activation under the ER stress triggered by loss of Grp78 [183]. However, the role of ATF6 in 
nutritional models of inflammation is not clear and previous studies have found no sign of 
ATF6 activation in the liver of high-fructose or high-fat fed mice in spite of elevated JNK 
phosphorylation [55, 153]. More recently, it has been shown that ER stress activates double-
stranded RNA-dependent protein kinase (PKR), which can increase JNK activity and directly 
regulate IRS1 phosphorylation and insulin action [184]. 
 
1.6 PROTEIN DEGRADATION PATHWAYS 
ER stress is closely related to both protein degradation and protein synthesis [185]. It is 
known that intercellular proteins are constantly turned over to replace damaged or unwanted 
proteins. Protein degradation provides a crucial chain in this process and has been reported to 
be upregulated during ER stress [185]. Two major systems for protein degradation are 
autophagy-lysosome and ubiquitin-proteasome. The lysosome was discovered by a Nobel 
Laureate Christian de Duve in the 1950s through cell fractionation [186]. It is a membrane-
bound organelle sequestered from the Golgi apparatus, with more than fifty different enzymes 
that are all active in its acidic environment. Lysosomes are the actual sites for the hydrolysis 
of proteins provided by phagocytosis, endocytosis and autophagy. Unlike phagocytosis and 
endocytosis, which are responsible for the removal of extracellular materials, autophagy 
delivers intracellular organelles and proteins to lysosomes for degradation. The discovery of 
ubiquitin-proteasome system (UPS) is more recent, by three other Nobel Laureates in 1980s 
[187]. In this system, proteasomes, which are complexes of proteases, mediate the protein 
hydrolysis. Proteasomes can be found in the nucleus and the cytoplasm of all eukaryotes; 
however, intracellular protein degradation is mainly carried out by the cytosolic 26S 
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proteasome, consisting of one 20S core particle and two 19S regulatory particles. Protein 
targets are recognized and delivered to proteasomes by an enzyme-catalysed three-step 
ubiquitin conjugation. In eukaryotic cells, the ubiquitin-proteasome system works coherently 
with autophagy-lysosome in the regulation of intercellular protein homeostasis. It is generally 
believed that short-lived proteins including regulatory proteins and unfolded proteins are 
degraded by ubiquitin-proteasome, while long-lived proteins and protein aggregates are 
degraded through autophagy-lysosome [188].  
1.6.1 Autophagy 
Autophagy literally means “self-eating” and the name derives from the observation of 
lysosomal degradation of mitochondria and other cytoplasmic components in rat liver after 
glucagon injection [189]. Autophagy is a basic catabolic process that degrades dysfunctional 
cellular organelles and large molecules through the action of lysosomes. There are three types 
of autophagy, namely macroautophagy, microautophagy, and chaperone-mediated autophagy. 
Macroautophagy involves the formation of a double-membraned autophagosome to include 
protein targets or organelles, which sequentially fuses with lysosome to form an autolysosome 
before the substrates can be degraded. In contrast, microautophagy is the direct engulfment of 
cytosolic components into the lysosome. Chaperone-mediated autophagy is a selective 
degradation process, in which targeted proteins are recognized by chaperone proteins like heat 
shock cognate protein 70 (Hsc70) and delivered to lysosome as a complex. Both 
macroautophagy and microautophagy are none-selective, with macroautophagy being the 
major type [188]. This thesis will focus on macroautpohagy (referred to as autophagy here 
after). 
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1.6.1.1 Autophagy process and regulation 
 
Figure 1.5 Molecular pathways of autophagy. Pathways are explained in the text below. 
Adapted from Levine B. et al. Nat Rev Immunol. 2007 [190]. 
 
The autophagy process Autophagy has been well characterised in yeast, and in mammalian 
cells to a lesser extent. This process is mediated by numerous autophagy-related genes (Atgs) 
and associated enzymes. As shown in Fig. 1.4, autophagy starts with the formation of 
phagophore, which is a fragment of double-membrane sequestered from ER, Golgi apparatus, 
or endosomes [191, 192]. This step requires the participation of UNC-51-like kinase 1 (ULK1, 
mammalian homologue to yeast Atg1) complex, which is composed of ULK1, FIP200 (also 
known as RB1CC1), Atg13l, and Atg101 [193]. Another prerequisite is class III 
phosphatidylinositol 3-kinase (PI3K) complex composed of vacuolar protein sorting 34 
(Vps34), p150 (mammalian homologue to yeast Vps15), Atg14, and Beclin1 (mammalian 
homologue to yeast Atg6/Vps30). Vps34 is the only known member of the class III PI3K 
family. It phosphorylates the 3-position of phosphatidylinositol (PI) to generate 
phosphatidylinositol 3-phosphate (PI3P), a key substrate for phagophore elongation [192]. 
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ULKs are the only serine/threonine kinases in autophagy pathway and are essential for the 
recruitment of Vps34 to the phagophore. Furthermore, the interaction between Beclin 1 and 
Vps34 enhances Vps34 catalytic activity and increases levels of PI3P. 
After being sequestered, the isolated membrane as described above undergoes elongation to 
form autophagy vesicles named autophagosome. This is carried out by two ubiquitin-like 
systems in parallel, Atg5-Atg12 and LC3. In the first system, Atg12 acts as ubiquitin and is 
activated by E1-like activating enzyme Atg7 in an ATP-dependent manner. Activated Atg12 
is then transferred to E2-like conjugating enzyme Atg10 and eventually attached to the 
internal lysine residue of the substrate protein Atg5, forming Atg12-Atg5 complex. Unlike 
ubiquitination, Atg12-Atg5 conjugation is irreversible and does not require the E3 ligase 
counterpart [194]. The Atg12-Atg5 conjugate further interacts with Atg16L on the opposite 
side to which Atg5 covalently binds to Atg12, forming a multimeric Atg5-Atg12-Atg16 
complex. This complex is then attached to the extending phagophore. The second ubiquitin-
like system during phagophore elongation requires the processing of LC3. LC3 is expressed 
as a full-length cytosolic protein. Upon autophagy induction, it is cleaved by cysteine protease 
Atg4 to expose a carboxyl glycine, generating LC3I. Similar to Atg12, LC3I is then activated 
by the E1-like activating enzyme Atg7 and transferred to E2-like conjugating enzyme Atg3. 
With the assistance of Atg5-Atg12-Atg16, which acts as E3 ubiquitin ligase, LC3I is 
conjugated to phosphatidylethanolamine (PE) via the carboxyl glycine to generate LC3II. 
During autophagosome formation, the Atg12-Atg5-Atg16L complex only resides on the outer 
membrane of the phagophore and is released into cytosol once the autophagosome is 
completed. In contrast, PE conjugated LC3II is found on both the inner side and the outer side 
of the membrane and still exists after the fusion of autophagosome and lysosome. 
Biosynthesis and processing of LC3 is also increased during autophagy, therefore, LC3 is a 
key readout for monitoring autophagy [195]. Similar to LC3, gamma-aminobutyric acid 
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receptor-associated protein (GABARAP) also undergoes lipidation during autophagy and 
GABARAP-II co-localizes with LC3II at autophagosomes, making itself another important 
marker of autophagy [196]. 
Before autophagosome is enclosed, cytosolic components such as protein aggregates, 
organelles and ribosomes are also engulfed during phagophore elongation. Although 
autophagy is considered as non-selective degradation process, growing evidence indicates 
phagophore membrane can selectively interact with autophagy targets. It is proposed that 
LC3II can act as cargo receptor on the phagophore and recruit adaptor proteins that bind 
targets to autophagy [197]. Among known adaptor proteins, p62/SQSTM1 is one of the best 
characterised and it promotes degradation of poly-ubiquitinated protein aggregates. Upon 
completing the formation of autophagosome, its outer membrane is fused with the lysosome 
to form an autolysosome. Although the molecular mechanism of this step is not clear, the 
lysosomal membrane protein LAMP-2 [198] and the small GTPase Rab7 [199] are required 
for the fusion process. After autophagosomes are fused with lysosomes, the autophagosomal 
contents are degraded by lysosomal acid proteases, including proteinases A, B and L [200]. 
The resulting hydrolysis products, particularly amino acids, are transported back the 
cytoplasm, where they can be re-used for protein synthesis or energy generation.  
Autophagy regulation Autophagy is responsive to nutrient and energy status, which can be 
monitored by mammalian target of rapamycin (mTOR) and AMPK respectively [193]. mTOR 
is a serine/threonine kinase that can be activated by a number of stimuli including amino acids 
and hormones to coordinate protein synthesis, cell growth and cell proliferation. mTOR acts 
in two forms of complexes: mTOR complex 1 (mTOC1) and mTORC2. The former carries 
the function for autophagy regulation. This complex is composed of mTOR itself, regulatory-
associated protein of mTOR (Raptor), mammalian lethal with SEC13 protein 8 (MLST8), and 
proline-rich Akt substrate of 40 kDa (PRAS40). mTORC1 interacts with the ULK1 complex 
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and  inhibits its kinase activity by direct phosphorylating ULK1 and Atg13l. Under nutrient 
deficiency, mTORC1 is inactivated to disinhibit the phosphorylation of ULK1 complex and 
allow the induction of autophagy. mTORC1 also indirectly regulates autophagy through its 
interaction with transcription factor EB (TFEB), a transcription factor that promotes 
autophagy and lysosome biogenesis. mTORC1 directly phosphorylates TFEB, resulting in its 
binding to YWHA (a 14-3-3 family member) and consequent nucleus exclusion. mTORC2 
consists of the rapamycin-insensitive companion of mTOR (RICTOR), GβL, mammalian 
stress-activated protein kinase interacting protein 1 (mSIN1) and Protor 1/2. It contributes to 
the regulation of autophagy through the Akt-FoxO axis, where FoxO mediates the expression 
of a number of autophagy genes [201]. 
AMPK is another serine/threonine kinase, consisting of a catalytic α subunit, a scaffolding β 
subunit, and a regulatory γ subunit. It senses energy status through the ratio of ATP to AMP 
via the γ subunit and is activated when energy levels are low. AMPK can also be activated by 
calcium/calmodulin-dependent kinase kinase β (CAMKKβ) and serine/threonine kinase 11 
(STK11, also liver kinase B1, LKB1) via phosphorylation of the α subunit [202]. It stimulates 
autophagy by activating the pro-autophagy Vps34 complex and inhibiting non-autophagy 
Vps34 complex via phosphorylation [203]. AMPK can also inhibit mTORC1 and relieve 
mTORC1-mediated repression on autophagy. This is accomplished by its inhibitory 
phosphorylation of mTORC1 subunit Raptor, or its activation of the mTOR suppressor 
tuberous sclerosis complex (TSC1/2). AMPK is also required for ULK1 activation and 
autophagy induction during glucose starvation [193]. In addition, AMPK indirectly promotes 
autophagy gene expression via activation and nuclear relocalization of the Forkhead box 
protein O3 (FoxO3) transcription factor [204]. 
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The transcription factor CCAAT-enhancer-binding protein β (C/EBPβ) has also been shown 
to control autophagy. The expression of C/EBPβ and the conversion of LC3I to LC3II are 
found to be rhythmic, under the regulation of both circadian and nutritional signals. C/EBPβ 
coordinates autophagy rhythm by directly binding to the promoter of autophagy genes, 
including Bnip3, cathepsin L and Gabarap and this rhythmic change in autophagy is 
abolished by genetic deletion of C/EBPβ [205]. In addition, C/EBPβ promotes the expression 
of Atg4B, a cysteine protease that cleaves LC3 to facilitate autophagy process [206].  
 
Figure 1.6 The regulation of autophagy Pathways are explained in the text below. 
 
1.6.1.2 Autophagy and metabolism 
As reviewed above, autophagy is tightly associated with nutrition and energy status. It also 
plays critical roles in metabolic processes in various tissues. 
Adipose tissue Autophagy is crucial for adipogenesis in both white adipose tissue and brown 
adipose tissue. Disruption of autophagy functions by genetic deletion of Atg7/Atg5 or 
treatments with pharmacological inhibitors in 3T3-L1 preadipocytes reduces lipid 
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accumulation and blocks differentiation [207]. Global knockout of Atg7 in mice results in 
lower body weight and reduced white adipose tissue mass [208]. Moreover, the adipocytes are 
smaller in size and contain more mitochondria, which are consistent with enhanced fatty acid 
β-oxidation and reduced lipolysis. In spite of these resemblances to brown adipose tissue, 
there was no change in the expression of adipocyte-specific genes. Tissue-specific Atg7 
knockout in adipose tissue protects mice from high-fat diet-induced obesity and insulin 
resistance. This was associated with lower plasma levels of triglycerides and cholesterol [208], 
as well as reduced lipid accumulation in liver and muscle [207]. Interestingly, in the tissue-
specific knockout mice, white adipose tissue develops histological characteristics of brown 
adipose tissue with increased expression of uncoupling protein 1 (UCP1), PPARγ coactivator 
1α (PGC-1α), cytochrome oxidase, and cytochrome C [207]. In humans, obesity has been 
observed to be associated with the induction of autophagy in subcutaneous adipose tissue, and 
this induction was attenuated after body weight loss [209]. Increased autophagy in adipose 
tissue correlates with both inflammation and systemic insulin resistance, whereas inhibition of 
autophagy can suppress the inflammatory response [210]. Mechanistically, autophagy may 
promote adipogenesis by mediating the degradation of two negative regulators Kruppel-like 
factor 2 (Klf2) and Klf3, which are targeted by the adaptor protein p62/SQSTM1 [206]. 
Autophagy has also shown to be essential for brown adipose tissue differentiation. Deletion of 
Atg7 in the myogenic factor 5 positive (Myf5+) progenitor cells impaired their differentiation 
into brown adipocytes, with decreased expression of both brown adipocyte genes, ucp1, cidea, 
elovl3, prdm16 and zic1, and adipocyte genes, c/ebpa, c/ebpb, pparg and ap2 [211]. 
Skeletal muscle Autophagy is required to maintain muscle mass and functions. Muscle-
specific Atg7 knockout results in profound muscle atrophy with decreased myofiber size and 
muscle-to-body weight ratio in both female and male mice. The muscle atrophy is mediated 
by atrophy-related ubiquitin ligases atrogin-1 and MuRF1, which are upregulated in Atg7 
Chapter 1 – Introduction and Literature Review 
 
41 
knockout muscle. On the other hand, increased proteasomal function and apoptosis due to 
impaired autophagy also contribute to muscle loss [212]. At whole body level, muscle-
specific Atg7 knockout mice have reduced lean mass and fat mass. Interestingly, these mice 
have higher energy expenditure and are protected from diet-induced obesity and insulin 
resistance. These effects are largely attributed to enhanced lipolysis and fatty acid oxidation, 
as well as browning of white adipose tissue, which is mediated by fibroblast growth factor 21 
(Fgf21) secreted from the autophagy deficient muscle [213]. Autophagy in skeletal muscle is 
also inducible by exercise. Mice lacking of autophagy protein Beclin show reduced 
autophagic flux in skeletal muscle after exercise, which is associated with less mitochondrial 
content and angiogenesis [214]. Similarly, mice with defective B-cell lymphoma 2 (Bcl2) 
phosphorylation fail to induce autophagy in response to exercise or starvation. These mice 
have altered glucose metabolism during exercise and are not protected against high-fat diet 
induced glucose intolerance after chronic exercise [215].  
Liver The role of autophagy in liver is more complicated. Autophagy can directly control lipid 
catabolism both in vitro and in vivo. There is evidence to show autophagosomes co-localize 
with lipid droplets and direct them toward lysosomal degradation [216]. This process, termed 
as lypophagy, is more active during fasting. Additionally, liver-specific knockout of Atg7 in 
chow diet-fed mice leads to marked elevation in lipid levels. In both wild type and Atg7 
knockout mice, high-fat feeding reduces lipid-containing autophagosomes, along with 
accumulation of enlarged lipid droplets [216]. Knockout of another key autophagy protein 
Vps34 in the liver results in reduced hyaloplasmic glycogen content, accumulated lipid 
droplets and defective mitochondrial fusion [217]. Genetic deletion of hepatic Transcription 
Factor EB (TFEB), a master transcription factor for both autophagy and lysosome genes, has 
similar effects on lipid accumulation in the liver after starvation or high-fat feeding. Moreover, 
overexpression of TFEB reverses obesity and metabolic syndrome in ob/ob mice [218]. 
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However, in contrast to these findings, decreased hepatic lipid content has also been reported 
in autophagy deficient mice [213, 219]. This effect was attributed to enhanced lipid 
catabolism by the increase in FGF21 secretion [213], as well as downregulation of lipogenic 
enzymes in the liver with autophagy deficiency [220]. In addition, autophagy also coordinates 
glucose metabolism through regulation of gluconeogenesis and glycogen storage [220].  
1.6.1.3 Autophagy and ER stress 
Autophagy is closely associated with ER homeostasis. It is well established that ER stress can 
activate autophagy as a protective mechanism. However, few studies have examined whether 
ER stress may result from defective autophagy. 
Interaction between autophagy and ER stress can be triggered by low levels of ER calcium. 
Depletion of ER calcium store leads to protein unfolding and ER stress and at the same time, 
the resultant rise in cytosolic calcium levels has been shown to initiate autophagy [221]. This 
calcium-induced autophagy is dependent on the activation of CaMKKβ, which senses the 
cellular calcium levels. Activated CaMKKβ further stimulates AMPK for phagophore 
induction. In addition, Beclin1 inhibitor Bcl2 is found to repress autophagy by localizing to 
ER membrane and reducing calcium leak from the ER [222]. Expression of Bcl2 has been 
shown to be reduced by ER stress effector CHOP, which may also contribute to autophagy 
activation [223]. IRE1-initiated JNK activation also inhibits Bcl2 via phosphorylation, 
resulting in its dissociation from Beclin’s BH3 domain and alleviation of its repression on 
autophagy [224]. PERK-eIF2α phosphorylation is reported to be essential for the conversion 
of LC3I to L3II, a process in phagophore membrane elongation. Expression of dominant 
negative PERK or mutation in eIF2α phosphorylation site inhibits ER stress-induced LC3 
conversion [185]. At transcriptional level, a number of autophagy genes are under the 
regulation of ER stress. It has been shown that LC3B and Atg5 mRNA levels are increased 
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during hypoxic exposure, and these increases are mediated by PERK-dependent activation of 
ATF4 and CHOP respectively [225]. Induction of ER stress by expressing malfolded protein 
aggregates leads to the upregulation of Atg5, Atg7, Atg12, and Atg16 mRNAs via eIF2α 
phosphorylation, which can be abolished  by mutating eIF2α phosphorylation site [185]. 
Recently, more autophagy genes have been identified as ATF4-CHOP targets. Among these 
genes, expression of Atg16l, Map1lc3b, Atg12, Atg3, Becn1 and Gabarapl2 is ATF4-
dependent but CHOP-independent in response to amino acid starvation, while expression of 
Nbr1 and Atg7 can be regulated by either ATF4 or CHOP while both ATF4 and CHOP are 
needed for  Atg10, Gabarap and Atg5 are upregulated through [226]. In addition, ER stress 
can regulate autophagy through the interaction with FoxO1. Nucleus FoxO1 has been shown 
to promote the expression of autophagy genes, while acetylated cytosolic FoxO1 can bind to 
Atg7 and enhance autophagy activity [227]. XBP1 deficiency increases autophagy in both 
cells and animals, owing to the augmented expression of FoxO1 [228]. Under glutamine 
starvation condition, unspliced XBP1 is phosphorylated by extracellular signal-regulated 
kinase 1/2 (ERK1/2) and binds to cytosolic FoxO1, leading to the proteasomal degradation of 
FoxO1 [229]. Furthermore, spliced XBP1 has also been demonstrated to direct the 
degradation of FoxO1 and reduce FoxO1 transcription activity [230]. 
Disturbance of autophagy has also been suggested to cause ER stress. Temporally, impaired 
autophagy caused by depletion of intact coatomer complex I (COPI) has been found to 
precede ER stress [231]. When exposed to tunicamycin or thapsigargin, Atg5-deficient cells 
are more vulnerable to ER stress and apoptosis compared to wild type cells. On the other hand, 
cells pretreated with autophagy inducer rapamycin are resistant to ER stress and associated 
cell death [232]. In ob/ob mice or high-fat diet-fed mice, hepatic autophagy is suppressed with 
a reduction in Atg7 protein expression along with ER stress and insulin resistance. Atg7 
deletion both in vitro and in vivo results in ER stress and defective insulin signalling, which 
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can be abrogated by restoration of Atg7 expression [233]. In diabetic Akita mice with 
proinsulin mutation, stimulation of autophagy with pharmacologic agents is able to attenuate 
ER stress and apoptosis in pancreatic β cells. This consequently leads to improved insulin 
secretion and reversal of diabetes [123]. However, the interactions between autophagy and ER 
stress in the pathogenesis of hepatic insulin resistance in nutritional models are not clear. 
1.6.2 Ubiquitin proteasome system (UPS) 
The ubiquitin proteasome system (UPS) is a cytoplasmic network responsible for the 
degradation of short-lived and dysfunctional proteins. Unlike autophagy, the UPS is a 
selective degradation process. The target specificity is provided by a post-translational 
modification called ubiquitination [188]. This process involves concerted actions of three 
types of enzymes to covalently attach ubiquitins, which are the signalling polypeptides, onto 
protein targets. The first enzyme is ubiquitin-activating enzyme (E1). It catalyses ubiquitin C-
terminal acyl-adenylation and binds to ubiquitin by creating a thioester bond between the C-
terminal of ubiquitin and the E1 cysteine sulfhydryl group. The second enzyme, ubiquitin-
conjugating enzyme (E2), which binds to both activated ubiquitin and the E1 enzyme, 
catalyses the transfer of ubiquitin from E1 to its active cysteine site. The third enzyme, E3 
ubiquitin ligase catalyses the final step of the ubiquitination. E3 ubiquitin ligases are unique 
as they recognize target proteins and confer the specificity. They directly bind to E2s and 
substrates and mediate the transfer of ubiquitin from E2s to the substrates. Most commonly, 
the C-terminal of an ubiquitin is linked to a specific lysine residue (e.g. K48, K29) from the 
N-terminal of a target protein. Proteins can be mono-ubiquitinated, or poly-ubiquitinated with 
the successive addition of ubiquitin. Ubiquitination is a multifunctional process not only for 
proteasomal degradation, but also for lysosomal degradation and protein translocation. The 
destination of ubiquitinated proteins is also determined by E3 ubiquitin ligases. Only poly-
ubiquitinated proteins on certain lysine residues (e.g. K48) can be directed towards the 26S 
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proteasome for degradation. Other ubiquitinated proteins may be degraded in the lysosome or 
function as endocytic trafficking [234]. It was estimated that in mammalian cells there are 
more than 500 E3 ligases, 30 E2 conjugating enzymes and 2 E1 activating enzymes [235]. 
1.6.2.1 UPS and ER stress 
UPS is a core element of ER-associated degradation (ERAD), the protein quality control 
machinery by which unfolded proteins are transported back to the cytosol and degraded [236]. 
During ER stress, the retrotranslocation of unfolded proteins to the cytosol and upregulation 
of UPS-dependent degradation is an integrated part of the UPR. It is therefore not surprising 
that interruption of UPS function can lead to ER stress [237]. Bortezomib is the first 
therapeutic proteasome inhibitor approved by Food and Drug Administration (FDA) for the 
treatment of multiple myeloma. Mechanistically, bortezomib has been shown to induce ER 
stress-mediated apoptosis both in vivo and in vitro [238]. It was found that bortezomib 
induces eIF2α-ATF4 signalling in neuroblastoma and melanoma cell lines along with the 
induction of pro-apoptotic proteins. This apoptotic effect of bortezomib is abolished by ATF4 
ablation [239]. MG132 is another proteasome inhibitor and has also been shown to induce ER 
stress and apoptosis via JNK activation [240]. On the other hand, ER stress itself has been 
suggested to compromise the UPS function. ER stress inducers have been demonstrated to 
cause a delayed degradation and accumulation of UPS substrates in reporter cell lines [241]. 
In MIN6 pancreatic β cell line and primary human pancreatic β cells, ER stress induced by 
islet amyloid polypeptide (hIAPP) aggregation can reduce proteasome activity and lead to 
intracellular accumulation of ubiquitinated proteins [242]. Furthermore, a number of E3 
ubiquitin ligases have also been suggested to participate in the UPR initiated by ER stress, 
and a majority of them are ER membrane-bound proteins, including RING (Really Interesting 
New Gene) finger ubiquitin ligases Hrd1/synoviolin, gp78, RNF-121, and Siah1/2 [243-246]. 
Treating HEK293 cells with ER stress-inducing agents upregulates UPR components and 
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Hrd1 expression, whereas overexpression of Hrd1, but not the mutant rescues cells from ER 
stress and apoptosis [243]. In the liver of zebrafish, tunicamycin induces ER stress and 
increases gp78 expression, and ER stress is exacerbated by liver-specific overexpression of 
dominant-negative form of gp78 [244]. In C. elegans, depletion of RNF-121 has been shown 
to result in UPR induction under basal conditions [245]. Siah1/2 was also found to be 
upregulated by UPR transducers ATF4 and sXBP1, which in turn leads to the stabilization of 
ATF4 and its augmented transcriptional activity [246]. Another ER stress responsive ubiquitin 
ligase is Parkin, the expression of which is induced by ATF4 and repressed by inflammatory 
protein c-Jun. Parkin protects cells from ER stress-induced mitochondrial damage and 
apoptosis, although it does not reduce the level of ER stress [247]. Taken together, these 
reports suggest E3 ubiquitin ligases play an important role in ER stress-triggered unfolded 
protein response.  
1.6.2.2 Cross talk of UPS and autophagy 
Although UPS and autophagy carry out their functions synergistically and independently, 
there is also crosstalk between these two protein degradation systems. For example, it is well 
established that inhibition of the proteasome leads to autophagy activation as a compensative 
response [248-252]. In cancer cells, autophagy induced by proteasome inhibitors exerts a 
cytoprotective role against apoptosis while inhibition of autophagy potentiates the apoptotic 
effect caused by proteasome inhibitors [249-251]. During this process, UPR has been reported 
to play a crucial role in the activation of autophagy. IRE1 deletion in cells results in a 
dramatic reduction in autophagy response after exposing cells to proteasome inhibitors or ER 
stress inducers [249]. Another UPR downstream effector, eIF2α has been suggested to be 
responsible for the upregulation of Atg5 and Atg7 after proteasome inhibition and this effect 
is independent of ATF4 [251]. Other mechanisms responsible for autophagy activation after 
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proteasome inhibition have also been proposed, such as a suppression of the PI3K-Akt-mTOR 
pathway [252].  
The direct effect of UPS on autophagy is largely achieved through E3 ubiquitin ligases. On 
one hand, ubiquitinated substrates can be recruited by adaptor proteins and fed into 
autophagy-mediated lysosomal degradation. These adaptors includes p62 [253], BH3-only 
protein Nix [254], nuclear dot protein 52kd (Ndp52) [255], and optineurin [256]. In support of 
this notion, autophagy deficiency by Atg5 deletion in neuronal cells results in extensive 
accumulation of ubiquitinated proteins [257]. On the other hand, ubiquitin ligases can also 
regulate autophagy through degradation or stabilization of autophagy upstream mediators via 
ubiquitination. One of the key autophagy mediators for this interaction is tumor suppressor 
protein p53. Cytoplasmic p53 has been suggested to repress autophagy, whereas the nuclear 
p53 transcriptionally induces autophagy genes [258]. Human homolog of mouse MDM2 
(HDM2) has been shown to enhance autophagy by targeting cytoplasmic p53 for proteasomal 
degradation via the ubiquitin ligase activity and is essential for starvation-induced autophagy 
[259]. Activity of ULK1 can also be regulated by E3 ubiquitin ligases. It has been suggested 
that the RING finger ubiquitin ligase TNF-receptor-associated factor 6 (TRAF6) can interfere 
with dephosphorylated Beclin and stabilize ULK1 by K63 ubiquitination, which is required 
for ULK1 self-association and activation [260]. Multi-protein E3 ubiquitin ligase complex 
Skp, cullin, F-box-containing complex (SCF) βTrCP has been shown to mediate the degradation 
of DEP domain-containing mTOR-interacting protein (DEPTOR), an inhibitory protein of 
mTORC1. Once stimulated by growth factors, DEPTOR is phosphorylated and binds βTrCP 
for proteasomal degradation to suppress autophagy by activating mTORC1 [261]. Another 
RING finger ubiquitin ligase, RNF5 has been reported to induce the ubiquitination and 
proteasomal degradation of membrane fraction of Atg4B to inhibit LC3 processing and 
autophagosome formation [262]. In contrast, RNF185 facilitates the formation of 
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autophagosomes through K63-linked ubiquitination of Bcl-2 family protein BNIP1 and 
recruitment of autophagy receptor p62 [263]. Mitochondria associated ubiquitin ligase Parkin 
has been shown to mono-ubiquitinate and stabilize Bcl-2, which enhances the interactions 
between Bcl-2 and Beclin 1 and the resultant repression of autophagy [264]. In addition, upon 
activation by PTEN-induced putative kinase 1 (PINK1), Parkin co-localizes with 
mitochondria and ubiquitinates mitochondrial proteins such as voltage-dependent anion-
selective channel protein 1 (VDAC1) and mitofusins Mfn1/2. This leads to the recruitment of 
autophagy adaptor p62 to mitochondrial clusters and facilitate mitochondria degradation [265]. 
Collectively, accumulating evidence has been showing E3 ubiquitin ligases provides a link 
between UPS and autophagy to coordinate protein degradation and this crosstalk may be 
pivotal in ER stress response. 
1.6.2.3 Nedd4 ubiquitin ligase family  
Neural precursor cell expressed developmentally down-regulated protein 4 (Nedd4) represents 
a large HECT type E3 ubiquitin ligase protein family, including Nedd4, Nedd4-2 (Nedd4l), 
Itch, Smurf1, SMURF2, WWP1, WWP2, NEDL1, and NEDL2 in humans [266]. Among 
these members, Nedd4 and Nedd4-2 share similar structural homology, which contains an N-
terminal C2 domain (calcium/lipid-binding domain), two to four WW domains (substrate 
binding domain), and a C-terminal HECT domain (ubiquitin-protein ligase domain). The best 
characterised physiological role of Nedd4 and Nedd4-2 is mediating intracellular sodium 
homeostasis by degrading epithelial Na channel (ENaC) via ubiquitination [267]. 
It has been reported that Nedd4 expression is upregulated in neuron cells in response to 
oxidative stress induced by zinc and hydrogen superoxide via reactive oxygen species (ROS)-
responsive FOXM1B [268]. In addition, Nedd4 polyubiquitinates Beclin1 with Lys11- and 
Lys63-linked chains and controls its stability. Genetic deletion of Beclin1 binding partner 
Vps34 results in Nedd4-mediated degradation of Beclin1, via the Lys11-linked chains [269]. 
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Nedd4 deficiency also leads to a downregulation in insulin receptor in mouse embryonic 
fibroblasts (MEFs). Consequently, insulin-stimulated tyrosine-phosphorylation of insulin 
receptor and serine/tyrosine-phosphorylation of Akt are reduced in Nedd4 deficient MEFs 
[270]. However, the role of Nedd4/Nedd4-2 in ER stress and the related metabolic disorders 
remains unknown. 
 
1.7 SUMMARY, AIMS AND THESIS FOCUS 
Diabetes is a major disease affecting millions of people worldwide (Section 1.1.1) with 
serious complications (Section 1.1.2.). Type 2 diabetes is the most common type of diabetes, 
resulting from insulin resistance and insufficient insulin secretion (Section 1.1.2). Insulin 
resistance can be described as impaired insulin action on glucose metabolism and disrupted 
insulin signal transduction is a major mechanism (Section 1.2.1). While the causes of insulin 
resistance are multifactorial, excess dietary fat and carbohydrate are the major nutritional 
contributors and liver is affected by these nutritional insults at an early stage (Section 1.2.2). 
Over consumption of dietary fat and carbohydrate (particularly fructose) results in 
dysregulated lipid metabolism, leading to the accumulation of ectopic lipids and lipid 
intermediates (Section 1.3). These lipids and lipid intermediates interfere with insulin 
signalling either directly (Section 1.3) or through the resultant activation of inflammatory 
pathways (Section 1.5.1). Another emerging mechanism is chronic activation of UPR in 
response to ER stress induced by high-fat or high-carbohydrate diet (Sections 1.4). UPR can 
inhibit insulin signalling through activating inflammatory enzymes and cytokines (Section 
1.5.2) and promoting lipogenesis to contribute to lipid-mediated insulin resistance (Section 
1.4.2).  
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Since UPR occurs conjointly with lipogenesis and lipid accumulation, it is still not clear 
which one is the early event during high-fat or high-carbohydrate diet feeding. ER stress 
results from accumulation of unfolded proteins, in which protein degradation pathways have 
been suggested to have a reciprocal role (Section 1.6). On one hand, ER stress triggers protein 
degradation to restore ER homeostasis by facilitating protein clearance; on the other hand, 
defective protein degradation also induces ER stress. Autophagy and UPS are the major 
pathways involved in protein degradation and their role in diet-induced ER stress and insulin 
resistance remains to be investigated. 
 
Figure 1.7 A schematic view of the research aims 
Therefore, the overall aim of this thesis was to investigate the role of protein degradation 
pathways in ER stress and insulin resistance (Fig. 1.5). As ER stress is closely associated with 
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lipogenesis, the first aim was to identify the temporal sequence of ER stress and lipogenesis 
during high-fat or high-fructose diet feeding in mice. This would be followed by interrogation 
of the role of ER stress in diet-induced insulin resistance. Once the possible causal 
relationship between ER stress and insulin resistance was established, the second aim would 
be to examine the individual role of two protein degradation pathways in ER stress, namely 
autophagy and UPS. In the UPS pathway, I would investigate the selected E3 ubiquitin ligases 
Nedd4 and Nedd4-2 as an example to examine the associated changes or responses in ER 
stress and/or autophagy. I would also evaluate possible mechanisms involved in these 
pathological processes. 
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2.1 INTRODUCTION 
This chapter explains in detail all the common methods and techniques used for the studies 
described in Chapter 3, Chapter 4 and Chapter 5. 
2.2 ANIMALS 
Male C57BL/6 mice (10-12 weeks) were purchased from the Animal Resources Centre (Perth, 
Australia). Mice were allowed to acclimatise for 1-2 weeks in RMIT animal facility upon 
arrival and were fed ad libitum standard chow diet during this period. Mice were kept in a 
temperature-controlled room (22 ± 1°C) on a 12-h light/dark cycle. Food intake, which was 
measured by the weight difference of the diet divided by the number of days was monitored 
on twice a week basis. Body weight of mice was also measured twice a week. At the end of 
experiments, mice were killed by cervical dislocation and tissues of interest were immediately 
freeze-clamped and stored in -80°C. 
All experimental procedures were approved by the Animal Ethics Committee of RMIT 
University (#1012 and #1340) in accordance with the National Health and Medical Research 
Council of Australia Guidelines on Animal Experimentation. 
2.3 DIETS 
Standard chow diet (CH; Rat and Mouse Cubes, 3.3 kcal/g, 12% fat, 70 % carhohydrate, 23% 
protein) was purchased from Specialty Feeds, Western Australia.  
High-fructose diet (HFru, 3.6 kcal/g, 10% fat, 35% fructose, 35% non-fructose carbohydrate, 
20% protein) or High-fat diet (HFat, 4.9 kcal/g, 45% fat, 35% carbohydrate, 20% protein) was 
prepared in-house (Table 2.1 and Table 2.2) based on previous report [153].  
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Table 2.1 Composition of the high-fructose diet. 
Ingredients Manufacturer Catalogue No. Amount (g) 
Casein MPD Dairy Products ACIDCASEIN 200 
Fructose Sigma-Aldrich F0127-5KG 350 
Starch (cornflour) Hudson Pacific Corp. FLCO1 350 
AIN-76 Mineral Mixture MP Biomedicals 0290545502 53 
Trace Minerals MP Biomedicals 0296026401 14.8 
Bran Hudson Pacific Corp. BC20KGA 40 
Methionine Sigma-Aldrich M9500 2 
Gelatine Hudson Pacific Corp. GEPO1 15 
Choline bitartrate Sigma-Aldrich C1629 4.6 
Safflower oil Stoney Creek Oil Products SAFFLOWER 6.2 
Lard Allowrie Prime Lard 37.8 
AIN Vitamin Mix 76 - A MP Biomedicals 0296009801 10.0 
MilliQ Water   100 
  Total 1183.4 
 
Table 2.2 Composition of the high-fat diet. 
Ingredients Manufacturer Catalogue No. Amount (g) 
Casein MPD Dairy Products ACIDCASEIN 261 
Sucrose Hudson Pacific Corp. - 230 
Starch (cornflour) Hudson Pacific Corp. FLCO1 193 
AIN-76 Mineral Mixture MP Biomedicals 0290545502 51 
Trace Minerals MP Biomedicals 0296026401 14.8 
Bran Hudson Pacific Corp. BC20KGA 57 
Methionine Sigma-Aldrich M9500 3.4 
Gelatine Hudson Pacific Corp. GEPO1 23 
Choline bitartrate Sigma-Aldrich C1629 4.6 
Safflower oil Stoney Creek Oil Products SAFFLOWER 34 
Lard Allowrie Prime Lard 250 
AIN Vitamin Mix 76 - A MP Biomedicals 0296009801 14.8 
  Total 1136.6 
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2.4 BLOOD AND PLASMA PARAMETERS 
Blood glucose levels were measured using a glucometer (Accu-Chek Performa Nano; Roche, 
Australia). For plasma measurement, blood samples were firstly collected from the tail of 
mice with heparinised capillary tubes (SteriHealth Laboratory Products, Australia), which 
were immediately diluted with the same volume of saline to avoid poteintial coagulation and 
kept on ice. Plasma was obtained by centrifugation (13,000 rpm, 1 min) and stored at -80°C 
for subsequent measurements. Plasma insulin levels were determined by radioimmunoassay 
(Catalogue No. SRI-13K, Merck Millipore, Australia). Fasting blood glucose levels were 
measured in mice 5-7 hours after food removal. Blood samples were also collected for the 
measurement of plasma insulin levels. 
 
2.5 GLUCOSE TOLERANCE TEST 
Body weight of mice was obtained the day before glucose tolerance test (GTT) for the 
calculation of glucose loads. On the day of experiment, food was removed 5-7 hours prior to 
the test. Around 1-2 pm during the day, 2.5 g/kg body weight of glucose was injected 
intraperitoneally based on our previous studies [69, 153]. Blood glucose was measured before 
injection and 10 min, 15 min, 30 min 60 min and 120 min after injection. Meanwhile, 20 µl of 
blood samples were collected at these time points for the measurement of insulin. Values of 
blood glucose from GTT were plotted against time and incremental area under the curve 
(iAUC) was calculated to assess glucose tolerance. 
 
2.6 TRIGLYCERIDE EXTRACTION AND DETERMINATION 
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Triglyceride extraction Frozen liver samples were chipped (20-30 mg) and homogenised in 4 
ml of extraction solution (chloroform/methanol, 2:1) using a glass pestle tissue grinder. Tissue 
homogenate was then transferred into 15 ml falcon tubes. The grinder was rinsed twice with 
another 2 ml of extraction solution, which was combined with the homogenate. Triglycerides 
were further extracted by rotating the tubes on a vertical rotator at room temperature 
overnight. The next day, 2 ml of 0.6% NaCl was added to the tubes followed by vigorous 
vortex mixing. Tubes were then centrifuged at 2,000 rpm for 10 min to separate the aqueous 
phase from the organic phase. Triglyceride containing organic phase was carefully transferred 
into glass tubes. The organic solvent was dried completely with constant air blow into the 
tubes at 45°C. The resulting triglyceride pellets were reconstituted in 500 µl absolute ethanol. 
Triglyceride determination Triglyceride concentration was measured by Peridochrom 
triglyceride GPO-PAP kit (Roche Diagnostics, Australia). Briefly, 5 µl of liver triglyceride 
sample or standard glycerol solution (Catalogue No.G5516, Sigma-Aldrich, Australia) was 
mixed with 300 µl of triglyceride reagent and then incubated at 37°C for 10 min. The 
absorbance was measured at 485 nm using a POLARstar microplate reader (BMG Labtech, 
Germany). 
 
2.7 TISSUE HISTOLOGY 
Fixing Liver tissues were freshly collected from mice. Two pieces (~0.5 mm× 0.5 mm) of 
liver tissue were carefully dissected from the centre of the big loop and placed in an 
embedding cassette (Grale HDS, Australia). The cassette was immediately submerged in 10% 
neutral buffered formalin solution (Sigma-Aldrich, Australia) and tissues were fixed in 
formalin at 4°C overnight. 
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Processing Fixed tissues were processed through a series of solutions  for dehydration 
(ethanol), clearing (xylene) and infiltration (paraffin) using a tissue processor (Automated 
Vacuum Tissue Processor Leica ASP6025, Leica Biosystems, Germany). 
Embedding Paraffin-infiltrated tissues were embedded in wax onto cassettes using a Heated 
Paraffin Embedding Module (EG1150 H, Leica Biosystems, Germany). Tissues were placed 
into metal molds along with hot wax, on top of which the cassettes were laid. Through 
cooling, the wax covering tissues was hardened and formed a block. 
Sectioning Embedded tissue blocks were firstly trimmed to reveal the “full face” of the tissue. 
Then tissues were cut into 5 µm thick sections using a Rotary Microtome (RM2235, Leica 
Biosystems, Germany). Sections were mounted onto glass slides (Menzel, Germany) and 
incubated at 37°C overnight prior to staining. 
Staining (Hematoxylin and eosin, H & E) Slides with sections were dewaxed in xylene 
(Grale Scientific Pty. Ltd., #XL005/10) for 5 mins to remove the paraffin. Sections were then 
submerged twice in 100% ethanol (1 min each) and briefly washed in 70% ethanol (by 
submerging slides into the solution 5 times). Sections were then rehydrated in distilled water 
for 2 mins. Sections were stained with the nucleus stain Mayer’s haematoxylin (Grale 
Scientific Pty. Ltd., #MH-1L) for 2 mins and rinsed with tap water, followed by cytoplasmic 
stain 1% Aqueous eosin (Grale Scientific Pty. Ltd., #EOA-1L) for 90 seconds. Sections were 
then dehydrated by repeatedly (10 times) submerging the slides in ethanol, 70% and 100% 
stepwise. Finally, slides were immersed in xylene and coverslipped with a dibutylphthalate 
polystyrene xylene (DPX) mounting medium (Grale Scientific Pty. Ltd., #3197). 
2.8 WESTERN BLOT 
Reagents / Buffers All reagents and buffers for Western blot are as followed (Table 2.3). 
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Table 2.3 Preparation of reagents and buffers for Western blot. 
Name Ingredients 
RIPA buffer 65 mM Trizma® base (Tris), 150 mM NaCl, 5mM EDTA, 1% 
Nonide-P 40 Substitute (NP-40, Catalogue No. 74385), 0.05% 
sodium-deoxycholate (Catalogue No. D6750), 0.1% (w/v) sodium 
dodecyl sulphate (SDS, Catalogue No. L4390), 10% glycerol 
(Catalogue No. 49770), pH 7.5 and stored at 4°C. 
Lysis buffer 10 mM sodium fluoride (NaF, Catalogue No.S7920), 1 mM sodium 
orthovanadate (Na3VO4, Catalogue No. S6508), 1 mM 
phenylmethanesulfonyl fluoride (dissolved in 100% ethanol, 
Catalogue No. 78830), 10 µl/ml protease inhibitor cocktail 
(Catalogue No. P8340) and 10 µl/ml phosphatase inhibitor cocktail 
(Catalogue No. P5726) in RIPA buffer. 
4x Laemmli’s 
buffer (100 ml) 
8.2 g SDS, 40ml glycerol, 50 ml 0.5 M Tris, 500 µl 1% 
bromo-phenol blue (Catalogue No. 114391) in dH2O, pH 6.8 and 
stored at -20°C. 62 mg/ml DL-dithiothreitol (DTT, Catalogue No. 
D9779) was added before use. 
10x Running buffer 
(1 L) 
30 g Tris, 144 g glycine (Catalogue No. G8898) and 10 g SDS in 
dH2O, pH 8.8 and stored at room temperature. 
10x Transfer 
buffer (1L) 
30 g Tris, 144 g glycine in dH2O and stored at room temperature. 
10x TBS (1 L) 24.2 g Tris and 80 g NaCl in dH2O, pH 7.6 and stored at room 
temperature. 
1x TBST (1 L) 100 ml 10x TBS buffer and 500 µl Tween® 20 (Catalogue No. 
P9416) in 900 ml dH2O and stored at room temperature. 
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Name Ingredients 
Blocking buffer 3% (w/v) Bovine serum albumin (BSA, Bovogen Biological Ltd., 
Australia) in 1x TBST and stored at 4°C. 
Stripping buffer 
(1L) 
6.25% 1 M Tris-HCl (pH 6.7), 10% (w/v) 20% SDS in dH2O and 
stored at room temperature. 100 mM 2-mercaptoethanol (Catalogue 
No. M7154) is added before use. 
All chemicals/reagents were purchased from Sigma-Aldrich, Australia unless otherwise stated. 
Protein extraction For animal tissues, 20-30 mg freeze-clamped liver or muscle samples were 
chipped and homogenised in 200-300 µl ice-cold RIPA lysis buffer using a Polytron 
Homogeniser. Tissue homogenates were solubilised for 2 hours at 4°C. After centrifugation at 
15,000 rpm for 10 min at 4°C, supernatant containing protein extraction was collected and 
stored at -80°C. For cell lyastes, cells were firstly washed with ice-cold PBS and 100-200 µl 
of RIPA buffer was added into each well. The gel-like cell lysates were then homogenized by 
passing through a 29 gauge needle (BD Insulin Syringe Ultra-Fine Needle 29 Gauge, BD, 
Australia) 10 times. After centrifugation at 15,000 rpm for 10 min at 4°C, supernatant without 
cell debris was collected and stored at -80°C. 
Preparation of loading samples Protein concentrations from the tissue and cell extraction 
were determined using Pierce™ Bicinchoninic Acid Protein Assay Kit (Thermo Scientific, 
Australia). Briefly, 20 µl of protein standards and diluted samples (1:20 dilution for tissues 
and 1:10 dilution for cells) were mixed with 200 µl of reagent master mix. The reaction was 
incubated at 37°C for 30 min prior to the determination of absorbance by spectrophotometry 
at 562 nm using a POLARstar microplate reader (BMG Labtech, Germany). 40-50 µg of 
protein extracted from tissue or 10-25 µg of protein extracted from cells were mixed with 5 µl 
of 4× laemmli’s buffer (supplemented with DTT) and MilliQ water to reach a total loading 
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volume of 20 µl. Samples were then boiled at 95°C for 10 min prior to cooling down on ice 
and stored at -80°C. 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is used 
for the separation of proteins. Glycine based polyacrylamide gels of different percentages 
were prepared for separation of proteins according to their molecular weights (Table 2.4). 
After polymerisation of the running gel (Table 2.5), stacking gel (Table 2.6) was poured on 
top of the running gel and polymerised. 20 µl of samples were loaded onto gels for separation 
under a constant voltage of 140 V. 
Table 2.4 Recommended polyacrylamide% for separation in denaturing gels 
Polyacrylamide % Effective range of separation (kDa) 
8 25-200 
10 15-100 
12.5 10-70 
15 12-45 
20 4-40 
 
Table 2.5 Composition of the running gel 
Ingredients Volume for 2 gels with different polyacrylamide % 
(ml) 8% 10% 12% 14% 
1.5M Tris Buffer, pH 8.8 5 5 5 5 
30% Acrylamide/Bis-acrylamide 5.3 6.7 8 9.3 
10% SDS 0.2 0.2 0.2 0.2 
dH2O 9.5 8.1 6.8 5.5 
10% APS 0.2 0.2 0.2 0.2 
TEMED 0.02 0.02 0.02 0.02 
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Table 2.6 Composition of the stacking gel 
Ingredients Volume (ml) for 2 gels 
1.5M Tris Buffer, pH 8.8 5 
30% Acrylamide/Bis-acrylamide 5.3 
10% SDS 0.2 
dH2O 9.5 
10% APS 0.2 
TEMED 0.02 
 
Immunoblotting After separation by SDS-PAGE, proteins were transferred onto a PVDF 
membrane (Bio-Rad Laboratories Inc., USA) at 90 V for 90 min. The membrane was blocked 
with 3% bovine serum albumin (BSA, Bovogen Biological Ltd., Australia) in TBST at room 
temperature for 1 hour. The membrane was then incubated with specific primary antibodies 
(Table 2.7) (1:1000-1:200 dilution in TBST containing 1% BSA and 0.1% sodium azide) 
overnight at 4°C. The following day, membranes were washed 6 times with TBST (10 min 
each time) to remove any unbounded antibody. Then membranes were incubated with 
corresponding horseradish peroxidase-conjugated secondary antibodies (1:3000 dilution in 
TBST containing 1% BSA) (Table 2.7) for 2 hours at room temperature, followed by 6 
washes with TBST (10 min each time) to remove unbounded secondary antibody. 
Chemiluminescence substrate (Western Lighting Ultra Solution, Perkin Elmer, Australia) was 
evenly applied onto the membrane and was exposed in a ChemiDoc (Bio-Rad Laboratories 
Inc., USA) with quantitative densitometry analysis of bands of interest using Image Lab 
software (Bio-Rad Laboratories Inc., USA). Briefly, a square that fits the size of the band was 
drawn and background was chosen. The density of the band was calculated by substracting 
the mean density of background from the band which was then multiplied by the area of the 
band. When applicable, total protein, Tubulin, GAPDH or Actin was used as loading control. 
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These raw values were normalized to the average of control group and data were presented as 
fold of change. 
Table 2.7 Antibody list 
Name Supplier Catalogue No. 
4E-BP1 Cell Signalling Technology 9644 
Acetyl-CoA Carboxylase  Cell Signalling Technology 3676 
Akt Cell Signalling Technology 9272 
ATF-6α Santa Cruz sc-22799  
Atg5 Cell Signalling Technology 2630 
Atg7 Cell Signalling Technology 2631 
c-Jun Cell Signalling Technology 9165 
eIF2α  Cell Signalling Technology 9722 
Fatty Acid Synthase Cell Signalling Technology 3180 
Grp78/Bip Cell Signalling Technology 3183 
GSK-3β Cell Signalling Technology 9315 
IKK-β Cell Signalling Technology 2370 
IRE1 Abcam ab37073  
LC3 Cell Signalling Technology 12741 
mTOR Cell Signalling Technology 2983 
p62 Cell Signalling Technology 5114 
p70 S6 Kinase  Cell Signalling Technology 9202 
Phospho-4E-BP1 (Thr37/46) Cell Signalling Technology 2855 
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Name Supplier Catalogue No. 
Phospho-Akt (Ser473) Cell Signalling Technology 9271 
Phospho-c-Jun (Ser73) Cell Signalling Technology 3270 
Phospho-eIF2α (Ser51) Cell Signalling Technology 9721 
Phospho-GSK-3β (Ser9)  Cell Signalling Technology 5558 
Phospho-IKK-α/β(Ser176/180)  Cell Signalling Technology 2694 
Phospho-IRE1 (S724) Abcam ab48187 
Phospho-IRS1 (Ser307) Antibody Millipore 07-247  
Phospho-mTOR (Ser2448) Cell Signalling Technology 5536 
Phospho-p70 S6 Kinase (Thr389)  Cell Signalling Technology 9234 
Phospho-PERK Cell Signalling Technology 3179 
Phospho-SAPK/JNK (Thr183/Tyr185) Cell Signalling Technology 4668 
SAPK/JNK Cell Signalling Technology 9252 
SCD1 Cell Signalling Technology 2283 
SREBP-1 Santa Cruz sc-367  
XBP1(M-186) Santa Cruz sc-7160  
 
2.9 PLASMID AMPLIFICATION 
Luria Broth (LB) was prepared from Luria Broth Base (Miller’s LB Broth Base) 
supplemented with 100 µg/ml ampicillin (all from Invitrogen, Australia). LB agar was 
prepared from LB broth with 1.5% agar. 20-25 ml of pre-heated LB agar was immediately 
poured into petri dishes to make LB agar plates. DH5α™ competent cells (Invitrogen, 
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Australia) were used for the amplification of proteins of interest and were transformed 
following manufacturer protocol. Briefly, DH5α™ cells were thawed on wet ice and 15 ml 
falcon tubes (Corning, Australia) were pre-cooled on ice. For each reaction, 50 µl of cells was 
taken from the vial and put into the ice-cold falcon tube, to which 1µl of the DNA solution 
was added. The tube was tapped gently to mix and then incubated on ice for 30 minutes. The 
cells were heat-shocked for 45 seconds in 42°C water bath before being placed on ice for 
another 2 minutes. 0.9 ml room temperature Super Optimal broth with Catabolite repression 
medium (S.O.C., Invitrogen, Australia) was then added to the cells and the culture was placed 
on an orbital shaker at 37°C for 1 hour. The reaction was diluted using S.O.C. medium 1:100 
and 100 µl of the reaction was spread evenly on LB agar plates. 1:10000 dilution was also 
prepared in the same way. The rest of the cells were diluted with glycerol 1:1 and frozen 
down in -80°C freezer. Plates were incubated overnight in a 37°C oven. The next day, white 
colonies formed on the plates and a single colony was picked using a sterile yellow tip. The 
tip with cells was placed in a 15 ml falcon tube containing 2 ml of LB broth and the culture 
was incubated with vigorous shaking overnight (~300 rpm). The next day, 100 µl of the 
culture was transferred into 250 ml conical bottles containing 100 ml LB broth (1:1000 
dilution) and the culture was grown for another day with vigorous shaking. 
 
2.10 PLASMIDS PURIFICATION 
Bacterial cells were harvested and plasmids were extracted and purified using Qiagen Plasmid 
Midi Kit (Qiagen, Australia) following manufacturer protocols. Briefly, bacterial cells were 
pelleted from the culture by centrifugation at 6, 000 g for 15 min at 4°C and resuspended with 
4 ml of Buffer P1 (LyseBlue and RNase A added). 4 ml of Buffer P2 was then added and the 
solution was well mixed. 4 ml ice-cold Buffer P3 was added and mixed again. After 15 min of 
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incubation on ice, the solution was centrifuged at 20, 000 g for 30 min at 4°C. The plasmid 
containing supernatant was loaded onto equilibrated QIAGEN-tip 100 columns for DNA 
binding. Columns were first washed with Buffer QC and DNA was eluted by Buffer QF. 
DNA in the eluent was precipitated by adding 3.5 ml isopropanol and pelleted by centrifuging 
at 15, 000 g for 30 min at 4°C. DNA pellets were washed with 2 ml 70% ethanol and the 
supernatant was decanted after a final centrifugation. The solvent was removed through air-
drying and the DNA pellet was resuspended in Tris-EDTA buffer (pH 8.0). 
 
2.11 CELL CULTURE 
Mouse embryonic fibroblasts (MEFs), Human Embryonic Kidney (HEK) 293 and HeLa cells 
were obtained from University of Melbourne and cultured in Dulbecco’s modified essential 
medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS) and 1% Penicillin 
Streptomycin (Pen Strep, all from Invitrogen, Australia) in T75 flasks (Corning, Australia) 
and were kept at 37°C with 5% CO2. Culture medium was changed every two to three days. 
When reaching 70%~80% of confluence, cells were subcultured. Briefly, cells were first 
washed with phosphate buffered saline buffer (PBS, pH 7.4) after medium was removed. 1 ml 
of 0.25% Trypsin-EDTA (Invitrogen, Australia) was added into the flask to detach the cells, 
after which 4 ml of growth medium was then added to stop the process. Clusters of cells were 
broken down by pipetting the medium up and down a few times. The desired volume of the 
cell-containing medium was transferred into a new T75 flask with fresh growth medium. 
The day before experiment, cells were seeded in 12-well plates (Corning, Australia). 
Treatments were performed by incubating cells with different culture mediums or drug 
containing mediums on the following day. For protein knockdown or overexpression 
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experiments, treatments were performed 48 hours after siRNA transfection or 24 hours after 
plasmid transfection.  
 
2.12 TRANSFECTION 
Both siRNAs and plasmids were transfected with Lipofectamine 2000 (Invitrogen, Australia) 
following manufacturer protocols. Briefly, the day before transfection, 0.8×105 HeLa cells or 
1.5×105 HEK293 cells in 1ml of growth medium without antibiotics (DMEM supplemented 
with 10% FBS, no Pen-Strep) were plated into each well of 12-well plates. On the day of 
transfection, 0.5 µg plasmids or 40 pmol siRNAs were diluted with 100 µl Opti-MEM 
(Invitrogen, Australia) and 2 µl Lipofectamine 2000 Reagent was diluted with 100 µl Opti-
MEM. After 5 min of incubation, the two dilutions were combined and further incubated for 
another 5 min. The 200 µl of complexes were then added into each well and mixed by rocking 
the plates back and forth. 
 
2.13 INDIRECT IMMUNOFLUORESCENCE 
Glass coverslips were placed in 12-well plates and coated with poly-lysine by incubating with 
1 ml 0.01% poly-lysine (Sigma-Aldrich, Australia) for 30 min. Then poly-lysine was removed 
and wells were washed with sterile water. HeLa cells or HEK293 cells were grown on 
coverslips in the wells at a density of 0.5×105 cells/ml. Following treatments and/or 
transfections, cells were washed with PBS and fixed with 4% paraformaldehyde (Sigma-
Aldrich, Australia) for 30 min upon removal of medium. Then coverslips attached with cells 
were transferred to new 12-well plates with cell side up and cells were permeabilized with 0.2% 
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Triton X-100 (Sigma-Aldrich, Australia) in PBS for 30 min (Sigma-Aldrich, Australia). 
Coverslips were then washed with 0.15 M glycine in PBS for 10 min. After that, cells were 
blocked with 1% BSA (BovoStar, Bovogen Biological Ltd., Australia) in PBS for 30 min, 
followed by 1 hour of incubation with corresponding primary antibodies (Cell Signalling 
Technology, 1:100 in 1% BSA). Cells were washed with 0.1% BSA in PBS 2-3 times for 5 
min, after which cells were further incubated with corresponding Alexa Fluor secondary 
antibodies (Cell Signalling Technology, 1:100) for 30 min. Coverslips attached with cells 
were mounted onto Superfrost™ Plus slides (Menzel, Germany) in Fluorescence Mounting 
Medium (Dako, US). Slides were examined with a Nikon A1R-A1 confocal microscope. 
 
2.14 LONG-LIVED PROTEIN DEGRADATION ASSAY 
Long-lived protein degradation assay was performed based on Chan et al. with modifications 
[264, 271]. 12-well plates were coated with poly-lysine as described in Section 2.13 to 
prevent loss of cells during washing. HeLa cells cells at a density of 0.8-1.5×105 cells/ml were 
grown in 12-well plates in growth medium without antibiotics (DMEM supplemented with 10% 
FBS, no Pen-Strep). The next day, cells were transfected with siRNAs as described in Section 
2.12. One day after siRNA transfection, the culture medium was changed to labelling medium 
(65 nM cold leucine plus 1 µCi/ml hot leucine in DMEM supplemented with 10% FBS; cold 
leucine was purchased from Sigma-Aldrich, Australia and L-[2,3,5-3H(N)]-leucine, 1 mCi/ml, 
was purchased from Perkin Elmer, Australia). 24 hours after labelling, medium was discarded. 
Cells were washed with PBS and further incubated in chasing medium (2 µM cold leucine in 
DMEM supplemented with 10% FBS) for 4 hours to degrade short-lived proteins. Four hours 
later, the chasing medium was discarded. Cells were washed PBS again and incubated in 
starvation medium (2 µM cold leucine in Earle's Balanced Salt Solution, EBSS, Invitrogen, 
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Australia) or control medium (2 µM cold leucine in DMEM supplemented with 10% FBS). 
After 2 hours, 0.9 mL of medium was collected from each well, to which 100 µl of 100% 
trichloroacetic acid (TCA) was added. The solution was centrifuged at 15,000 rpm at 4 °C for 
5 min and supernatant was used to measure the radioactivity in medium. Cells in the plates 
were washed with PBS and fixed with 1 ml of 10% TCA. Then 1 ml of 0.2 M NaOH was 
added to dissolve the cells. The solution was used to determine the radioactivity in cells. 400 
µl of each sample solution was taken to mix with 4 ml scintillation fluid (Ultima Gold™ XR, 
Catalogue No. 6013119, Perkin Elmer, US) and radioactivity was determined by a Tri-Carb 
Liquid Scintillation Counter (Perkin Elmer, US). Long-lived protein degradation rate was 
calculated by the ratio of the degraded protiens (reading from medium) to the total amount of 
labelled proteins (added reading of both the medium and the cells). 
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3.1 INTRODUCTION 
It is now well established that excessive consumption of dietary fat and/or carbohydrate 
(mainly fructose) is a major factor in the development of insulin resistance [80, 272]. As a 
common sweetener, fructose is frequently used in soft drinks and bakery products, in the form 
of simple fructose, high fructose corn syrup (HFCS) or sucrose [72]. It is almost entirely 
cleared at the first pass in the liver after absorption [57]. As a result, the liver is the first to 
show signs of insulin resistance (within days) compared to other organs such as muscle which 
typically only exhibit impaired insulin action after a few weeks of high fructose consumption 
[153, 273]. In addition, compared to glucose, fructose also appears to be more deleterious to 
insulin action in both humans and animals [61].  
After ingestion, both fat and carbohydrate are immediately metabolised to generate energy. 
The intermediate metabolites can also be converted into glycogen for storage in liver and 
muscle, or into lipids for energy reserve in adipose tissue. However, under overconsumption 
conditions, ectopic lipids can be stored in non-adipose tissue such as liver and skeletal muscle. 
Excessive ectopic lipid storage in these tissues can disrupt insulin signalling, leading to 
insulin resistance [80]. The mechanistic basis for this appears to involve certain lipid 
intermediates (such as DAGs and ceramides) that can activate protein kinase Cs (PKCs), 
which further phosphorylate insulin receptor substrates (IRS) at serine/threonine sites and 
block insulin signal transduction [75].  
Based on current reports, insulin resistance may also be linked to an increase in the ER stress 
response [119], although whether it is a direct causative factor or a consequence of insulin 
resistance is debated [274]. Evidence for a link has come from studies demonstrating that ER 
stress triggers the canonical unfolded protein respsones (UPR) pathways such as IRE1 and 
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PERK that subsequently activate c-Jun N-terminal kinases (JNK)/ IκB kinase (IKK) and 
inhibit insulin signal transduction by serine-phosphorylation of IRS1 [119, 126].  
Apart from this proposed direct effect on insulin signalling, the spliced form of X-box-
binding protein 1 (sXBP1), which is an IRE1 downstream effector, has also been shown to 
promote lipogenesis and potentially leads to lipid-induced insulin resistance by additional 
mechanisms involving PKC as described above [146]. 
Given the fact that ER stress can promote lipogenesis and the resultant increase in lipids can 
subsequently lead to insulin resistance, the purpose of this study therefore was to investigate 
the role of ER stress and lipogenesis in the development of insulin resistance. The hypothesis 
was ER stress may have a direct effect on insulin signalling which is independent of ectopic 
lipid accumulation. Attempts were made to identify the individual roles of these processes in 
insulin resistance. This study used mice that were given chow, high-fat or high-fructose diet 
for specified durations, and markers of insulin signalling were correlated with markers of ER 
stress and ectopic lipogenesis. 
 
3.2 MATERIALS AND METHODS 
3.2.1 Animal models 
3.2.1.1 Chronic feeding 
All mice were first acclimatized for 1-2 weeks on chow diet (CH) and then fed ad libitum for 
up to 2 weeks on CH, high-fat diet (HFat) or high-fructose diet (HFru) (n=8-12, detailed 
recipes of the diets are provided in Section 2.3). Ten days after HFru/HFat feeding, a glucose 
tolerance test (GTT; glucose dose 2.5 g/kg BW, i.p.) was performed on mice as described in 
Section 2.4. At the end of 2 weeks, mice were fasted for 5-7 hours before culled for tissues 
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and 20 min prior to culling, were injected intraperitoneally with insulin (2 U/kg body weight) 
or vehicle (equivalent volume of saline) to assess insulin signalling. After culling of mice by 
cervical dislocation, liver tissues were collected and freeze-clamped immediately. 
3.2.1.2 Acute feeding 
All mice were first acclimatized for 1-2 weeks on a CH prior to 24 hours of fasting. Mice 
were then fed a CH or HFru for the time periods (2-12 hours) as indicated in the results (n=6-
8). Mice were killed by cervical dislocation at the end of each feeding period and liver tissues 
were freeze-clamped immediately. To assess insulin action, insulin signalling was examined. 
Another cohort of mice was treated as described above. Fourty min before tissues were 
collected, these mice were injected with insulin (5 U/kg body weight, to override the high 
level of endogenous insulin after refeeding) i.p. along with glucose (3 g/kg body weight, to 
avoid hypoglycaemia). After culling of mice by cervical dislocation, liver tissues were freeze-
clamped immediately. 
3.2.2 Glucose tolerance test 
During the GTT, blood glucose levels were measured before and 15, 30, 60 and 120 min after 
the injection of glucose. Plasma samples were collected at the same time for the measurement 
of insulin levels using radioimmunoassay (Section 2.5). Fasting blood glucose levels were 
measured as described in Section 2.4. All experiments were approved by the Animal Ethics 
Committee of RMIT University. 
3.2.3 Liver triglycerides 
Liver triglycerides were extracted and measured as described in Section 2.6. 
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3.2.4 Liver histology 
The preparation of liver sections and H&E staining are described in Section 2.7. 
3.2.5 Western blot 
Freeze-clamped tissues were homogenized in ice-cold RIPA lysis buffer at pH 7.5 
supplemented with protease/phosphatase inhibitors. Protein levels in the homogenates were 
determined using the bi-cinchonnic acid (BCA) method. Proteins were resolved by SDS-
PAGE. Levels of proteins were examined by immunoblotting using specific antibodies. 
Details were described Section 2.8. 
3.2.6 Statistical analyses 
Data are presented as means ± SEM. One-way analysis of variance was used for comparison 
between relevant groups unless stated otherwise. When significant variations were found, the 
Tukey-Kramer multiple comparisons test was applied. Differences at p< 0.05 were considered 
to be statistically significant. 
 
3.3 RESULTS 
3.3.1 Chronic HFru and HFat feeding induced obesity and insulin resistance 
After being fed an HFru for 2 weeks, mice had a significantly higher food intake and calorie 
intake compared to CH fed mice (both p<0.01). This also resulted in a significant increase in 
body weight gain (>2 fold vs CH, p<0.05) and adiposity (~40% vs CH, p<0.05) (Table 3.1). 
Fasting blood glucose was significantly higher in HFru-fed mice (~20% vs CH, p<0.05), but 
no apparent differences in plasma insulin levels were observed. 
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The dietary effects on body weight gain and adiposity were more pronounced with HFat 
feeding (>6 fold and >3 fold vs CH respectively, both p<0.01), although the calorie intake 
was similar to that of HFru. Moreover, HFat feeding not only elevated fasting blood glucose 
but also raised circulating plasma insulin levels. 
Table 3.1 Basal metabolic parameters of CH-, HFru- and HFat-fed mice 
  CH HFru HFat 
Food intake (g/kg.day) 124.4±2.4 152.3±3.3** 112.1±4.3** 
Caloric intake (kcal/kg.day) 414.7±7.9 543.8±11.7** 553.7±22.4** 
Body weight gain (g) 0.6±0.3 1.3±0.2* 3.9±0.2** 
Epididymal fat mass (BW %) 1.0±0.1 1.4±0.1* 3.3±0.2* 
Fasting blood glucose (mM) 8.8±0.4 10.5±0.7* 11.8±0.5** 
Plasma insulin (ng/ml) 1.14±0.07 1.25±0.02 1.88±0.06** 
Male C57BL/6 mice were fed a CH, HFru or HFat for 2 weeks. Blood samples were collected 
from mice following 5-7 hour of fasting before mice were culled. Blood glucose and plasma 
insulin levels were measured as described in the methods. Body weight and epididymal fat 
mass were measured at the end of the study. 8-12 mice per group. * p< 0.05, ** p<0.01 
compared to CH. 
 
Glucose homeostasis was assessed by the glucose tolerance test. HFru-fed mice had impaired 
glucose tolerance, as indicated by higher levels of blood glucose compared to CH-fed mice 
after the injection of glucose (Fig. 3.1A). This was also reflected by a 30% (p<0.05 vs CH) 
increase in the glucose incremental area under the curve (iAUC) (Fig. 3.1B). This effect was 
observed in the absence of any significant changes in the circulating levels of insulin during 
the glucose tolerance test (Fig. 3.1C). HFat-fed mice also displayed severe impairment in 
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glucose tolerance (Figs. 3.1A, B) but similar to HFru fed mice, this was not associated with 
changes in plasma insulin concentration. 
 
 
Figure 3.1 HFru and HFat feeding induced insulin resistance. (A) Glucose tolerance test 
(GTT) was performed in 2 weeks HFru (■), HFat (♦) or CH (○)-fed mice and glucose 
tolerance was assessed by (B) iAUC. Plasma insulin levels (C) during GTT (15 min-50 min 
after injection) were measured. 8-12 mice per group. * p<0.05, ** p<0.01 compared to CH. 
 
3.3.2 Impairment in hepatic insulin signalling was associated with steatosis 
Since liver is one of the major organs responsible for insulin-driven glucose utilization, 
hepatic insulin signalling pathway was further examined as an indicator of insulin action in 
the liver. This was assessed by determining the extent of phosphorylation of Akt and its 
substrate GSK3β after insulin stimulation using Western blot as depicted in Figs. 3.2A and B. 
Control CH-fed mice exhibited a dramatic elevation in the phosphorylation of both Akt and 
GSK3β in the liver after insulin injection (by 14 and 3 fold vs pre-stimulated levels of 
phosphorylation, respectively; both p<0.01). Compared to CH-fed mice, both HFru- and 
HFat-fed mice elicited 40%-50% reduction in insulin-stimulated phosphorylation of Akt 
(p<0.01) and GSK3β (p<0.01). 
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In addition, liver triglyceride levels were elevated by more than two fold in both HFru- and 
HFat-fed mice compared to CH-fed mice (Fig. 3.2C). The elevated triglyceride levels in these 
treatment groups were also consistent with observed morphological changes in the liver. H&E 
staining of liver sections revealed clear signs of hepatic steatosis (arrows in Fig 3.2D) in these 
groups but not CH fed animals. Interestingly, there was more macrosteatosis in the liver of 
HFru-fed mice whereas in HFat-fed mice, more microsteatosis was observed. 
 
Figure 3.2 HFru feeding impaired insulin signal transduction. Mice were injected with 
insulin (2 U/kg) or saline after 5-7 hours fasting. Twenty minutes after injection, mice were 
culled and liver insulin signal transduction was determined by phosphorylation of (A) Akt and 
(B) GSK3β in response to insulin stimulation using Western blot. Values of density were 
normalized by non-insulin stimulated CH group and data were presented as fold change. Two-
way ANOVA analysis was used to compare insulin-stimulated Akt and GSK3β 
phosphorylation levels between different diets. * p<0.05, ** p<0.01 compared to the 
corresponding non-insulin stimulation group (vehicle control). # p<0.05, ## p<0.01 compared 
to CH fed mice with insulin stimulation. (C) Liver triglycerides were measured in CH, HFru 
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and HFat fed mice. (D) H&E staining of liver morphology of CH-, HFru- and HFat-fed mice. 
Arrows point to the lipids. 6-10 mice per group. 
 
3.3.3 ER stress and lipogenesis are associated with HFru-induced insulin resistance 
ER stress is another key factor that may lead to the impairment of hepatic insulin signal 
transduction. Notably, two weeks of HFru feeding induced ER stress in the liver. This was 
evidenced by the activation of two canonical UPR pathways, namely IRE1-XPB1 and PERK-
eIF2α pathway. There was a 2.6 fold increase in the phosphorylation of IRE1 (p<0.01) as 
well as a 1.6 fold increase (p<0.01) in the spliced form of IRE1 downstream target XBP1 
(sXPB1) in HFru-fed mice compared to CH-fed mice (Fig. 3.3A). Meanwhile, HFru-fed mice 
exhibited a 1.8 fold increase in the phosphorylation of eIF2α, a downstream target of PERK, 
in HFru-fed mice, although no significant changes were observed in the phosphorylation of 
PERK. The levels of ATF6, a marker from the third arm of the UPR pathways, were not 
affected by HFru feeding. On the other hand, HFat feeding did not activate any of these ER 
stress markers. 
Both IRE1 and PERK have been reported to stimulate lipogenesis [146, 149]. In agreement 
with the activation of IRE1 and PERK pathways with HFru feeding, the mature form of the 
lipogenic transcription factor SREBP-1c (mSREBP-1c) was significantly elevated (3 fold vs 
CH, p<0.01, Fig. 3.3B). The elevation of mSREBP-1c also resulted in an upregulation of its 
target lipogenic enzymes, including ACC (3 fold vs CH, p<0.01), FAS (2 fold vs CH, p<0.01) 
and SCD1 (1.7 fold vs CH, p<0.01) compared to CH-fed mice (Fig. 3.3B). Again, HFat 
feeding did not show any effect on the expression of these lipogenic proteins. These results 
suggest dietary compositions of HFat and HFru may have distinct mechanisms towards the 
induction of insulin resistance. While HFat only involved lipid accumulation, HFru involved 
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both lipids and ER stress. Since ER stress is a major focus of this thesis, HFat model was not 
included in later studies. 
 
Figure 3.3 HFru feeding increased hepatic lipogenesis and ER stress. (A) ER stress 
markers phospho/total-IRE1, sXBP1, phospho-PERK, phospho/total-eIF2α and ATF6, as well 
as (B) lipogenic proteins, mSREBP-1c, ACC, FAS and SCD1 were measured by Western 
blot. Values of density were normalized by CH group and data were presented as fold change. 
8-12 mice per group. * p<0.05, ** p<0.01 compared to CH. 
 
3.3.4 ER stress occurred prior to lipogenesis during acute feeding 
As ER stress and ectopic lipid accumulation were both apparent after 2 weeks of HFru 
feeding, experiments using shorter feeding periods were employed to determine which of 
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these events is manifested earlier. Co-occurrence of these events was also observed even after 
1 day of HFru feeding [55]. Therefore, a 2-12 hours of acute feeding with HFru was 
employed. To ensure that mice would ingest the diet within the short period of time, they 
were fasted 24 hours prior to feeding. 
Significant elevation of ER stress markers Grp78, phospho-IRE1 and sXPB1 was observed 
after 6 hours of HFru feeding (3.7 fold, 7.6 fold, and 44% vs Basal, respectively, all p<0.05) 
(Figs. 3.4A-D). Phospho-eIF2α, on the other hand, increased after 2 hours of HFru feeding 
(88% vs Basal, p<0.01, Fig. 3.4E). 
No difference in liver triglycerides was found during acute HFru feeding. Consistently, 
lipogenic markers were not changed until 12 hours of HFru feeding, when a significant 
increase in ACC and FAS was observed (60-80% vs Basal, p<0.05) along with a much 
greater upregulation of SCD1 (30 fold vs Basal, p<0.01, Figs. 3.4F, H-J). mSREBP-1c, on the 
other hand, remained unchanged throughout this feeding period (Fig. 3.4F-G, K). These 
results suggest acute HFru feeding induced ER stress prior to the initiation of lipogenesis and 
these events occurred without altering liver triglyceride levels. 
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Figure 3.4 HFru feeding activated ER stress and lipogenesis sequentially. Mice were 
fasted for 24 hours (Basal) before fed HFru for 2-12 hours. Hepatic ER stress and lipogenesis 
were measured by protein markers using Western blot: (A) Grp78, phospho-IRE1, sXBP1, 
phospho-eIF2α with densitometry (B-E); (F) mSREBP-1c, ACC, FAS, and SCD1 with 
densitometry (G-J). Values of density were normalized by CH group and data were presented 
as fold change. (K) triglyceride (TG) content in the liver was also analysed. 5-6 mice per 
group. * p<0.05, ** p<0.01 compared to Basal. 
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3.3.5 ER stress dampened insulin signal transduction via activation of JNK/IKK  
At 6 hour of HFru feeding, there was marked induction in ER stress but no apparent increase 
in lipogenesis or triglycerides in the liver. Therefore this time point was chosen for further 
examination of insulin signalling pathways. As ER stress has been reported to activate 
JNK/IKK to impair insulin signal transduction by serine-phosphorylation of IRS1 (16,19-21), 
these signalling pathways were also measured. In agreement with the activation of IRE1 and 
PERK pathways, following 6 hours of HFru feeding, there was significant increase in JNK 
phosphorylation (60% vs Basal, p<0.05, Fig. 3.5A). This effect was more pronounced on the 
phosphorylation of the downstream of JNK − cJun, where a 5 fold increase was observed. 
Meanwhile, IKK was also activated, indicated by 2.4 fold increase in its phosphorylation. 
Consistently, protein levels of serine-phosphorylated IRS1 were elevated by 40% after 6 
hours of HFru feeding. These events led to blunted insulin signal transduction, supported by a 
marked reduction in insulin-stimulated phosphorylation of Akt and GSK3β (by 40% and 30% 
respectively vs Basal, p<0.01, Fig. 3.5B). These results together suggest that acute HFru 
feeding is able to induce ER stress and its associated impairment in insulin signal transduction 
prior to lipogenesis or accumulation of lipids. 
 
Chapter 3 – ER Stress in Diet-induced Insulin Resistance 
 
82 
 
Figure 3.5 Acute HFru feeding impaired insulin signal transduction in the liver. (A) 
Liver homogenates from fasted mice (Basal) or 6-hour HFru refed mice were immunoblotted 
for phospho/total-JNK, phospho/total-cJun, phospho/total-IKK and serine-phosphorylated 
IRS1. Values of density were normalized by CH group and data were presented as fold 
change. 5-6 mice per group. * p<0.05, ** p<0.01 compared to Basal. (B) In a separate cohort 
of mice in which insulin was injected, hepatic insulin signalling was assessed by 
phosphorylation of Akt and GSK3β in response to insulin stimulation. Values of density were 
normalized by CH group and data were presented as fold change. 6-8 mice per group. * 
p<0.05, ** p<0.01 compared to Basal. 
 
3.3.6 Effects of HFru on ER stress and lipogenesis are independent of refeeding 
Feeding mice CH after fasting has also been reported to induce ER stress [275]. To determine 
whether the observed effects on ER stress and lipogenesis during acute HFru feeding were 
due to the diet or the feeding regime, mice were acutely fed CH for 6 hours to compare with 
those fed HFru. As shown in Fig. 3.6A, CH feeding only elevated the levels of ER stress 
markers Grp78 and phospho-IRE1, but not sXBP1 or phospho-eIF2α. HFru feeding, on the 
other hand, increased all the ER stress markers measured. Furthermore, HFru feeding also had 
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stronger effects on activation of Grp78 and phospho-IRE1 compared to CH feeding (p<0.05). 
No significant increase in any lipogenic proteins was observed with CH feeding but there was 
significant increase in ACC and SCD1 proteins with HFru feeding (Fig. 3.6B). These results 
suggest HFru has its specific role in the induction of ER stress and lipogenesis. 
 
Figure 3.6 HFru exacerbated the refeeding effects in liver. A seperate cohort of mice were 
fasted for 24 hours and one group were culled after fasting (Basal), whereas the rest were 
refed with either a CH or HFru for 6 hours. Liver homogenates were immunoblotted for 
markers from (A) ER stress pathway and (B) lipogenesis pathway as indicated. Values of 
density were normalized by CH group and data were presented as fold change. 6-8 mice per 
group. * p<0.05, ** p<0.01 vs Basal.  # p<0.05, ## p<0.01 vs CH. 
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3.3.7 CH did not affect hepatic insulin signalling during acute feeding 
Since chow diet only induced moderate ER stress during acute feeding, the sequential changes 
in inflammatory response and insulin signalling pathway were further examined. As shown in 
Fig. 3.7A, CH feeding was not able to induce the phosphorylation of JNK or IKK. 
Consistently, no difference was observed in serine-phosphorylated IRS1 (Fig. 3.7A) or 
insulin-stimulated phosphorylation of Akt with CH feeding (Fig. 3.8B).  
  
Figure 3.7 CH refeeding did not affect insulin signalling in liver. (A) Liver homogenates 
from fasted mice (Basal), 6-hour CH-refed or 6-hour HFru-refed mice were immunoblotted 
for phospho-JNK, phospho-IKKα/β and serine-phosphorylated IRS1. (B) In another cohort of 
mice, hepatic insulin signalling was assessed following insulin injection by phosphorylation 
of Akt using Western blot. Values of density were normalized by CH group and data were 
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presented as fold change. 5-8 mice per group. * p<0.05, ** p<0.01 vs Basal.  # p<0.05, ## 
p<0.01 vs CH. 
 
3.4 DISCUSSION 
The study in this chapter investigated the role of ER stress in insulin resistance using HFat 
and HFru fed mouse models. The results showed both HFat and HFru led to glucose 
intolerance and hepatic insulin resistance. While hepatic steatosis was apparent in both 
models, ER stress was only detected in HFru model, which was associated with an 
upregulation of lipogenic proteins. Further acute feeding experiments revealed that ER stress 
preceded lipogenesis and lipid accumulation and ER stress by itself was able to dampen 
insulin signal transduction, likely via activation of JNK and IKK. These effects were specific 
to HFru but not to CH, suggesting a unique mechanism of ER stress-induced insulin 
resistance under HFru feeding. 
Overconsumption of dietary fat and carbohydrate is a major factor leading to insulin 
resistance, which has been suggested to originate from the liver. Rats fed an HFat for 3 days 
showed hepatic insulin resistance without affecting insulin sensitivity in muscle [276]. A 
clinical study has shown that healthy subjects consuming a high-fructose diet for 6 days had 
impaired insulin action in the liver while skeletal muscle was unaffected [273]. In the current 
study, similar dietary compositions were used: diet enriched in fat (HFat) and diet enriched in 
fructose (HFru). The results showed that 2 weeks of HFat or HFru feeding in mice was 
sufficient to cause glucose intolerance. In addition, fasting blood glucose in both HFat- and 
HFru-fed mice was higher than CH-fed mice, suggesting dysregulated hepatic glucose 
production in these mice. This disruption may result from insulin resistance in the liver. 
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Indeed, further examination of insulin-stimulated phosphorylation of Akt and GSK3 revealed 
a blunted insulin signal transduction in the liver of both HFat- and HFru-fed mice. 
Both ectopic lipids and ER stress can account for the observed hepatic insulin resistance. 
Interestingly, increased liver triglycerides were detected in both HFat- and HFru-fed mice, 
while activated UPR pathways were only found in HFru-fed mice. The likely explanation for 
this discrepancy may come from the different pathways involved in dietary fat and dietary 
fructose-mediated lipid synthesis. In HFat-fed mice, fatty acids are directly provided to the 
liver. However, in HFru-fed mice, fatty acids need to be synthesized by lipogenic pathway 
from fructose metabolites. In support of this, upregulation of lipogenic proteins was only 
observed in HFru-fed mice. ER stress has been shown to regulate lipogenesis through IRE1 
and PERK pathways [146, 149]. Consistently, activation of these two pathways was also 
observed with HFru feeding, but not with HFat feeding. These results suggest HFat may cause 
hepatic insulin resistance via ectopic lipids while HFru may involve both lipid accumulation 
and ER stress. 
Using acute HFru feeding, ER stress was differentiated from lipogenesis. At 6 hours of HFru 
feeding, IRE1 and PERK pathways were already activated. However, there was no significant 
increase in the levels of lipogenic proteins (e.g. ACC, FAS, and SCD1) until 12 hours of 
feeding. In addition, liver triglycerides were not changed over these acute feeding periods. 
These results suggest that HFru-induced ER stress is likely to be a cause rather than a 
consequence of lipogenesis and lipid accumulation. Moreover, both JNK and IKK were 
activated at this point, likely through IRE1 or PERK [119, 277]. Activation of these two 
proteins further led to the phosphorylation of IRS1 at serine 307 site, resulting in the 
suppression of insulin signal transduction, supported by the reduction in insulin-stimulated 
Akt and GSK3 phosphorylation. These results suggest the upregulation of lipogenesis with 
HFru feeding may result from ER stress and ER stress by itself can cause the impairment in 
Chapter 3 – ER Stress in Diet-induced Insulin Resistance 
 
87 
insulin signal transduction, although my current results do not provide direct evidence that the 
upregulation of lipogenesis is due to activaition of ER stress. It is plausible that at an early 
stage of HFru feeding, ER stress plays a dominant role in the development of insulin 
resistance. This ocurrs before ER stress-initiated lipogenesis and lipid accumulation start to 
contribute. 
One confounding factor is the refeeding effect, as feeding mice CH after fasting has also been 
reported to induce ER stress [275]. However, in this study, mice fed the same amount of CH 
as HFru only exhibited minor ER stress, the degree of which is not comparable to that of 
HFru. In addition, no impairment in insulin signal transduction was observed in CH-fed mice. 
These results clearly indicate the specific role of fructose in the induction of ER stress and its 
associated impairment in insulin signal transduction. 
In summary, this study found that both HFat and HFru can lead to impaired glucose tolerance 
and hepatic insulin resistance. However, distinct mechanisms may be involved. ER stress only 
occurs to HFru feeding, which precedes upregulation of lipogenesis and accumulation of 
lipids. In addition, ER stress by itself can impair insulin signal transduction via activation of 
JNK/IKK. 
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Figure 3.8 Proposed mechanisms for HFru- and HFat-induced insulin resistance. Dietary 
fructose induces ER stress in the liver, which can activate inflammatory enzymes (e.g. JNK, 
IKK) and lead to insulin resistance; meanwhile, via activating SREBP-1c, ER stress also 
promotes hepatic steatosis which contributes to insulin resistance. Dietary fat, on the other 
hand, does not involve in the induction of ER stress and leads to insulin resistance largely 
through accumulation of ectopic lipids. 
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4.1 INTRODUCTION 
Autophagy, which literally means self-eating, is a non-selective bulk degradation process to 
maintain cellular homeostasis. It is a conserved survival mechanism and defective autophagy 
plays an important role in the pathogenesis of many diseases such as cancer, 
neurodegenerative, infectious and metabolic diseases [278]. The process of autophagy starts 
with sequestration of double-membraned phagophore from ER or Golgi, followed by the 
elongation of the phagophore membrane. This stage involves the participatation of a series of 
autophagy related genes (Atgs) and during this stage, autophagy targets such as protein 
aggregates or organelles are also engulfed by phagophore. Once the autophagosome vesicles 
are formed, they are fused with lysosomes and the protein contents are hydrolysed in 
autolysosomes. 
Endoplasmic reticulum (ER) is a multifunctional organelle in cells responsible for protein 
synthesis, folding and transportation. Under certain physiological or pathological conditions, 
normal ER functions can also be perturbed. This leads to the accumulation of unfolded 
proteins in the ER causing ER stress. Upon sensing the stress, a rescue mechanism− unfolded 
protein response (UPR) is thereby triggered to resolve the stress, through increasing ER 
folding capacity, reducing protein load and enhancing protein clearance. If the refolding is 
unsuccessful, unfolded/malfolded proteins need to be cleared through degradation. Over the 
past decade, there has been growing evidence to show autophagy is closely associated with 
ER stress [188, 279-281]. It is also suggested that autophagy is an alternative machinery to 
dispose unfolded proteins apart from ER-associated proteasomal degradation (ERAD) [188]. 
A number of studies have indicated that autophagy can be activated in response to ER stress 
as a protective mechanism [279-281]. On the other hand, autophagy has been reported to be 
suppressed in the liver of high-fat fed mice in association with ER stress [233, 282]. 
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Furthermore, disruption of autophagy function by genetic ablation of Atg7 in the liver led to 
hepatic ER stress and insulin resistance [233]. In pancreatic β cells, stimulation of autophagy 
by pharmacological agents attenuated ER stress and apoptosis, which led to the improvement 
in insulin secretion and reversal of diabetes [123]. 
The data presented in Chapter 3 show that ER stress by itself can impair insulin signal 
transduction via activation of JNK/IKK with HFru feeding. However, the mechanism by 
which fructose leads to ER stress is unknown. Therefore, the aim of this study is to investigate 
the role of autophagy in HFru-induced ER stress and insulin resistance and the effects of 
autophagy modulation on these metabolic events. 
 
4.2 MATERIALS AND METHODS 
4.2.1 Animal models 
4.2.1.1 Chronic and acute feeding 
Details were described in Section 3.2.1.1 and Section 3.2.1.2. 
4.2.1.2 Drug interventions 
All mice were first acclimatized for 1-2 weeks on a CH prior to fasting for 24 hours. Mice 
were then fed HFru for 6 hours. Rapamycin (Rap, 4 mg/kg, Santa Cruz Biotechnology, 
Australia), spermidine (Spd, 50 mg/kg, Sigma-Aldrich, Australia), resveratrol (Rsv, 25 mg/kg, 
Sigma-Aldrich, Australia) or carrier (Veh, 4% ethanol, 5% polyethylene glycol 400, 5% 
Tween 80) was injected intraperitoneally 1 hour prior to feeding [283-285]. To assess insulin 
action, another cohort of mice were injected with insulin (5 U/kg body weight) 
intraperitoneally along with glucose (3 g/kg body weight, to avoid hypoglycaemia) 40 min 
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before mice were culled. At the end of the experiments, mice were killed by cervical 
dislocation and liver tissues were freeze-clamped immediately. All experiments were 
approved by the Animal Ethics Committee of RMIT University. 
4.2.2 Liver explants 
Ex vivo studies were conducted as described previously [286]. Briefly, liver tissues were 
collected from CH-fed male C57BL/6 mice and immediately put into ice-cold Krebs-
Henseleit Buffer (KHB, containing 118 mM NaCl, 5 mM KCl, 1.2 mM MgSO4, 2.5 mM 
CaCl2, 1.2 mM KH2PO4, 25 mM NaHCO3, 1.1 mM MgSO4, 10 mM HEPES, 5 mM Glucose, 
pH 7.4, pre-gassed with carbogen). Tissues were then rinsed and chopped into 1-2 mm 
explants, followed by 30 min pre-incubation at 37oC under continuous gassing with carbogen. 
Liver explants were then incubated in KHB with or without 50 mM fructose for 2 hours as 
indicated. At the end of the experiments, tissues were pelleted and freeze-clamped for further 
analysis. 
4.2.3 Western blot 
Freeze-clamped tissues were homogenized in ice-cold RIPA lysis buffer at pH 7.5 
supplemented with protease/phosphatase inhibitors. Protein levels in the homogenates were 
determined using the bi-cinchonnic acid (BCA) method. Proteins were resolved by SDS-
PAGE. Levels of proteins were examined by immunoblotting using specific antibodies. 
Details were described in Section 2.8. 
4.2.4 Statistical analyses 
Data are presented as means ± SEM. One-way analysis of variance was used for comparison 
of relevant groups unless stated otherwise. When significant variations were found, the 
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Tukey-Kramer multiple comparisons test was applied. Differences at p < 0.05 were 
considered to be statistically significant. 
 
4.3 RESULTS 
4.3.1 Autophagy was suppressed in the liver of HFru-fed mice 
It was shown in Section 3.3.3 that 2 weeks of feeding with HFru but not HFat induced ER 
stress in the liver. In this study, the effect of diet on autophagy and the association with ER 
stress were examined. As shown in Fig. 4.1, levels of Atg 5 and Atg 7, two proteins involved 
in the phagophore membrane elongation were significantly reduced by 12% and 27% 
respectively in the liver of HFru-fed mice (p<0.05 vs CH), while neither of them was altered 
in HFat-fed mice. Autophagy activity is commonly assessed by the conversion of LC3II from 
LC3I [195], which is a key process during autophagosome formation. The results showed that 
HFru feeding reduced LC3II/LC3I ratio in the liver by 30% (p<0.05) compared with CH 
feeding, suggesting a suppression of autophagy activity. This suppression was further 
supported by accumulation of p62 (30% increase, p<0.05), a cargo receptor that directs target 
proteins to autophagic degradation [195]. Neither the ratio of LC3II/LC3I nor the protein 
levels of p62 was changed by HFat feeding. These results suggest that HFru suppressed 
autophagy in the liver, which may contribute to observed ER stress and insulin resistance. 
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Figure 4.1 HFru feeding suppressed hepatic autophagy. Autophagy was assessed in the 
liver of 2 weeks CH-, HFru- and HFat-fed mice by autophagy proteins Atg7, Atg5, 
LC3II/LC3I, and p62 using Western blot. Values of density were normalized by CH group 
and data were presented as fold change. 8-12 mice per group. * p<0.05, ** p<0.01 compared 
to CH. 
 
4.3.2 Both mTOR and AMPK were activated in the liver of HFru-fed mice 
mTOR and AMPK are two major regulators of autophagy activity [193]. Therefore, whether 
the suppression of autophagy induced by HFru was due to activation of mTOR/suppression of 
AMPK was examined. As shown in Fig. 4.2A, HFru feeding indeed activated mTOR in the 
liver, indicated by a 70% increase in phosphorylation compared to CH. This was further 
supported by the augmentation in the phosphorylation of two mTOR downstream targets, p70 
S6K (2.5 fold, p<0.05 vs CH) and 4E-BP1 (30%, p<0.05 vs CH). Interestingly, AMPK was 
also activated by HFru as indicated by increased phosphorylation of AMPK and AMPK 
downstream target ACC (60% and 40% respectively, both p<0.05 vs CH).  As AMPK is a 
positive regulator of autophagy, the results suggest activation of mTOR but not AMPK by 
HFru feeding contributes to the suppression of autophagy. 
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Figure 4.2 HFru feeding activated hepatic mTOR and AMPK. Activity of mTOR in the 
liver of 2-week CH- and HFru-fed mice was determined by the phosphorylation status of (A) 
mTOR and its downstream targets p70 S6K and 4E-BP1 using Western blot. Similarly, 
activity of AMPK was determined by the phosphorylation status of (B) AMPK and ACC. 
Values of density were normalized by CH group and data were presented as fold change. 8-12 
mice per group. * p<0.05, ** p<0.01 compared to CH. 
 
4.3.3 Fructose activated mTOR, suppressed autophagy and induced ER stress in liver 
explants 
It has been reported that mTOR can be activated by amino acids or insulin. In order to 
examine whether fructose had an independent effect on mTOR activation, liver explants were 
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incubated with fructose medium in the absence of amino acids or insulin. As shown in Fig. 
4.3, mTOR was activated by fructose in liver explants, suggested by a small but significant 
elevation in the levels of phosphorylated mTOR (25%, p<0.05 vs Control). This elevation 
was more apparent in the levels of phosphorylated p70 S6K (50%, p<0.05 vs Control). 
Activation of mTOR pathway was accompanied with suppressed autophagy, indicated by 25% 
reduction in LC3II/LC3I ratio. Moreover, ER stress was also observed after incubation with 
fructose medium, shown by a ~70% increase in two the ER stress markers phospho-IRE1 and 
phospho-eIF2α (both p<0.05 vs Control).  
 
Figure 4.3 Fructose activated mTOR, suppressed autophagy and induced ER stress ex 
vivo. Tissue homogenates from liver explants after 2 hours of incubation in medium with or 
without 50 mM frucose were immunoblotted for phospho-mTOR, phospho-p70 S6K, 
LC3II/LC3I, phospho-IRE1, phospho-eIF2α and GAPDH. Values of density were normalized 
by CH group and data were presented as fold change. * p<0.05 compared to Control (n=6). 
 
4.3.4 Change in mTOR-autophagy was an early event during HFru feeding 
Increased phosphorylation of mTOR and p70 S6K (2-4 fold vs CH), reduced LC3II/LC3I (25% 
vs CH, p<0.05) as well as accumulated p62 (30% vs CH, p<0.05) were also observed in the 
liver of 1-day HFru-fed mice (Fig. 4.4). Results from Section 3.3.4 showed that ER stress 
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occurred 6 hours after HFru feeding. To determine the temporal sequence of alteration in 
mTOR-autophagy pathway and induction of ER stress, these events were further examined in 
the acute HFru feeding model. The results showed that increases in the phosphorylation of 
mTOR (2.6 fold) and its downstream targets, p70 S6K (7 fold) and 4E-BP1 (25%) can be 
detected as early as 2 hours after HFru feeding (all p<0.05 vs Basal). At the same time, levels 
of autophagy protein Atg5 in the liver were significantly reduced (20% vs Basal, p<0.01) and 
Atg7 also showed a similar trend. Consistently, the ratio of LC3II/LC3I was reduced by 60% 
(p<0.01 vs Basal) whereas the p62 levels were increased by 60% (p<0.05 vs Basal) after 2 
hours of HFru feeding. 
 
Figure 4.4 One day of HFru feeding suppressed autophagy and activated mTOR. Liver 
tissues from 1-day CH and HFru-fed mice were immunoblotted for markers of mTOR and 
autophagy pathways: (left) representative blots of LC3II/LC3I, p62, phospho-mTOR, and 
phospho-p70 S6K with (right) densitometry. Values of density were normalized by CH group 
and data were presented as fold change. 4-6 mice per group. * p<0.05, ** p<0.01 compared to 
CH. 
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Figure 4.5 Acute HFru feeding activated mTOR and suppressed autophagy. Hepatic 
mTOR was determined by phosphorylation status of (A) mTOR, p70 S6K and 4E-BP1 using 
Western blot (B-D). Hepatic autophagy was assessed by autophagy proteins (E) Atg7, Atg5, 
LC3II/LC3I and p62 using Western blot (F-I). Values of density were normalized by Basal 
group and data were presented as fold change. 5-6 mice per group. * p<0.05, ** p<0.01 
compared to Basal.  
Chapter 4 – Autophagy and ER Stress 
 
99 
4.3.5 Restoration of autophagy alleviated ER stress 
To investigate whether HFru-induced ER stress is due to the suppression of autophagy, 
autophagy drug inducers were administrated to HFru-fed mice. Among these drugs, 
rapamycin (Rap) is mTOR-dependent while spermidine (Spd) and resveratrol (Rsv) are 
mTOR-independent. As expected, Rap suppressed mTOR phosphorylation (30%, p<0.01 vs 
Veh) and completely abolished p70 S6K phosphorylation induced by HFru feeding (Figs. 
4.6A-C). In contrast, neither Spd nor Rsv affected the phosphorylation status of these 
enzymes during the feeding period (Figs. 4.6A-C). Importantly, all three drugs were able to 
restore autophagy under HFru feeding, indicated by increased LC3II/LC3I ratio and reduced 
p62 protein level (Fig. 4.6A, D-E). Meanwhile, ER stress markers Grp78, phospho-IRE1, 
sXBP1 and phospho-eIF2α were all significantly reduced (Figs. 4.6F-J, all p<0.05 vs Veh). 
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Figure 4.6 Restoration of autophagy alleviated fructose-induced ER stress. After 24 
hours of fasting (Basal), mice were injected with vehicle control (Veh), rapamycin (Rap), 
spermidine (Spd) or resveratrol (Rsv) before acutely fed HFru for 6 hours. Markers of mTOR, 
autophagy and ER stress pathways in the liver of mice injected with vehicle (Veh), rapamycin 
(Rap), spermidine (Spd) or resveratrol (Rsv) were measured by Western blot: (A) phospho-
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mTOR, phospho-p70 S6K, Atg7, Atg5, LC3II/LC3I, p62 and respective densitometry (B-E); 
(F) Grp78, phospho-IRE1, sXBP1 and phospho-eIF2α with densitometry (G-J). Values of 
density were normalized by Basal group and data were presented as fold change. 6-8 mice per 
group. * p<0.05, ** p<0.01 compared to Basal, while # p<0.05, ## p<0.01 compared to Veh. 
 
4.3.6 Restoration of autophagy abolished JNK/IKK activation and improved insulin 
signalling  
Previous results from Section 3.3.5 showed HFru-induced ER stress impaired insulin signal 
transduction via activation of JNK/IKK and serine-phosphorylation of IRS1. Since treatments 
of autophagy inducers attenuated HFru-induced ER stress, these downstream events were 
further examined. As shown in Figs. 4.7A-E, in Rap, Rsv and Spd-treated mice, activation of 
JNK/IKK and serine-phosphorylation of IRS1 induced by HFru were completely abolished. In 
the meantime, insulin-stimulated phosphorylation of Akt was restored after the treatment of 
these autophagy drug inducers (all p<0.05 vs Veh) (Fig. 4.7F). Similar trend was also 
observed for insulin-stimulated phosphorylation of GSK3β, although no statistical difference 
was achieved (Fig. 4.7G). 
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Figure 4.7 Restoration of autophagy improved insulin signal transduction. JNK/IKK-
IRS1 signalling cascade was measured in the liver of mice injected with vehicle (Veh), 
rapamycin (Rap), spermidine (Spd) or resveratrol (Rsv) by Western blot: (A) representative 
blots of phospho/total-JNK, phospho/total-cJun, phospho/total-IKK, and phospho-IRS1 with 
densitometry (B-E). Hepatic insulin signalling was assessed in another cohort of mice 
following insulin injection by the phosphorylation of (F) Akt and (G) GSK3β using Western 
blot. Values of density were normalized by Basal group and data were presented as fold 
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change.6-8 mice per group. * p<0.05, ** p<0.01 compared to Basal, while # p<0.05, ## p<0.01 
compared to Veh. 
 
4.4 DISCUSSION 
The study in this chapter investigated the role of autophagy in the development of diet-
induced ER stress and insulin resistance. Several major findings have emerged from this study. 
Firstly, for the first time HFru feeding was found to result in suppression of autophagy in the 
liver. Secondly, this suppression is likely to be mediated by mTOR, which is activated by 
fructose independent of insulin and amino acids. Finally, restoration of autophagy by 
pharmacological agents is able to ameliorate ER stress and normalize insulin signalling 
irrespective of mTOR activity (Fig. 4.8). 
In Chapter 3, ER stress was shown only to be detected in the liver of HFru-fed mice but not in 
HFat-fed mice. Interestingly, autophagy was also found to be altered in HFru-fed mice only, 
indicating a close link between autophagy and diet-induced ER stress. Autophagy has been 
suggested to be triggered by ER stress in assistance of protein clearance [281]. Intriguingly, 
this study showed that autophagy was suppressed rather than activated in the presence of ER 
stress in the liver after mice were fed HFru for a 2-week period. Similar observations were 
also made in mice acutely fed HFru for 2-12 hours and in liver explants incubated with 
fructose-containing medium. In support of this finding, recent studies from others have also 
shown hepatic ER stress is associated with  suppression of autophagy in HFat-fed and ob/ob 
mice [233] and disruption of autophagy function by genetic ablation of Atg proteins can lead 
to ER stress [233, 287]. Collectively, these data suggest hepatic ER stress during HFru 
feeding may result from the suppression of autophagy. This is confirmed by the attenuation of 
ER stress after restoration of autophagy using pharmacological agents under HFru feeding. 
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To investigate the mechanism responsible for the suppression of autophagy, the effect of 
HFru feeding on mTOR and AMPK was examined. mTOR and AMPK are two major 
regulators of the autophagy process and important nutrient/energy sensors [193]. Upon 
nutrient sufficiency, mTOR is activated and blocks the initiation of autophagy, while AMPK 
can disrupt this process and activate autophagy. Therefore, the observed suppression in 
autophagy by fructose can result from activation of mTOR, inhibition of AMPK or both. 
Interestingly, the results showed activity of both mTOR and AMPK was increased in the liver 
of HFru-fed mice. It was thus concluded that activated mTOR is likely to be responsible for 
the observed suppression in autophagy. Activation of mTOR pathways (mTOR, p70 S6K and 
4E-BP1) was also detected in the liver after mice were acutely fed HFru for 2-12 hours. 
Furthermore, inhibition of mTOR with rapamycin in HFru-fed mice was shown to relieve the 
suppression of autophagy. These data further confirm that fructose-mediated suppression of 
autophagy resulted from the activation of mTOR. mTOR can be activated by insulin and 
amino acids [288, 289]. However, despite overt activation of mTOR after two weeks of HFru 
feeding, plasma insulin levels and basal phosphorylation of Akt and GSK3β in the liver were 
unaltered. The protein content in the HFru is similar to that in CH, therefore, it is unlikely that 
HFru may increase the concentration of amino acids in the circulation although this was not 
measured. In liver explants, fructose also activated mTOR in the absence of insulin and amino 
acids, although the chosen dose of fructose was higher than physiological conditions. These 
data indicate that fructose may directly activate mTOR in the liver. 
Although stimulation of autophagy through inhibition of mTOR was able to ameliorate ER 
stress, mTOR itself has also been reported to affect ER stress and insulin action [290, 291]. 
To examine the independent role of autophagy in HFru-induced ER stress, mTOR-
independent autophagy inducers spermidine and resveratrol were used [283, 285]. The results 
showed that both drugs were able to restore autophagy and alleviate ER stress without 
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affecting fructose-induced mTOR activation. In addition, Bachar-Wikstrom et al also 
demonstrated attenuation of ER stress by stimulating autophagy through mTOR inhibition 
and this effect on ER stress was abolished after co-treatment of autophagy inhibitors [123]. 
These data together suggest that the role of autophagy in ER stress is independent of mTOR. 
As shown in Chapter 3, 6 hours of HFru feeding was sufficient to impair insulin signal 
transduction in the liver. This impairment was accompanied with activation of JNK/IKK 
pathways and serine-phosphorylation of IRS1. Importantly, when ER stress was alleviated by 
stimulation of autophagy, both JNK/IKK and Akt/GSK3β signalling cascades were corrected. 
These results indicate that restoration of autophagy is able to ameliorate ER stress and abolish 
the impairment of insulin signal transduction induced by HFru feeding. 
In conclusion, this study provides the first evidence that suppressed autophagy contributes to 
hepatic ER stress and insulin resistance induced by HFru. The results show that restoration of 
the normal functions of autophagy is able to alleviate ER and improve insulin signal 
transduction. These findings also provide the scientific rationale for targeting the autophagy 
pathway for the treatment of hepatic insulin resistance and associated metabolic disorders. 
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Figure 4.8 Proposed mechanisms for fructose-induced ER stress and insulin resistance. 
Dietary fructose activates mTOR in the liver, resulting in a suppression of autophagy. 
Suppressed autophagy leads to ER stress and associated steatosis and insulin resistance. These 
metabolic defects can be reversed by stimulation of autophagy through either mTOR 
inhibition (Rapamycin) or mTOR-independent mechanisms (Spermidine and Resveratrol). 
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5.1 INTRODUCTION 
The endoplasmic reticulum (ER) is a primary location for the synthesis and folding of 
proteins prior to trafficking to appropriate cellular compartments. It is also the site where 
misfolded and defective proteins are targeted for degradation via the ubiquitin protease 
system (UPS) [292] or autophagy [293]. For normal physiological cellular functions to be 
maintained, these processes must work in a co-ordinated manner so that damaged/misfolded 
proteins are efficiently removed [294]. Accumulation of proteins, where one or more of these 
processes is sub-optimal or defective, can lead to ER stress and is associated with many 
chronic diseases such as Alzheimer’s disease, Parkinson’s disease, cardiovascular disease, 
non-alcoholic fatty liver disease and diabetes [121]. 
In an attempt to restore the protein homeostasis in the ER, a canonical unfolded protein 
response (UPR) is initiated, of which upregulation of machineries responsible for the 
degradation of unfolded proteins is a key element [121]. Protein degradation is carried out by 
two major pathways: the ubiquitin proteasome system (UPS) and autophagy. UPS has been 
associated with the proteasomal degradation of small, short-lived proteins ubiquitinated by E3 
ubiquitin ligases whereas autophagy has been associated with the degradation of long-lived 
proteins/protein aggregates via engulfment into autophagosomes and subsequent fusion with 
lysosomes [295]. Meanwhile, there is also crosstalk between these two pathways, in which E3 
ubiquitin ligases play a central role [295, 296]. To date, more than 10 E3 ubiquitin ligases 
have been discovered to interfere with autophagy [296]. One possible mechanism of this 
interaction is that E3 ubiquitin ligase-mediated ubiquitination may regulate the stability of 
certain autophagy proteins or upstream regulators [297]. The other possible mechanism is that 
E3 ubiquitin ligases may act as cargo receptors, directing ubiquitinated substrates to 
autophagy for degradation [234, 298]. 
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Studies from this lab [299] and other groups [232, 300] have demonstrated the important role 
of autophagy in ER stress. UPS has also been shown to be closely related to ER stress. It was 
reported that chemical-induced ER stress can compromise the UPS function and cause the 
accumulation of UPS reporter substrates in cells [241]. Inhibition of proteasome has also been 
shown to induce ER stress and ER stress-associated apoptosis [301]. Importantly, a number of 
E3 ubiquitin ligases have been identified to be upregulated by ER stress, such as RNF-121 
[245] and Siah1/2 [246]. Overexpressing certain E3 ubiquitin ligases like gp78 and HRD1 has 
also been shown to protect against ER stress [243, 244]. 
Neural precursor cell expressed developmentally down-regulated protein 4 (Nedd4) is a 
family of E3 ubiquitin ligases, of which Nedd4 and Nedd4-2 are the closest members. Nedd4 
and Nedd4-2 are structurally similar, featuring an N-terminal C2 domain (Ca2+/lipid-binding 
domain), two to four WW domains (substrate binding domain), and a C-terminal HECT 
domain (ubiquitin-protein ligase domain) [267]. Recently, it was reported that Nedd4 was 
upregulated in mouse brain tissue under oxidative stress [268], suggesting Nedd4 can be 
responsive to stress conditions. Moreover, Nedd4 was also shown to control the stability of 
autophagy protein Beclin1 via polyubiquitination with Lys11- and Lys63-linked chains, 
although the specific effect on autophagy activity is still unknown [269]. However, no report 
has been found characterising the relationship between Nedd4-2 and ER stress/autophagy. 
Therefore, the aim of this study was to investigate the role of Nedd4 and Nedd4-2 in ER stress 
and examine their possible interaction with autophagy. 
 
5.2 MATERIALS AND METHODS 
5.2.1 Animal models 
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Two to eighteen-week chronic feeding on CH, HFat or HFru was performed as described in 
Section 3.2.1.1. Two to twelve-hour acute feeding on HFru was described in Section 3.2.1.2. 
5.2.2 Cell culture, RNA oligos, plasmids, and transfections 
Mouse embryonic fibroblasts (MEFs), HeLa cells and HEK293 cells were cultured in 
Dulbecco’s modified essential medium (DMEM) supplemented with 10% Fetal Bovine 
Serum and 1% Penicillin Streptomycin (all from Invitrogen, Australia). Nedd4-2 specific and 
AllStars Negative Control small interfering RNAs (siRNAs) were purchased from Qiagen, 
Australia. ON-TARGETplus XBP1 specific and Non-targeting Control siRNAs were 
purchased from GE Healthcare, Australia. FLAG-tagged Nedd4-2 plasmids and control 
pcDNA3 plasmids were generous gifts from Prof. Sharad Kumar, University of Adelaide. 
Both siRNAs and plasmids were transfected with Lipofectamine 2000 following manufacturer 
protocols (Invitrogen, Australia). Drug treatments were performed 24 hours after transfection. 
5.2.3 Pharmacological stimulation of ER stress and starvation 
The day before treatments, MEFs were seeded into 12-well plates. The next day, cells were 
incubated with ER stress inducer tunicamycin (Tm, 1µg/ml) or thapsigargin (Tg, 100 nM) for 
6 hours or 24 hours (both from Sigma-Aldrich, Australia). After the incubation, cells were 
washed with PBS and harvested for protein analysis by Western blot. 
Twenty four hours after transfection, HEK293 cells were either subjected to the drug 
treatments as described above or a starvation protocol. The starvation protocol involved 
incubating the cells for 2 hours with Earle's Balanced Salt Solution (EBSS, Invitrogen, 
Australia) prior to washing in PBS. Cells were then harvested for protein analysis prior to 
washing in PBS and harvested for protein analysis by Western blot. 
5.2.4 Western blot 
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Freeze-clamped tissues were homogenized in ice-cold RIPA lysis buffer at pH 7.5 
supplemented with protease/phosphatase inhibitors. Protein levels in the homogenates were 
determined using the bi-cinchonnic acid (BCA) method. Proteins were resolved by SDS-
PAGE. Levels of proteins were examined by immunoblotting using specific antibodies. 
Details were described in Section 2.8. 
5.2.5 Measurement of autophagic flux 
Indirect immunofluorescence was performed as described in Section 2.13. FLAG-Nedd4-2 
was detected by immune-labelled FLAG protein and autophagic puncta were detected by 
immune-labelled LC3 protein. To determine autophagy flux, numbers of LC3 puncta 
representing autophagosomes and numbers of nucleus were counted respectively. Autophagy 
flux was expressed as an average of LC3 puncta per cell in a minimum of 100 cells. 
5.2.6 Long-lived protein degradation assay 
Long-lived protein degradation assay was performed as described in Section 2.14. 
5.2.7 Statistical analyses 
Data are presented as means ± SEM. One-way ANOVA analysis of variance was used for 
comparison of the relevant groups unless stated otherwise. When significant differences were 
found, the Tukey-Kramer multiple comparisons test was applied. Differences at p<0.05 were 
considered to be statistically significant. 
 
5.3 RESULTS 
5.3.1 Nedd4-2 but not Nedd4 is upregulated with HFru and HFat-induced ER stress 
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Previously it was shown that ER stress can be induced by HFru feeding in mice [153]. 
Consistent with this report, after 2 weeks of HFru feeding, there were significant increases in 
ER stress markers in the liver compared to CH controls, namely phosphorylated IRE1 (5.2 
fold), IRE1 target− sXPB1 (1.6 fold), phosphorylated PERK (1.9 fold) and phosphorylated 
eIF2α (2.0 fold, Fig. 5.1A). Nedd4-2 was also significantly increased (2.0 fold) in the liver of 
HFru-fed mice. In contrast, there was no change in any of these ER stress markers or Nedd4-2 
protein levels in HFat-fed mice after the same period. In addition, there was no difference in 
Nedd4 protein levels in any experimental group. 
Since long-term HFat feeding (16 weeks) has been suggested to cause ER stress [118], I 
studied whether the upregulation of Nedd4-2 specifically resulted from an HFru feeding or 
could be upregulated by any diet that induces ER stress. To test this, I further fed mice HFru 
or HFat chronically for 18 weeks. Consistent with previous report, chronic HFat feeding was 
able to cause ER stress as indicated by a 1.7 fold increase in sXBP1 and 1.8 fold increase in 
phosphorylated eIF2α (Fig. 5.1B). Importantly, there was also a 1.4 fold increase in the 
protein levels of Nedd4-2. HFru feeding over the same time period generated very similar 
data to 2-week HFru feeding, demonstrating that elevation of phospho-IRE1, sXBP1, 
phospho-PERK, phospho-eIF2α and Nedd4-2 levels were sustained for at least 18 weeks. No 
difference in Nedd4 protein levels was observed in chronically HFru- or HFat-fed mice. 
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Figure 5.1 Nedd4-2 but not Nedd4 was upregulated in the liver with ER stress. C57BL/6 
mice were fed on CH, HFru or HFat for (A) 2 weeks or (B) 18 weeks. Liver tissues were 
collected at the end of the experiment and tissue homogenates were prepared for Western blot 
to analyze ER stress markers, namely p-IRE1, sXBP1, p-PERK, p-eIF2α and eIF2α, as well 
as Nedd4 and Nedd4-2. Values of density were normalized by CH group and data were 
presented as fold change. 8-12 mice per group in 2-week feeding experiment and 4 mice per 
group in 18-week feeding experiment. * p<0.05, ** p<0.01 compared to CH. 
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5.3.2 Nedd4-2 was upregulated by ER stress inducers in vitro 
As the increase in Nedd4-2 protein observed in dietary animal models may be regulated by 
other factors apart from ER stress, Nedd4-2 protein levels were further examined in MEFs 
using the well-established ER stress inducers, tunicamycin (Tm) and thapsigargain (Tg). Tm 
causes ER stress by inhibiting N-linked glycosylation which disrupts protein folding whereas 
Tg compromises ER function by depleting ER calcium stores [302]. MEFs were incubated 
with Tm (1 µg/ml) or Tg (100 nM) for 6 hours or 24 hours, after which protein levels of ER 
stress markers and Nedd4-2 were measured (Fig. 5.2). As expected, a 6-hour treatment of Tm 
or Tg resulted in activation of both the IRE1 and PERK branch of UPR pathways in MEFs. 
Activation of the IRE1 pathway was supported by 2-4 fold increases in the protein levels of 
phospho-IRE1 and sXPB1 in Tm- and Tg-treated cells comparing to control cells (Fig. 5.2A, 
B). This activation was more pronounced in the PERK pathway, evidenced by 3-5 fold 
increases in eIF2α phosphorylation and CHOP expression, as well as 8-12 fold increases in 
ATF4 expression (Figs. 5.2C-E). Notably, a ~2 fold increase in Nedd4-2 expression was 
observed in association with these changes (Fig. 5.2F). After 24 hours of treatment with Tm, 
levels of these ER stress markers were still comparable to the ones after 6 hours of Tm 
treatment. However, in Tg-treated cells, levels of these markers dropped after 24 hours of 
incubation, possibly due to reduced cell viability. Consistently, Nedd4-2 expression was 
increased only in Tm-treated cells but not in Tg-treated cells at 24-hour time point. 
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Figure 5.2 Nedd4-2 was upregulated in MEFs after treatments of ER stress inducers. 
Cell lysates from MEFs were treated with tunicamycin (Tm, 1µg/ml) or thapsigargin (Tg, 100 
nM) for 6 hours or 24 hours were subjected to Western blot to measure ER stress markers, 
namely (A) p-IRE1, (B) sXBP1, (C) p-eIF2α, (D) ATF4 and (E) Chop, as well as (F) Nedd4-
2. Values of density were normalized by Con group and data were presented as fold change. 
Bars represent the mean ± SE of 4 independent experiments; * p<0.05, ** p<0.01 compared 
to vehicle control (Con). 
 
5.3.3 Nedd4-2 protein expression may be modulated by XBP1 
I next studied whether changes in Nedd4-2 levels was specifically related to the activation of 
the IRE1 pathway or the PERK pathway. I have previously reported that the IRE1 but not the 
PERK pathway is the first UPR branch to be activated in the liver when mice were subjected 
to 1 day of HFru feeding [55]. Interestingly, a significant increase in Nedd4-2 protein 
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expression was also observed over the same HFru-feeding period (1.5 fold, p<0.05 vs CH, Fig. 
5.3A). Refeeding after fasting has been shown to activate XBP1 [275]. I therefore fasted mice 
for 24 hours before refeeding them with HFru for 2 hours, 6 hours, or 12 hours. The results 
showed that after 6 hours of HFru-refeeding there was already a significant increase in sXBP1 
protein levels (1.3 fold, p<0.05 vs FD, Fig. 5.3B). This increase became more apparent after 
12 hours of refeeding (1.7 fold, p<0.01 vs FD). Increase in Nedd4-2 expression followed a 
similar trend as sXPB1, a 1.6-fold increase was observed at the 6-hour time point and a 2-fold 
increase at the 12-hour time point (both p<0.01 vs FD, Fig. 5.3C). Further analysis of these 
data showed a significant correlation between Nedd4-2 and sXBP1 protein levels during 
refeeding (r2=0.4937, p<0.01, Fig. 5.3D). This led to the hypothesis that the alteration in 
Nedd4-2 protein expression may be modulated by sXBP1. To confirm whether there is a 
direct causal link between XPB1 and Nedd4-2 expression, I knocked down XBP1 protein in 
HEK293 cells using siRNAs. Compared to scrambled siRNAs (Scr), transfection of XBP1 
siRNAs (XBP1) resulted in ~40% reduction in sXBP1 protein levels. This also resulted in a 
~30% decrease in the expression of a XPB1 target Grp78 (p<0.05 vs Scr) [303] and a ~30% 
reduction in Nedd4-2 expression (p<0.05 vs Scr, Fig. 5.3E). 
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Figure 5.3 Nedd4-2 may be regulated by XPB1. (A) Liver tissues from mice fed CH, HFru 
or HFat for 1 day were prepared for Western blot to analyze Nedd4-2. Values of density were 
normalized by CH group and data were presented as fold change. 6 mice per group. * p<0.05, 
**
 p<0.01 compared to CH. (B-C) C57BL/6 mice were fasted for 24 hours (FD) and then fed 
with HFru for 2 hours, 6 hours or 12 hours. Liver tissues were collected at the end of each 
time point and tissue homogenates were analyzed by Western blot to measure sXBP1 and 
Nedd4-2. Values of density were normalized by FD group and data were presented as fold 
change. 6-8 mice per group. * p<0.05, ** p<0.01 compared to FD. (D) Correlation of 
sXBP1/Tubulin with Nedd4-2/Tubulin by a best-fit regression analysis. (E) HEK293 cells 
were transfected with scrambled (Scr) or XBP1 specific siRNAs. 48 hours after transfection, 
proteins were extracted from cells and analyzed by Western blot to measure sXBP1, Grp78 
and Nedd4-2. Values of density were normalized by Scr group and data were presented as 
fold change. 
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5.3.4 Nedd4-2 deficiency exacerbated ER stress and inhibited autophagy 
To investigate the functional role of Nedd4-2 in ER stress, I further knocked down 
endogenous Nedd4-2 in HEK293 cells before exposed them to Tm and Tg. The results 
confirmed that transfection of Nedd4-2 specific siRNAs markedly reduced Nedd4-2 protein 
levels by approximately in ~80% compared to scrambled siRNAs (p<0.01) (Fig. 5.4A). This 
was associated with a ~1.5 fold increase in ER stress marker phosopho-IRE1, but no 
difference in phospho-eIF2α levels was observed (Fig. 5.4B, C). Tm and Tg treatments 
induced phosphorylation of IRE1 in control cells, and this phosphorylation was further 
elevated in Nedd4-2 deficient cells (Fig. 5.4B). Increased eIF2α phosphorylation was also 
observed with Tm and Tg treatment, but there was no difference between the control and 
Nedd4-2 knockdown cells (Fig. 5.4C). 
To examine whether autophagy is affected by Nedd4-2 deficiency, I measured autophagy 
levels by quantifying the ratio of the autophagy proteins LC3II and LC3I. The conversion of 
LC3I to LC3II is a key step during autophagosome formation. As shown in Figure 5.4D, 
treatment with either Tm or Tg increased the ratio of LC3II/LC3I by 6 fold and 1.3 fold 
respectively. Knockdown of Nedd4-2 not only suppressed these responses under ER stress 
conditions (p<0.05 vs Tm- or Tg-treated control cells) but also reduced the LC3II/LC3I ratio 
by 40% at basal stage (p<0.05 vs untreated control cell). The effect of Nedd4-2 deletion on 
autophagy was further assessed by the formation of autophagosomes, which were detected by 
fluorescent LC3 puncta. In agreement with the elevation in LC3II protein, treatment with Tm 
significantly increased the number of LC3 puncta in control cells (>2 fold, p<0.01vs Scr-Con, 
Fig. 5.4E). In Nedd4-2 deficient cells, basal levels of LC3 puncta were reduced by over 50% 
comparing to control cells (p<0.01 vs Scr-Con). This reduction was still apparent after the 
treatment of Tm (p<0.01 vs Scr-Tm). The effect of Nedd4-2 deletion on autophagy was 
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further examined by long-lived protein degradation assay in HeLa cells. In control cells, 
starvation increased the degradation rate by 2.7 fold, which was slightly lower in Nedd4-2 
deficient cells, although no significant difference was achieved. I next studied whether 
autophagy was also suppressed in liver of mice with Nedd4-2 deficiency. As depletion of 
Nedd4-2 causes neonatal death in mice [304], I examined the levels of autophagy markers in 
livers from Nedd4-2 heterozygous (Het) mice with reduced Nedd4-2 protein levels (70%, 
p<0.01 compared to wild type mice) (Fig. 5.4G). Consistent with results observed in cell lines, 
livers from Nedd4-2 Het mice exhibited a 30% reduction in LC3II/LC3I ratio compared to the 
wild type (WT) litter mates (p<0.05, Fig. 5.4G). In addition, a 20%-30% reduction in the 
expression of other autophagy related protein, including Beclin1, Atg4B and Atg3 was also 
observed (p<0.05 vs WT). 
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Figure 5.4 Nedd4-2 deficiency exacerbated ER stress and inhibited autophagy. (A) 
Proteins extracted from HEK293 cells transfected with scrambled (Scr) or Nedd4-2 (ND4) 
specific siRNAs for 48 hours were analyzed by Western blot to measure Nedd4-2 protein 
levels. Values of density were normalized by Scr group and data were presented as fold 
change. (B-D) Twenty-four hours of siRNA transfection, HEK293 cells were treated with 1 
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µg/ml Tm, 100 nM Tg or DMSO (Con) for another 24 hours. Cell lysates were analyzed by 
Western blot to measure ER stress markers p-IRE1 and eIF2α, as well as autophagy marker 
LC3. Values of density were normalized by Con_Scr group and data were presented as fold 
change. Data were from 3 independent experiments; * p<0.05, ** p<0.01 compared to 
scrambled siRNA group (Scr); # p<0.05, ## p<0.01 compared to drug-treated scrambled 
siRNA group (Scr). (E) Twenty-four hours of siRNA transfection, HEK293 cells were treated 
with 1 µg/ml Tm or DMSO (Con) for another 24 hours. Cells were fixed for confocal study to 
measure autophagic puncta. Autophagosomes were labelled and detected by LC3 antibody 
(green) whereas nuclei were stained with DAPI (blue). The number of LC3 puncta were 
counted in a minimum of 100 cells and presented as mean ± SE per cell; ** p<0.01 compared 
to untreated control group (Scr, Con); ## p<0.01 compared to Tm-treated control group (Scr-
Tm). (F) HeLa cells transfected with Src or ND4 siRNAs were incubated with 3H-labeled 
leucine (1 μCi/ml) for 24 hours. Autophagy activity was measured as the degradation of 
long-lived proteins in growth medium or starvation medium (EBSS) for 2 hours. Values were 
normalized by Con_Scr group and data were presented as fold change. Data were from 3 
independent experiments; * p<0.05, ** p<0.01 compared to respective basal group (Con). (G) 
Liver tissues were collected from age matched Nedd4-2 heterozygous mice (Het) and their 
litter mates (WT). Tissue homogenates were prepared for Western blot to analyze Nedd4-2 
and autophagy markers Beclin1, Atg4B, Atg5-Atg12, Atg7, Atg3 and LC3. Values of density 
were normalized by WT group and data were presented as fold change. 5 mice per group. * 
p<0.05, ** p<0.01 compared to WT. 
 
5.3.5 Nedd4-2 overexpression activated autophagy in HEK293 cells 
The results above indicate that reduction in Nedd4-2 protein levels leads to inhibition of 
autophagy and possible elevation of ER stress. I next reasoned that overexpression of Nedd4-
2 may enhance autophagy and on the contrary, protect cells against ER stress. To test this, 
control vector (pcDNA3) or Nedd4-2 expressing vector (Nedd4-2-FLAG) were transfected 
into HEK293 cells (Fig. 5.5A). Autophagy was assessed by the ratio of LC3II/LC3I and the 
number of LC3 puncta before (standard growth medium) and after a 2-hour starvation (EBSS 
medium). As shown in Fig. 5.5B, Nedd4-2 overexpression increased autophagy at basal stage, 
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supported by a 1.5 fold increase in LC3II/LCI (p<0.05 vs non-starved control). As expected, 
nutrient starvation by incubating cells in EBSS medium for 2 hours activated autophagy, as 
indicated by a 2.3 fold increase in LC3II/LCI. This increase was further enhanced by Nedd4-2 
overexpression (p<0.01 vs EBSS-starved control). Consistently, confocal analysis of LC3 
puncta revealed that Nedd4-2 overexpression increased the number of LC3 puncta by ~2 fold 
at basal stage (p<0.05 vs non-starved control, Fig. 5.5C and D). Starvation with EBSS 
medium caused a 2-fold increase (p<0.05 vs non-starved control) in the number of LC3 
puncta in control cells. Overexpression of Nedd4-2 further increased starvation-induced LC3 
puncta by 1.6 fold (p<0.05 vs starved control). 
 
Figure 5.5 Nedd4-2 overexpression activated autophagy in HEK cells.(A) Proteins 
extracted from HEK293 cells transfected with control vector (Con) or vector expressing 
Nedd4-2-FLAG were analyzed by Western blot to measure Nedd4-2 protein. (B) HEK293 
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cells were transfected as described in (A) and were then incubated in full growth medium or 
starvation medium (EBSS) for 2 hours. Proteins were extracted from cells and detected by 
Western Blot to measure LC3. Values of density were normalized by Con (-EBSS) group and 
data were presented as fold change. Bars represent the mean ± SE of 3 independent 
experiments. * p<0.05, ** p<0.01 compared to non-starved control group (Con, -EBSS); ## 
p<0.01 compared to the starved control group (Con, +EBSS). (C) HEK293 cells were treated 
as described in (B). Then cells were fixed for confocal study to measure autophagic puncta. 
Exogenous Nedd4-2 was labelled and detected by FLAG antibody (green); autophagosomes 
were labelled and detected by LC3 antibody (red); nuclei were stained with DAPI (blue). (D) 
The number of LC3 puncta were counted in a minimum of 100 cells and presented as mean ± 
SE per cell; ** p<0.01 compared to non-starved control group; ## p<0.01 compared to starved 
control group (Con, +EBSS). 
 
5.3.6 Nedd4-2 overexpression reduced ER stress 
I next examined whether Nedd4-2 overexpression was also able to reduce ER stress induced 
by Tg. As shown in Figure 5.6, Tg treatment increased the levels of ER stress markers 
phospho-IRE1 and sXBP1 by 1.6 fold and 1.5 fold respectively in control cells. Meanwhile, 
1.8-fold increase in phospho-eIF2α and 2.2-fold increase in ATF4 were also observed in Tg-
treated control cells. Overexpression of Nedd4-2 significantly reduced levels of sXBP1, 
phospho-eIF2α and ATF4 elevated by Tg treatment, although no difference was observed in 
the phosphorylation of IRE-1 (p<0.05 vs Tg-treated control cells). 
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Figure 5.6 Nedd4-2 protects against thapsigargin-induced ER stress. HEK293 cells were 
transfected with control vector (Con) or vector expressing Nedd4-2-FLAG. 24 hours after 
transfection, cells were incubated in growth medium with either 0.1% DMSO (-Tg) or 0.1% 
DMSO containing 100 nM Tg (+Tg) for another 24 hours. At the end of experiments, proteins 
were extracted from cells and detected by Western Blot to measure ER stress markers (A) p-
IRE1, (B) sXBP1, (C) p-eIF2α and (D) ATF4. Values of density were normalized by Con(-
TG) group and data were presented as fold change. Bars represent the mean ± SE of 4 
independent experiments. * p<0.05, ** p<0.01, compared to untreated control cells (-Tg); # 
p<0.05, compared to Tg-treated control cells (+Tg). 
 
5.4 DISCUSSION 
The current study investigated the role of E3 ubiquitin ligases Nedd4-2 in ER stress and its 
possible interaction with autophagy. The results revealed that Nedd4-2 but not Nedd4 was 
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upregulated with HFru- and HFat-induced ER stress in the liver of mice. Upregulation of 
Nedd4-2 was also observed in cells after the treatment of ER stress drug inducers Tm and Tg. 
Moreover, protein level of Nedd4-2 correlated with that of sXPB1 and knockdown of XBP1 
in cells appeared to lower Nedd4-2 expression. Interestingly, Nedd4-2 was also shown to 
modulate autophagy, where deletion of Nedd4-2 inhibited autophagy and overexpression of 
Nedd4-2 had an opposite effect. Finally, Nedd4-2 overexpression exerted a protective role 
against Tg-induced ER stress (Fig. 5.7).  
E3 ubiquitin ligases are involved in the last step of ubiquitination of proteins, targeting for 
trafficking or degradation [234]. As an important component of protein degradation, the UPS 
has been shown to participate in the UPR [237]. A number of ubiquitin ligases have been 
identified to be responsive to ER stress, such as Parkin, HRD1 and gp78 [243, 244, 247]. In 
addition to these findings, this study found that another E3 ubiquitin ligase−Nedd4-2 can be 
upregulated by ER stress in response to a number of physiologic or pathologic stimuli, such as 
nutrients and drugs. The concurrent increases in sXPB1 and Nedd4-2 proteins demonstrated a 
great correlation of the expression of these two proteins. Of the three UPR pathways, the 
IRE1-XBP1 arm has been shown to play an important role in protein degradation [305]. It has 
been reported that induction of ER stress by introducing misfolded proteins diminished XPB1 
protein in neurons, which was followed by prominent ubiquitin aggregation, suggesting ER 
stress-induced XPB1 depletion may impair the UPS functions [306]. Moreover, as a 
transcriptional factor, XPB1 has been shown to regulate the expression of a variety of proteins 
in response to ER stress, such as Derlin-2 [307] and Grp78 [303]. In view of this I 
hypothesised that upregulation of Nedd4-2 with ER stress may be mediated by XBP1. Indeed, 
knockdown of XBP1 by siRNAs in HEK293 cells resulted in a reduction in Nedd4-2 protein 
expression, suggesting Nedd4-2 may be an XBP1 target. A recent study has demonstrated 
Nedd4-2 expression can be regulated by CREB protein in hepatocytes [308]. As a member of 
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the CREB/ATF family, XPB1 also has a high binding affinity to CRE/CRE-like sequence 
[309]. It is plausible that XBP1 and CREB may share some of the regulatory regions and both 
can bind to Nedd4-2 promoter and regulate its expression. 
Although E3 ubiquitin ligases and ubiquitination can be upregulated by ER stress, it is 
interesting to note that ER stress can also induce autophagy without affecting proteasome 
activity in neuronal cells [310]. It is possible that unfolded proteins or protein aggregates that 
are targeted by certain E3 ubiquitin ligases can be directed to autophagosomes, instead of 
being delivered to proteasomes for degradation. In this process of selective autophagy, E3 
ubiquitin ligases could be acting as cargo receptors for the protein targets [298]. Interestingly, 
I observed that knockdown of Nedd4-2 significantly suppressed autophagy at basal stage, 
both in vitro and in vivo. Additionally, consistent with a previous report [232], autophagy was 
activated by ER stress inducers Tm and Tg as a cytoprotective response in control cells, and 
this response was impaired in Nedd4-2 deficient cells. The correlation between Nedd4-2 
expression and autophagy was further varied in cells overexpressing Nedd4-2. 
Overexpression of Nedd4-2 increased autophagy under both basal condition and nutrient 
starvation condition. These results altogether suggest that Nedd4-2 is a positive regulator of 
autophagy. It may be argued that disruption in the UPS pathway can have a feedback effect 
and activate autophagy. However, deletion of Nedd4-2 suppressed autophagy rather than 
activated it. Therefore, the regulatory effect of Nedd4-2 on autophagy is unlikely to be 
resulted from a feedback response and Nedd4-2 may directly target autophagy pathway. 
However, further research is warranted to examine the mechanism by which Nedd4-2 
regulates autophagy. 
Previous studies from us [299] and others [233] have shown that suppression of autophagy 
can lead to ER stress whereas stimulation of autophagy has opposite effects. In this study it 
was also found that suppression of autophagy by Nedd4-2 knockdown correlated with the 
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elevation in phosphorylated-IRE1 in HEK293 cells. In comparison, activation of autophagy 
by Nedd4-2 overexpression partly protected cells from Tg-induced ER stress. These results 
indicate Nedd4-2 may play a protective role against ER stress, possibly through activation of 
autophagy. Further studies are required to investigate whether the protective effects of Nedd4-
2 on ER stress is dependent on autophagy. 
In summary, this study reported for the first time that E3 ubiquitin ligase Nedd4-2 is 
upregulated by ER stress, like through XPB1. Upregulation of Nedd4-2 may protect against 
ER stress in a negative feedback manner and autophagy may be involved in this process. 
 
Figure 5.7 Proposed mechanism for the upregulation of Nedd4-2 to induce autophagy in 
response to ER stress. In response to ER stress stimuli, XPB1 mRNA undergoes splicing to 
translate the spliced form of XPB1 (sXBP1). sXBP1 then translocates into the nucleus and 
binds to Nedd4-2 promoter to upregulate its expression. The upregulation of Nedd4-2 triggers 
autophagy and may alleviate ER stress, possibly via enhancing the clearance of unfolded 
proteins/protein aggregates. 
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The chapter will summarize the overall findings of the thesis, discuss the limitations of the 
studies and also provide future directions for the investigation of protein degradation 
pathways in hepatic ER stress and insulin resistance. 
 
6.1 MAJOR FINDINGS 
As reviewed in Chapter 1, type 2 diabetes is a serious health issue which is still growing at an 
alarming rate worldwide. While the causes of diabetes are complex, environmental factors 
especially sedentary lifestyle are believed to be fundamental contributors. Overconsumption 
of dietary fat and/or carbohydrate, in combination with reduced exercise, disturbs metabolic 
homeostasis and leads to insulin resistance, which can eventually progress to type 2 diabetes. 
ER stress and Insulin Resistance It is now clear that the etiology of insulin resistance is 
multifactorial. Mechanistically, it has been well established that insulin resistance can result 
from the disruption in insulin signalling in metabolic tissues [24, 311]. Both ectopic lipids and 
ER stress have been suggested to be responsible for the inhibition of insulin signalling. In 
animal models, it has been shown that ER stress is closely associated with ectopic lipids [118, 
119], partly due to the upregulation of lipogenesis by UPR [146, 147]. Chapter 3 
demonstrated that ER stress was only observed in the liver of high-fructose diet-fed mice but 
not in high-fat diet-fed mice, albeit both diets induced hepatic insulin resistance and steatosis. 
These results are consistent with previous report [153] and suggest that the two common 
dietary factors, fat and fructose, may lead to insulin resistance through different mechanisms. 
Additionally, lack of effect in high-fat diet-fed mice indicates ER stress is unlikely to be a 
consequence of ectopic lipids, despite its close association with insulin resistance. Although 
ER stress has been reported to be present in high-fat diet-fed mice after long-term feeding (16 
weeks) [118], it may be induced by other factors (e.g. activation of mTOR) rather than 
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accumulation of lipids per se [312]. On the other hand, in high-fructose diet-fed mice, the 
concurrence of ER stress and upregulation of lipogenesis indicates ER stress may be 
responsible for the disrupted lipid metabolism. The time course study in Section 3.3.4 
differentiated these two events and clearly showed ER stress occurs prior to the upregulation 
of lipogenesis or lipid accumulation. Therefore, it is highly plausible that ER stress triggers 
the lipogenic response during high-fructose diet feeding. These findings are in agreement with 
the reports that ER stress can enhance lipogenesis through the upregulation of key proteins 
such as SREBP-1c, FAS and SCD1 by IRE1-XBP1 pathway [146, 147].  
Defective fatty acid oxidation is another important factor leading to dysregulated lipid 
metabolism; however, previous studies suggest that β-oxidation in mitochondria is unaffected 
during chronic high-fructose diet feeding [153]. More importantly, in acute high-fructose diet 
feeding, UPR activated inflammatory response such as JNK and IKK signalling. The latter in 
turn led to the serine-phosphorylation of IRS1 and blunted insulin signal transduction. These 
events occurred without changes in lipogenic proteins or liver triglyceride levels, suggesting 
an independent role of ER stress in high-fructose diet-induced insulin resistance. However, it 
needs to be acknowledged that the acute feeding regime is not a physiological feeding 
condition. This is because mice were fasted 24 hours before they were fed high-fructose diet 
to ensure their food intake within the short periods. Nonetheless, the conclusions should not 
be compromised as the high-fructose diet-refed mice were compared with properly-controlled 
fasted mice (basal condition), while chow diet-refed mice after fasting did not show such 
changes. This experiment does not exclude the participation of ectopic lipids at basal stage, as 
it is known that fasting can cause lipid mobilisation and fatty acids influx into the liver [313]. 
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To conclude, high-fructose diet induces ER stress, independent of lipid accumulation. ER 
stress precedes lipogenesis during high-fructose diet feeding and dampens insulin signalling 
through activation of inflammatory pathways.  
Autophagy and ER stress Following establishment of the relationship between ER stress and 
insulin resistance, studies in Chapter 4 and Chapter 5 examined the possible mechanisms by 
which high-fructose diet feeding may lead to ER stress. Autophagy and ubiquitin-proteasome 
system are the major cellular machineries responsible for protein clearance. Of the two 
systems, it appears that the role of autophagy in ER stress is better characterised [123, 232]. 
Autophagy is a non-selective process for the bulk degradation of unfolded proteins and 
protein aggregates. At the same time, autophagy also disposes certain polyubiquitinated 
proteins derived from the ubiquitination pathway. It is well reported that autophagy can be 
triggered by ER stress as a cytoprotective mechanism [225, 232]. On the other hand, several 
studies have also found that autophagy was inhibited along with ER stress and obesity [231, 
233, 282] and this inhibition can be causal to ER stress and insulin resistance [233]. For these 
reasons, I hypothesised high-fructose diet inhibits autophagy in the liver, thus leading to ER 
stress and the resultant impairment in insulin signalling. The results in Chapter 4 showed that 
autophagy was indeed suppressed by high-fructose diet feeding, but not by high-fat diet 
feeding, suggesting a close link of autophagy to ER stress. Autophagy can respond to changes 
in nutrients and energy status and this is tightly regulated by mTOR and AMPK [193]. High 
levels of nutrients activate mTOR to suppress autophagy whereas low levels of ATP/AMP 
activate AMPK to induce autophagy [193]. The results from Chapter 4 showed high-fructose 
diet feeding increased the activity of both AMPK and mTOR. Activtion of AMPK can 
stimulate autophagy whereas activation of mTOR can suppress autophagy. Therefore, the 
inhibitory effect on autophagy can only be explained only by activated mTOR. However, it is 
still unknown how fructose stimulates AMPK and mTOR. Dietary fructose has been reported 
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to reduce ATP content in the liver [314] and it is plausible that the potential changes in 
ATP/AMP ratio may lead to AMPK activation. Insulin and amino acids are known to activate 
mTOR [288, 289]. However, in my studies, plasma levels of insulin were not changed after 
high-fructose diet feeding. In addition, the high-fructose diet has comparable protein content 
to that of chow diet and therefore is unlikely to cause a difference in levels of amino acids. 
More importantly, results from incubation of liver explants in the absence of insulin and 
amino acids indicate that fructose may have direct effect on mTOR.  
To investigate the possible role of autophagy in ER stress and ER stress-induced insulin 
resistance, the acute high-fructose diet feeding protocol established in Chapter 3 was 
employed for intervention studies on autophagy. The advantage of this model is that it does 
not involve lipid accumulation, a confounding factor for insulin resistance. Secondly, a short 
period of drug administration in this process can minimize the potential secondary effects and 
influence on food intake. Based on the results from these intervention studies, the hypothesis 
was supported firstly by the effect of rapamycin administration under high-fructose diet 
feeding. Rapamycin abrogated mTOR activation and restored autophagy and this in turn led 
to diminished ER stress and improved insulin signal transduction. Chronic treatment of 
rapamycin has been previously shown to induce insulin resistance [315, 316]. However, this 
effect is not mediated by its inhibition on mTORC1, but on mTORC2, which is an upstream 
regulator of Akt [316]. As mTORC2 is not a major target of rapamycin, the short period of 
treatment (6 hours) in Chapter 4 may not be sufficient to suppress mTORC2 signalling. 
Additionally, the insulin resistance induced by rapamycin was observed in healthy animals 
[315], while in current study, rapamycin was used to counteract ER in high-fructose diet-fed 
mice, which were already insulin resistant. The difference in experimental protocol and 
subjects may explain the divergent effects of rapamycin and the results suggest inhibition of 
mTOR and activation of autophagy can be beneficial to insulin action. As mTOR itself 
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(mTORC1) has been shown to affect ER stress and insulin signalling [291], stimulation of 
autophagy through mTOR-independent mechanisms was accomplished by using resveratrol 
and spermidine. Both drugs have been suggested to induce autophagy through deacetylation 
of autophagy proteins [283]. Again, ameliorated ER stress and enhanced insulin signalling 
were observed after these treatments. Importantly, these effects were achieved without 
reducing mTOR activity.  
In summary, Chapter 4 clearly shows that suppression of autophagy by mTOR contributes to 
high-fructose diet induced ER stress and insulin resistance. Furthermore, restoration of 
autophagy is able to diminish ER stress and partially reverse the metabolic defects. 
Nedd4-2 and ER stress Apart from autophagy, UPS is another important mechanism for 
protein degradation where E3 ubiquitin ligases determine the specificity and destination of 
protein substrates [235]. Studies in Chapter 5 investigated the role of the ubiquitin ligases 
Nedd4/Nedd4-2 in ER stress and possible crosstalk between these ubiquitin ligases and 
autophagy. The initial observation that the protein level of Nedd4-2 was increased in high-
fructose diet-fed mice but not in high-fat diet-fed mice provided the first evidence that Nedd4-
2 expression is associated with ER stress. In agreement with this, when high-fat diet feeding 
was extended to 18 weeks, both ER stress and Nedd4-2 protein level were increased. 
Interestingly, Nedd4 was not changed in any diet group, indicating that the role of E3 
ubiquitin ligases in ER stress is highly specific. Several ubiquitin ligases have been reported 
to be upregulated by ER stress as part of ERAD to promote protein clearance [243-245, 247]. 
It is therefore conceivable to postulate that Nedd4-2 may also be targeted by ER stress. This 
hypothesis was tested in mouse embryonic fibroblasts by using specific ER stress drug 
inducers, namely thapsigargin and tunicamycin. Thapsigargin disrupts ER function through 
depleting ER calcium stores while tunicamycin causes protein unfolding through inhibiting N-
linked glycosylation. The results demonstrated both treatments effectively activated UPR 
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pathways and upregulated Nedd4-2 expression, confirming that upregulation of Nedd4-2 in 
response to ER stress. 
It was noticed that Nedd4-2 upregulation was still apparent after one day of high-fructose diet 
feeding, where only IRE1-XPB1 branch of the UPR was activated. This suggests XBP1 as a 
possible transcriptional factor responsible for the upregulation of Nedd4-2. XBP1 is a multi-
functional protein in UPR to mediate the expression of various target proteins, including the 
chaperone protein Grp78 [303] and the E3 ubiquitin ligase HRD1 [243]. Therefore, XBP1 
was proposed to regulate Nedd4-2 expression. This hypothesis was validated in cells where 
knockdown of XPB1 reduced Nedd4-2 protein level. 
To further understand the functional role of Nedd4-2 in ER stress, overexpression or 
knockdown of Nedd4-2 protein was performed in vitro. The results suggest that Nedd4-2 may 
impose a protective role against ER stress, as Nedd4-2 deficient cells developed more severe 
ER stress compared to control cells after challenged with thapsigargin and tunicamycin. 
Consistent with this, Nedd4-2 overexpression was able to partially reverse ER stress induced 
by these two drugs.  
Ubiquitinated proteins can be degraded through both the proteasome and autophagy. 
Interestingly, it has been reported that proteasome activity may not be affected by ER stress 
[310]. Chapter 4 confirmed the critical role of autophagy in ER stress and the finding is in 
agreement with several earlier studies done by others [123, 226, 231]. Therefore, the effect of 
Nedd4-2 on autophagy was further examined. Interestingly, autophagy induced by 
thapsigargin and tunicamycin was blocked by knockdown of Nedd4-2, suggesting Nedd4-2 is 
essential for autophagy functions. Nedd4-2 deficiency also tended to suppress long-lived 
protein degradation, which is mediated by starvation-induced autophagy. As expected, 
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overexpression of Nedd4-2 activated autophagy and increased autophagic puncta at both basal 
and starvation condition. 
The studies in Chapter 5 found that Nedd4-2 was upregulated by XPB1 in response to ER 
stress. However, this does not exclude the participation of other mechanisms or co-factors. 
Nedd4-2 may exert a protective role against ER stress and activation of autophagy is involved 
in this process. 
 
Figure 6.1 A schematic view of major findings 
As described in Section 1.7, the overall aim of this thesis was to investigate the role of protein 
degradation pathways in ER stress and insulin resistance. This was achieved with the findings 
showing that both autophagy and UPS pathways are altered under high-fructose diet induced 
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ER stress and insulin resistance. Suppression of autophagy by fructose can trigger ER stress 
and associated metabolic defects, whereas the UPS component Nedd4-2 defended cell against 
ER stress, likely through activation of autophagy (Fig. 6.1). 
 
6.2 FUTURE DIRECTIONS 
The studies in this thesis provide new insights into the molecular mechanisms of insulin 
resistance in a context of dietary conditions that are highly relevant to humans.  The high-fat 
diet and high-fructose diet used in animal studies resemble modern human diets, which have 
high content in fat and/or refined carbohydrates [317]. It has to be acknowledged that high 
consumption of HFCS occurs only in certain countries especially in America, but not in 
countries like Australia. However, it is interesting to note that there is a close association 
between the consumption of HFCS (0.3 kg/year per capita vs 24.7 kg/year per capita) and 
obesity (BMI 26.77 kg/m2 vs 27.99 kg/m2) or diabetes (IDF 5.67 vs 10.27) [318]. The amount 
of fructose (35% by calorie) in the diet is moderate compared to other similar studies in 
animals [319, 320]. However, as the awareness of public health grows, the fructose intake 
(even “high fructose intake”) in human is still lower than that has been used in most animal 
studies. It would be interesting to see if the effects from fructose persist when the fructose 
content is reduced to the levels within the range of human diet. 
Current studies in this thesis were set to investigate the mechanisms triggering insulin 
resistance; such that most experiments have been conducted in relatively short periods (2 
hours to 2 weeks). It might appear surprising at the first glance that ER stress, activation of 
inflammation and the resultant inhibition in insulin signalling can occur so rapidly after 
fructose ingestion (6 hours). It could be argued that short-term ER stress is an adaptive 
response aiming to restore ER homeostasis and ER functions. Thus these events need to be 
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examined in prolonged fructose-feeding model in future studies. The observation that ER 
stress preceded lipogenesis is intriguing and also consistent with the view that ER stress 
effector XBP1 mediates the upregulation of hepatic lipogenesis in response to dietary 
carbohydrates [146]. Shulman’s lab has shown that mice with global deletion of XPB1 had 
lower levels of ectopic lipids and were protected against fructose-induced insulin resistance in 
spite of ER stress and JNK activation [274]. Collectively, these results together suggest that 
ER stress may initiate a synergistic response of both lipogenesis and inflammation to inhibit 
insulin signalling. Further characterisation of the contribution from each component at 
different stages of fructose feeding is warranted. In addition, although lipogenesis is not a 
major pathway for lipid accumulation during high fat consumption, yet amelioration of ER 
stress has been reported to reduce steatosis in high-fat diet-fed mice [119]. Further studies in 
prolonged high-fat feeding may help to clarify this discrepancy. 
In Chapter 4, autophagy was found to be suppressed by fructose both in vivo and in vitro. This 
suppression was proposed to be mediated by mTOR, which was stimulated by fructose. One 
key issue to be resolved is the mechanism for the reduction in the protein levels of autophagy 
proteins Atg5 and Atg7 in these experiments. This may be due to the transcriptional inhibition 
and/or post-translational degradation of these two proteins. Future studies can address this 
question by measuring the mRNA expression of these genes. Interestingly, TFEB (a 
transcriptional regulator of autophagy and lysosome) has been shown to be inhibited by 
mTOR via phosphorylation and nucleus exclusion [321]. Therefore, mTOR may also regulate 
autophagy at transcription level to reduce the expression of autophagy-related proteins. It has 
recently been reported that peroxisome proliferator-activated receptor α (PPARα) directly 
binds autophagy gene promoter and activates autophagy. Notably, several reports suggest that 
PPARα activity is repressed by fructose feeding in mice [322, 323]. Future study may need to 
examine whether or not PPARα activity plays a role in fructose-mediated autophagy 
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suppression. At a post-translational level, Calpain 2 protease has been shown to be increased 
in ob/ob mice and suggested to be responsible for the reduction in autophagy proteins [233]. 
Likewise, the possible role of Calpain 2 in high-fructose diet-fed mice may need to be 
considered.  
Besides its role in ER stress, autophagy has been found to directly regulate intracellular lipids 
through the degradation of lipid droplets in the liver (lipophagy) [216]. Genetic ablation of 
Atg7 in the liver leads to ER stress and insulin resistance in chow diet-fed mice [233]. 
Interestingly, increased lipid droplets and higher levels of triglyceride and cholesterol were 
observed in a similar Atg7 knockout model [216]. It is plausible that impaired lipophagy may 
play a constitutive role in hepatic insulin resistance and the effect can be additional to that of 
ER stress. This ER stress-independent role of lipophagy can be examined by stimulating 
autophagy in short-term high-fat diet-fed mice because this model generates insulin resistance 
without the involvement of ER stress. For example, a very recent report has already suggested 
that caffeine stimulates fatty acid oxidation and reduces intracellular lipid content in liver 
through autophagy-lysosome pathway [324]. Another limitation of this thesis is that the 
studies have primarily focused on liver. It is worthwhile to examine autophagy in adipose 
tissue and muscle, in relation to metabolism in these tissues.  
Chapter 5 identified Nedd4-2 as an ER stress responsive ubiquitin ligase. Due to various 
constrictions of resources, it was not feasible to feed the Nedd4-2 heterozygous mice a high-
fructose/high-fat diet, or to challenge the mice with ER stress inducers to assess the response 
to ER stress and consequent changes in metabolic parameters. These possibilities can be 
explored in future studies. Secondly, in cell-based studies, it was initially designed to assess 
insulin signalling and insulin action in HepG2 cells. However, repeated attempts to 
overexpress or knock down Nedd4-2 in this cell line were not successful owing to the low 
transfection efficiency. Although the issue of molecular intervention was solved in HEK293 
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cells and HeLa cells, these cells are poorly equipped with the machinery of insulin signalling 
for the measurement of insulin action. Future studies can utilize more powerful transfection 
systems such as electrophoresis or viral infection to manipulate Nedd4-2 in liver cells such as 
HepG2 cells and primary hepatocytes to examine the ER stress response and insulin signalling. 
As discussed previously (Section 5.4), the effect of ER stress on proteasome activity is 
disputable at present. The fructose feeding model and ER stress cell model established in this 
thesis would be very useful to address this question. If proteasome activity was unaltered, it 
may further strengthen the link between Nedd4-2 and autophagy. The mechanism by which 
Nedd4-2 regulates autophagy warrants further investigation. Based on the results in this thesis, 
Nedd4-2 may act as a novel autophagy adaptor and facilitate autophagic degradation of 
ubiquitinated target proteins. To test this hypothesis, more detailed and sophisticated cell 
biology techniques need to be explored to analyse co-localization of Nedd4-2 and 
autophagosome during starvation or to examine Nedd4-2 in isolated autophagosomes. 
Alternatively, Nedd4-2 may regulate autophagy via affecting its upstream mediators, such as 
TFEB or Beclin. Proteomics can assist to map the changes in protein expression but are not 
easy to verify. 
Recently, it has been shown that Nedd4-2 may regulate intracellular calcium homeostasis by 
targeting calcium release-activated calcium channel protein 1 (Orai 1) for degradation [325]. 
Orai 1 is a calcium channel residing on the plasma membrane. Upon activation, it forms a 
complex with stromal interaction molecule 1 (STIM1) and mediates store-operated calcium 
influx. As both ER stress and autophagy activity are associated with calcium levels, the 
regulatory effect of Nedd4-2 on ER stress and autophagy may be dependent on the 
intracellular/ER calcium status. Preliminary implications can be obtained by the treatment of 
calcium chelators in control and Nedd4-2 deficient cells, such as BAPTA-AM or EGTA.  
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Overall, the studies in this thesis have laid a solid base for further investigation of the 
molecular mechanism of the role of protein degradation pathways in ER stress and associated 
insulin resistance. The results will facilitate our understanding of the pathogenesis of insulin 
resistance and type 2 diabetes. 
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